KOL | Rikard HolmdahlNational and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China | Medical ... |
KOL Resume for Rikard Holmdahl
| Year | |
|---|---|
| 2022 | National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China Medical Inflammation Research, MediCity Research Laboratory, University of Turku, Turku, Finland |
| 2021 | The Second Affiliated Hospital of Xi’an Jiaotong University (Xibei Hospital), Xi’an, China Department Medical Biochemistry and Biophysics, Division Medical Inflammation Research, Karolinska Institute, 171 77 Stockholm, Sweden;, (M.A.);, (X.C.);, (B.X.);, (G.F.L.);, (M.Y.B.);, (Y.H.);, (L.B.) Division of Medical Inflammation Research, Dept. of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden |
| 2020 | Dept. of Medical Inflammation Research, Section of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm Section for Medical Inflammation Research, BMCI11, Lund University, Lund, Sweden National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, 710004 Xi’an, China Karolinska Institutet |
| 2019 | Section for Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solnavägen 9, 171 65, Solna, Sweden Center for Medical Inflammation Research, Southern Medical University, Guangzhou, China R. Holmdahl and C.I. Svensson contributed equally to this paper. |
| 2018 | School of Pharmaceutical Science, Southern Medical University, Guangzhou, China Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden Medicity Research Laboratory, University of Turku, Turku, Finland |
| 2017 | Karolinska Institutet Division of Medical Inflammation Research Stockholm Sweden Center for Medical Immunopharmacology Research, Southern Medical University, 510515 Guangzhou, China. Medicity Research Laboratory, University of Turku, Turku, Finland, . |
Rikard Holmdahl: Influence Statistics
Open the FULL List in Excel
| Concept | World rank |
|---|---|
| oxidative burst disease | #1 |
| act389949 agonist | #1 |
| ifnbeta arthritis | #1 |
| nadph activation | #1 |
| induced arthritis | #1 |
| pia cia13 pia7 | #1 |
| nasal treatment ctbcii | #1 |
| therapeutic c4bp | #1 |
| plasminogendeficient mice arthritis | #1 |
| h2g7 haplotype nod | #1 |
| function targeted deletion | #1 |
| epitopes vivo | #1 |
| anti cii acpa | #1 |
| mem lglutamine | #1 |
| functional selective fpr1 | #1 |
| cia il10 | #1 |
| dth dominant hypersensitivity | #1 |
| arthritis promoting | #1 |
| fibroblast induced arthritis | #1 |
| targeted mutation ncf4 | #1 |
| tlr3 flss | #1 |
| major locus cia | #1 |
| predominant selection | #1 |
| fcγr3 | #1 |
| peptides aq | #1 |
| pia cix | #1 |
| psoriasis spread | #1 |
| potent disease accelerator | #1 |
| valphachain | #1 |
| periodontitis rats pia | #1 |
| pia experimental chromosomes | #1 |
| cia mhc | #1 |
| immunization heterologous peptide | #1 |
| 256 270 | #1 |
| immunization rat cii | #1 |
| anticcp2negative patients | #1 |
| alpha type collagen | #1 |
| glut4dependent glucose transport | #1 |
| encephalomyelitis arthritis | #1 |
| ul1 vivo | #1 |
| headache paradigm | #1 |
| cii induce | #1 |
| b10q b10riii | #1 |
| cia olive oil | #1 |
| comp experimental autoantibodies | #1 |
| loci arthritis | #1 |
| mcii707 | #1 |
| autoantibody formation cia | #1 |
| blocking arthritis | #1 |
| satellite encephalomyelitis | #1 |
| preformed cartilage | #1 |
| congenic mice vdr | #1 |
| position cii256270 | #1 |
| experimental autoantibodies | #1 |
| striking phenotypic similarities | #1 |
| u1 antibodies patients | #1 |
| oxoethyl6h | #1 |
| cii pia | #1 |
| cia opportunities | #1 |
| controlling collagen | #1 |
| arthritis severity rats | #1 |
| rats arthritis | #1 |
| gene ncf1 | #1 |
| immunization heterologous | #1 |
| tolerance induction cii | #1 |
| arthritis control mice | #1 |
| mip ncf4 | #1 |
| arthritis estrogen | #1 |
| lathyritic cii | #1 |
| inconsistent susceptibility | #1 |
| paamcryogel | #1 |
| pristane primed | #1 |
| pinealectomy exposure | #1 |
| lewis rat cia | #1 |
| estrogen immune responses | #1 |
| cells cii | #1 |
| dth antibody response | #1 |
| oestrogen lupus disease | #1 |
| arthritis development severity | #1 |
| ncf1 polymorphisms | #1 |
| cia cii | #1 |
| arthritis independent | #1 |
| polyi arthritis | #1 |
| arthritis amino | #1 |
| adaptive immunity fcγrs | #1 |
| tlr expression synovium | #1 |
| polymorphism ncf1 | #1 |
| chronic arthritis mice | #1 |
| epitopes cb10 fragment | #1 |
| hfdmets | #1 |
| animal models polychondritis | #1 |
| ciispecific antibodies | #1 |
| dba 1j | #1 |
| ncf1 genes | #1 |
| cd4 treatment | #1 |
| anticii response | #1 |
| phosphatase 22 | #1 |
| function acpas | #1 |
| induce arthritis | #1 |
| dba 1jpfp | #1 |
| cells mgps | #1 |
| chronic pristane | #1 |
| cii | #1 |
| liver histone deacetylase | #1 |
| c3hnb mice | #1 |
| arthritis susceptibility mice | #1 |
| cia rat cii | #1 |
| il10 cia | #1 |
| diabetes sialadenitis | #1 |
| day cii immunisation | #1 |
| collagen chains antibody | #1 |
| cia experimental arthritis | #1 |
| cia melatonin | #1 |
| nfr origin | #1 |
| rats cxi | #1 |
| phemagelatin | #1 |
| ifn signature mice | #1 |
| impact etoposide | #1 |
| deficient ncf1 | #1 |
| presence sex hormones | #1 |
| animals arthritis | #1 |
| eae b10riii mice | #1 |
| sialadenitis arthritis | #1 |
| lewis oia | #1 |
| loci eae39 | #1 |
| caia kgf | #1 |
| experimental collagen type | #1 |
| immunologic animals arthritis | #1 |
| dendritic cells collagen | #1 |
| cartilage stability cartilage | #1 |
| partial advanced | #1 |
| ym1 pneumonitis | #1 |
| loci controlling diabetes | #1 |
| susceptible cia | #1 |
| cia21 | #1 |
| h2p susceptibility | #1 |
| pia rats tlr3 | #1 |
| impact topoisomerase antagonist | #1 |
| cia5 region | #1 |
| strong response epitopes | #1 |
| cxi pia | #1 |
| phase arthritis | #1 |
| estrogen physiological doses | #1 |
| antibody cartilage blymphocyte | #1 |
| post‐partum exacerbation | #1 |
| antitype collagen | #1 |
| chronicity arthritis | #1 |
| concentrations mouse cii | #1 |
| cii experimental autoantigens | #1 |
| mabs monoclonal arthritis | #1 |
| pia rats arthritis | #1 |
| response cii | #1 |
| h2p h2q haplotype | #1 |
| ncf1 mice | #1 |
| cell specificity cii | #1 |
| mice arthritis | #1 |
| cxi comp | #1 |
| cia pia | #1 |
| tolerance arthritis susceptibility | #1 |
| superovulation rate | #1 |
| arthritogenic antibody | #1 |
| cb11 fragment | #1 |
| collagen type cii | #1 |
| cholera toxin study | #1 |
| arthritis rat | #1 |
| dominant traits | #1 |
| cartilage explants ciic1 | #1 |
| experimental arthritis autoimmune | #1 |
| aplec locus | #1 |
| hyaluronanreceptor cd44 | #1 |
| effects ciif4 | #1 |
| arthritis anticii abs | #1 |
| models rheumatoid | #1 |
| eae39 control disease | #1 |
| riiis alleles eae2 | #1 |
| oxa nzb mice | #1 |
| cia antibody response | #1 |
| antiidiotypic antibodies cd4 | #1 |
| synovial cells macrophages | #1 |
| frequency igaproducing cells | #1 |
| ros mip | #1 |
| cii disease | #1 |
| arthritis monoclonal | #1 |
| lpscaia | #1 |
| cartilaginous joints | #1 |
| pc4 pc117 | #1 |
| congenic strains rats | #1 |
| strains developed | #1 |
| major cii | #1 |
| collagen immunization | #1 |
| il10 mmc | #1 |
| mab cb268 | #1 |
| autoimmune diseases cnvs | #1 |
| hiit nox2 activity | #1 |
| manifestations lupus disease | #1 |
| disease development effects | #1 |
| anticii antibodies | #1 |
| rats chronic disease | #1 |
| hladrβ10402 | #1 |
| illness cia | #1 |
| cii olive oil | #1 |
| antibodies cii | #1 |
| 4 histone deacetylases | #1 |
| eae2 locus | #1 |
| caia riiis segment | #1 |
| anticardiolipin antibodies p005 | #1 |
| ncf1 mutation | #1 |
| mannan joints | #1 |
| cartilage antibody | #1 |
| cia rat | #1 |
| relapsing arthritis | #1 |
| arthritis toe stiffness | #1 |
| ncf1m1j mice | #1 |
| severe arthritis immunization | #1 |
| rats established pia | #1 |
| chromosome congenic strains | #1 |
| role ncf1 | #1 |
| sialadenitis congenic mice | #1 |
| cxi collagen fibers | #1 |
| arthritis ul1 | #1 |
| ros experimental arthritis | #1 |
| nzw parental | #1 |
| cartilage damage vivo | #1 |
| cia homologous cii | #1 |
| eae39 study | #1 |
| chronic relapsing arthritis | #1 |
| frequency chronic arthritis | #1 |
| induced arthritis rats | #1 |
| caia acute arthritis | #1 |
| mouse chromosome eae39 | #1 |
| arthritis tlr3 | #1 |
| arthritis estrus cycle | #1 |
| mice mutated type | #1 |
| cartilagespecific protein | #1 |
| citrullinated cii | #1 |
| ncf1 lyme arthritis | #1 |
| synthetic peptides cii | #1 |
| dba 1 background | #1 |
| lew ztm ncf1 | #1 |
| cia antigens haplotypes | #1 |
| susceptibility collagen | #1 |
| phytol arthritis | #1 |
| collagen antibodies | #1 |
| col2259 | #1 |
| ros ncf1 | #1 |
| glycosylated epitope structures | #1 |
| rat pia | #1 |
| collagen autoantibody | #1 |
| epitopes cb11 fragment | #1 |
| olive oil cii | #1 |
| lew1w rt1u | #1 |
| nzb dth | #1 |
| bqncf1m1j | #1 |
| c3hq mice cii | #1 |
| ncf1 mutant | #1 |
| cii experimental arthritis | #1 |
| ncf1m1j mice function | #1 |
| eae strains severity | #1 |
| collagen citrullination | #1 |
| cuiiidaligands | #1 |
| murine psoriasis model | #1 |
| act389949 | #1 |
| fab2 ciic1 | #1 |
| cathelicidin expression blood | #1 |
| comp cxi | #1 |
| immunization type | #1 |
| collagen 256 | #1 |
| autoantibodies cartilage | #1 |
| glycoprotein alpha1microglobulin | #1 |
| ll37 rcramp | #1 |
| pristane macrophages | #1 |
| rt1u lew1w | #1 |
| mouse cii reactivity | #1 |
| phenotypes ncf1m1j mice | #1 |
| chemical cartilage | #1 |
| rats pia9 alleles | #1 |
| cia pathogenesis | #1 |
| ciilysdnp | #1 |
| compdeficient mice | #1 |
| pristaneprimed cells | #1 |
| cii treatment | #1 |
| vpba pnipaam | #1 |
| pristaneinduced arthritis pia | #1 |
| dth response mrl | #1 |
| cb268 cii | #1 |
| rat cii | #1 |
| mcaia | #1 |
| leukosialin rats | #1 |
| h2q c3hnb | #1 |
| citrullinated collagen arthritis | #1 |
| developed arthritis | #1 |
| ii‐induced arthritis | #1 |
| rheumatoid disease models | #1 |
| cia ul1 | #1 |
| nrc ova | #1 |
| collagen dendritic cells | #1 |
| congenic fragment | #1 |
| mice anticd4 treatment | #1 |
| daf2cross | #1 |
| naive experimental chromosomes | #1 |
| b10q mice ncf1 | #1 |
| ncf1 gene | #1 |
| animal immunosuppressive agents | #1 |
| mcia1 | #1 |
| macrophages cii degradation | #1 |
| disease c4bp | #1 |
| human gpi protein | #1 |
| development pristaneinduced arthritis | #1 |
| ifnbeta deficiency | #1 |
| rt1bβ | #1 |
| pc8 pc117 | #1 |
| aq molecule | #1 |
| dth nzb | #1 |
| cii 6 | #1 |
| elisagenetyping | #1 |
| β1helix | #1 |
| muscle nox2 | #1 |
| cii citrullinated | #1 |
| effects fab2 | #1 |
| chronic development | #1 |
| suggestive locus chromosome | #1 |
| qtl positional cloning | #1 |
| acpa general population | #1 |
| rat pristaneinduced arthritis | #1 |
| cia b10q | #1 |
| cii cia | #1 |
| ncf1 association | #1 |
| spread psoriasis | #1 |
| arthritis pristane | #1 |
| resistance collageninduced arthritis | #1 |
| rats ncf1 gene | #1 |
| constant light order | #1 |
| spleen pristane injection | #1 |
| psich2nh2 | #1 |
| genetic control pia | #1 |
| nodq locus | #1 |
| estrogen differential outcome | #1 |
| pristane induced | #1 |
| transgenic nadph oxidase | #1 |
| ciispecific | #1 |
| nox2derived ros mice | #1 |
| enhanced autoimmunity | #1 |
| expressions cyp7a1 | #1 |
| arthritis rat strains | #1 |
| cii induced | #1 |
| physiological doses development | #1 |
| existence periodontitis | #1 |
| hladr1transgenic mice | #1 |
| pia11 | #1 |
| reduced oxidative burst | #1 |
| c3hq mice | #1 |
| arthritis monoclonal arthritis | #1 |
| treatment physiological doses | #1 |
| tlr3 tlr3 expression | #1 |
| pathway arthritis | #1 |
| arthritis animals | #1 |
| antibodies consensus motif | #1 |
| rat cii cii | #1 |
| arthritis pepsin | #1 |
| ncf4 | #1 |
| experimental carcinogens | #1 |
| autologous type collagen | #1 |
| 2 months beta | #1 |
| f1 hybrids disease | #1 |
| cells cb11 | #1 |
| pv cd4 cells | #1 |
| signaling characterization | #1 |
| arthritis induced | #1 |
| nox2 complex addition | #1 |
| authors hgpi325339 peptide | #1 |
| arthritis loci | #1 |
| arthritis estrogen treatment | #1 |
| emulsions induction | #1 |
| rheumatoid arthritis autoimmunity | #1 |
| mice cryogels | #1 |
| citrulline collagen | #1 |
| collagen‐induced arthritis | #1 |
| realtime pcr flss | #1 |
| b10qacb | #1 |
| eae2 chromosome | #1 |
| avridine arthritis | #1 |
| caia mutant mice | #1 |
| arthritis autoimmune | #1 |
| tolerance arthritis | #1 |
| function nox2 | #1 |
| cii256 270 | #1 |
| kupffer cells mir144 | #1 |
| rats hfdmets | #1 |
| immunization mouse | #1 |
| c1iii | #1 |
| arthritis animal | #1 |
| human α‐enolase | #1 |
| role eosinophilia | #1 |
| thps cii | #1 |
| glycosylation hla | #1 |
| fecq4 | #1 |
| cells heterologous cii | #1 |
| psa mip | #1 |
| rp autoimmune disease | #1 |
| ros continental ancestry | #1 |
| collagen epitopes | #1 |
| cia ifa | #1 |
| nonglycosylated peptide | #1 |
| cells rat cii | #1 |
| mir144 tlr2 | #1 |
| h‐2q | #1 |
| da1u rats expression | #1 |
| disease susceptibility castration | #1 |
| rat cb11 immunization | #1 |
| backcrosses nzb mice | #1 |
| kgf chondrocytes | #1 |
| m2139 ciic1 | #1 |
| glycopeptide stimulation | #1 |
| emission tomography mannan | #1 |
| spread induced psoriasis | #1 |
| genetic encephalomyelitis autoimmune | #1 |
| mhc cia | #1 |
| mutation ptdins3pbinding site | #1 |
| cartilage‐specific | #1 |
| monoclonal cartilage cattle | #1 |
| aq glycopeptide | #1 |
| arthritis incidence severity | #1 |
| male mice arthritis | #1 |
| peptide agonist fmlf | #1 |
| inability collagen | #1 |
| experimental collagen | #1 |
| protein expression genes | #1 |
| tolerance collagen | #1 |
| nzw parental strain | #1 |
| cd68‐expressing cells | #1 |
| arthritis traits | #1 |
| congenic | #1 |
| heterologous collagen | #1 |
| collagen arthritis progesterone | #1 |
| copy variation ncf1 | #1 |
| collagen arthritis iii | #1 |
| susceptibility collageninduced arthritis | #1 |
| exacerbation arthritis | #1 |
| collagen hybridomas | #1 |
| major role rp | #1 |
| experimental autoimmunity cells | #1 |
| stromal cells osteoclasts | #1 |
| ncf1da | #1 |
| innate‐associated disease | #1 |
| m2139 arthritogenic mab | #1 |
| sensitive wkymvm | #1 |
| autoimmune accelerating | #1 |
| arthritogenicity cells | #1 |
| pristane hexadecane | #1 |
| mhc mbp | #1 |
| cii immunodominant | #1 |
| cii 256 | #1 |
| ros rns inflammation | #1 |
| mice ncf1 | #1 |
| b10q1 | #1 |
| immune priming events | #1 |
| daiu | #1 |
| genetic regions | #1 |
| female preponderance development | #1 |
| ncf1 copy variation | #1 |
| dth nzb mice | #1 |
| ncf1m1j mice ncf1 | #1 |
| genes congenic | #1 |
| specificity ros rns | #1 |
| receptor γ pparγ | #1 |
| galactosylated peptide | #1 |
| 15a11 | #1 |
| ncf4 mice | #1 |
| cii major epitope | #1 |
| cells autologous cii | #1 |
| ides treatment severity | #1 |
| g6pi peptide | #1 |
| ability gut protection | #1 |
| specificity arthritis | #1 |
| upregulation tlr3 | #1 |
| rat cb10 cb11 | #1 |
| cii mouse | #1 |
| ros rheumatoid humans | #1 |
| phytol rna | #1 |
| arthritogenic mabs cii | #1 |
| hla–dr1 | #1 |
| cii256270 | #1 |
| lymphocytes collagen | #1 |
| denidritic cells | #1 |
| injection adjuvant oils | #1 |
| arthritis synovial tlr3 | #1 |
| rabeximod treatment | #1 |
| breeding capacity | #1 |
| homologous type | #1 |
| vivo monoclonal | #1 |
| siliac | #1 |
| genes animal models | #1 |
| role nox2derived ros | #1 |
| protective role cia | #1 |
| dominant hypersensitivity dth | #1 |
| arthritis chronic | #1 |
| c1iii type collagen | #1 |
| pia9 | #1 |
| flss tlr3 expression | #1 |
| psiechch | #1 |
| mab ciif4 ciic1 | #1 |
| ncf4 nox2 complex | #1 |
| t‐cell epitope cii260‐270 | #1 |
| disease genotype immunoglobulin | #1 |
| nss1 | #1 |
| phase cia | #1 |
| rats pristane | #1 |
| cia ros | #1 |
| caia monoclonal | #1 |
| rats antibody cartilage | #1 |
| reproductive performance identification | #1 |
| mice darkness | #1 |
| reactivity cb268 | #1 |
| arthritis cell | #1 |
| arthritis qtl pia7 | #1 |
| cii mhc | #1 |
| cii rheumatoid autoantibodies | #1 |
| rabeximod | #1 |
| models rheumatoid arthritis | #1 |
| minimal glycopeptide core | #1 |
| caia mab | #1 |
| collagen epitope expression | #1 |
| nox2 functionality | #1 |
| illness terpenes | #1 |
| animal genes cia | #1 |
| vridine‐induced arthritis | #1 |
| ethylene isostere | #1 |
| tlr3 expression flss | #1 |
| citrullinated type | #1 |
| cix cartilage | #1 |
| chronic active arthritis | #1 |
| tlr3 upregulation flss | #1 |
| cia2 cia9 | #1 |
| strains polychondritis | #1 |
| fpr1 agonist neutrophils | #1 |
| clec4b | #1 |
| dependent autoimmune | #1 |
| effector phase arthritis | #1 |
| macrophages cii | #1 |
| disease cd8 deficiency | #1 |
| citrullinated variants | #1 |
| mcaia ncf1 | #1 |
| arthritogenic antibodies | #1 |
| spleen cluster | #1 |
| eae2 | #1 |
| lys264 | #1 |
| polychondritis mice | #1 |
| fibroblasts ifnbetadeficient mice | #1 |
| cia13 | #1 |
| defined polymeric adjuvant | #1 |
| vivo monoclonal mouse | #1 |
| cia mip | #1 |
| findings new therapy | #1 |
| pia blocking arthritis | #1 |
| decreasing activation | #1 |
| histology vaccination | #1 |
| cia induced | #1 |
| tlr2 tlr2 regulation | #1 |
| lack arthritis | #1 |
| arthritis | #1 |
| cii acpa | #1 |
| arthritis immunisation | #1 |
| arthritis cia | #1 |
| pia rheumatoid arthritis | #1 |
| mannaninduced | #1 |
| cia mtx | #1 |
| disease collagen | #1 |
| promoter regions antigens | #1 |
| mice functional ncf1 | #1 |
| pregq2 | #1 |
| established arthritis | #1 |
| mbpc5a | #1 |
| rns type collagen | #1 |
| nodp nod | #1 |
| development cia | #1 |
| cia cartilage | #1 |
| sialadenitis strains | #1 |
| cell tolerance cii | #1 |
| ciif4 mab | #1 |
| cii h2p | #1 |
| intracellular processing cii | #1 |
| cii cartilage | #1 |
| qtl chip | #1 |
| chromosome pia | #1 |
| qa2 natural mutations | #1 |
| oestradiol exacerbation | #1 |
| milk titers | #1 |
| cxi chronic arthritis | #1 |
| arthritis collagen | #1 |
| cageeffects | #1 |
| cia21 cia22 | #1 |
| mucosal tolerance cii | #1 |
| mab mab ciic1 | #1 |
| disease affinity | #1 |
| insulitis strains | #1 |
| bb2bb3 | #1 |
| genes ncf1 | #1 |
| j1 epitope | #1 |
| synovium pia rats | #1 |
| arthritis epitopes | #1 |
| cia5 qtl | #1 |
| chromosomes eae loci | #1 |
| placental mhc class | #1 |
| cii cix | #1 |
| cia dominant epitope | #1 |
| caia model | #1 |
| ncf1 mutation mice | #1 |
| wild type ncf1 | #1 |
| immunization rat | #1 |
| pathogenesisis | #1 |
| ciispecific cells | #1 |
| cxi arthritis | #1 |
| collagen reactivity cxi | #1 |
| development humanized models | #1 |
| citrullinated type collagen | #1 |
| mice l012 | #1 |
| hybridomas multispecific antibodies | #1 |
| arthritis intraperitoneal injection | #1 |
| cell‐deficient mice | #1 |
| pia5 | #1 |
| response splenocytes | #1 |
| p47phox mutant | #1 |
| satellite encephalomyelitis autoimmune | #1 |
| pia model rats | #1 |
| tolerance immunodominant | #1 |
| inbred strains severity | #1 |
| aq class | #1 |
| mice interferon gamma | #1 |
| macrophages hladr1transgenic mice | #1 |
| polymorphism autoimmune diseases | #1 |
| arthritis pia | #1 |
| pia cii | #1 |
| sialadenitis incidence | #1 |
| vivo experimental arthritis | #1 |
| ciic1 mab ciif4 | #1 |
| rabeximod inflammatory cells | #1 |
| b10riii | #1 |
| cii259 273 | #1 |
| anticii antibody response | #1 |
| cia recognition | #1 |
| rheumatoid arthritis cia | #1 |
| rats ncf1 | #1 |
| ztmrhd | #1 |
| disease dba 1jpfp | #1 |
| lnchc cholesterol metabolism | #1 |
| c4bp alternative pathway | #1 |
| mhc aq | #1 |
| animal models complexity | #1 |
| ciic1 ciif4 | #1 |
| cii u1 | #1 |
| h2w17 | #1 |
| elimination carbohydrates | #1 |
| pristane cell death | #1 |
| mip cia | #1 |
| mmc transgene | #1 |
| severity pia | #1 |
| cia | #1 |
| contrast nodq | #1 |
| ciif4 cartilage explants | #1 |
| kgf cia | #1 |
| tumor colonization | #1 |
| pia3 pia4 | #1 |
| cii pepsin | #1 |
| oxidative burst inducers | #1 |
| 6 cii | #1 |
| cii ciif4 | #1 |
| hladrbound peptides | #1 |
| nucleotide reactive | #1 |
| ncf1 339 | #1 |
| chondrocytes kgf | #1 |
| cii261 | #1 |
| hyaluronanreceptor | #1 |
| eae mtx | #1 |
| macrophages mannans | #1 |
| increased salt exposure | #1 |
| development oia | #1 |
| cii lewis | #1 |
| adjuvant oils | #1 |
| hg6pi325 | #1 |
| hydrocarbon oil structure | #1 |
| autoimmune arthritis apcs | #1 |
| beta 10b mrl | #1 |
| cia compdeficient mice | #1 |
| rats terpenes | #1 |
| identification genetic regions | #1 |
| cii severe arthritis | #1 |
| immune response mbp | #1 |
| chromosome arthritis severity | #1 |
| cia11 | #1 |
| bond requirements | #1 |
| cii saline | #1 |
| disease transgenic models | #1 |
| chemiluminescent probe l012 | #1 |
| cia13 pia7 | #1 |
| ncf1339 allele | #1 |
| cryogel matrix cells | #1 |
| hg6pi | #1 |
| arthritis castration | #1 |
| chlorophyll component | #1 |
| model rheumatoid arthritis | #1 |
| ciiinduced arthritis | #1 |
| ym1deficient mice | #1 |
| representative swedish | #1 |
| cii260‐270 | #1 |
| lower capacity ros | #1 |
| rats adjuvant oil | #1 |
| immunodominant cii | #1 |
| mhc influence | #1 |
| acute arthritis neutrophils | #1 |
| cia eae39 | #1 |
| therapeutic cleavage | #1 |
| development inflammatory attack | #1 |
| streptococcal endo | #1 |
| pepsin arthritis | #1 |
| immunization heterologous cii | #1 |
| drb10401positive | #1 |
| severity cia | #1 |
| caia induced | #1 |
| cii 256270 peptide | #1 |
| arthritis transfer | #1 |
| ncf1 ros | #1 |
| dba mouse epitopes | #1 |
| disease suggestive locus | #1 |
| glycosylated cii | #1 |
| autoantibody responses cii | #1 |
| functional nox2 complex | #1 |
| induction oia | #1 |
| cii cartilage explants | #1 |
| expression ncf1 | #1 |
| ctbcii | #1 |
| experimental autoantigens | #1 |
| salivary glands antigen | #1 |
| congenic mice genes | #1 |
| h2p h2q | #1 |
| tcell experimental cartilage | #1 |
| nox2 function | #1 |
| ncf1 knockout | #1 |
| recognition lysine | #1 |
| oia induction | #1 |
| oils induce | #1 |
| cia congenic arthritis | #1 |
| cells cia | #1 |
| aq molecules | #1 |
| c57bl strains loci | #1 |
| fumia | #1 |
| type collagen cxi | #1 |
| genetically segregating crosses | #1 |
| b10q mice | #1 |
| rat comp arthritis | #1 |
| presence arthritogenic mabs | #1 |
| cii vaccination | #1 |
| inclusion negative predictive | #1 |
| ifa rats | #1 |
| pc117 extracellular structures | #1 |
| arthritis‐susceptibility loci | #1 |
| caia cia | #1 |
| cb268 | #1 |
| plcpip | #1 |
| cia7 chromosome | #1 |
| ppt medium | #1 |
| haplotype ltab | #1 |
| stages arthritis | #1 |
| pia7 | #1 |
| cd200 btla | #1 |
| mbp c5a | #1 |
| genistein collagen | #1 |
| mice mutated cii | #1 |
| lps caia | #1 |
| anticii abs | #1 |
| humanized models disease | #1 |
| epitopes cii | #1 |
| b10dr4ncf1 mice | #1 |
| disease monitoring rats | #1 |
| b10riii riiis | #1 |
| tlr3 pristane | #1 |
| antibody responses cii | #1 |
| clec4b activation | #1 |
| autoimmune diseases identification | #1 |
| nzb mice trait | #1 |
| lymphocytes cartilage | #1 |
| nodq×b10q | #1 |
| normal cartilage arthritis | #1 |
| dominant hypersensitivity | #1 |
| mice developed | #1 |
| qtl animal genes | #1 |
| cxb10qf2 | #1 |
| human immunopeptidome lung | #1 |
| arthritis arthritis loci | #1 |
| cia caia | #1 |
| pristane stimulation | #1 |
| mediate pulmonary inflammation | #1 |
| mechanism autoimmune | #1 |
| cells mouse cii | #1 |
| double deficiency qa2 | #1 |
| pia3 | #1 |
| phagocyte oxidative burst | #1 |
| compsufficient mice | #1 |
| suppression collagen | #1 |
| lew mol strain | #1 |
| healthy nzw | #1 |
| rheumatoid drug evaluation | #1 |
| hexadecane induce arthritis | #1 |
| re04001activatedfpr1 | #1 |
| cii immunisation | #1 |
| fecq4 locus | #1 |
| oestradiol suppression | #1 |
| treatment cii immunization | #1 |
| pristaneinduced arthritis | #1 |
| nox2derived ros | #1 |
| complex aq molecules | #1 |
| immunospecific reactions | #1 |
| inflammatory phase cia | #1 |
| mannan mice | #1 |
| collageninduced arthritis | #1 |
| rat placenta uterus | #1 |
| cia h2p | #1 |
| cia f1 males | #1 |
| arthritis aim | #1 |
| cii epitopes | #1 |
| transient joint inflammation | #1 |
| melatonin cia | #1 |
| type epitopes | #1 |
| pathogenesis cia | #1 |
| arthritis ides | #1 |
| rats pia | #1 |
| functional ncf1 macrophages | #1 |
| cartilage explants mabs | #1 |
| cii cxi | #1 |
| treatment pia | #1 |
| differential susceptibility cia | #1 |
| mice b10q | #1 |
| inbred strains cia | #1 |
| glycosylated determinant peptides | #1 |
| melatonin release pinealectomy | #1 |
| dr4 glycopeptides | #1 |
| h2p cia | #1 |
| cia tsc transgenic | #1 |
| inflammatory phase arthritis | #1 |
| tlr3 expression fls | #1 |
| arthritis antibody | #1 |
| oestrogen induced | #1 |
| fecq4 fragment | #1 |
| fecq3 | #1 |
| development collagen | #1 |
| rats pristaneinduced arthritis | #1 |
| carcinoma tumors ros | #1 |
| rats comp | #1 |
| periodontitis pristaneinduced arthritis | #1 |
| 237 females | #1 |
| ncf1 polymorphism | #1 |
| mutant p47phox | #1 |
| epitope cartilage | #1 |
| mice h2q | #1 |
| disease glycoproteins | #1 |
| differences ncf1 | #1 |
| major epitopes | #1 |
| polychondritis autoimmune disease | #1 |
| polymorphic fragment | #1 |
| dimethyl6n | #1 |
| spontaneous tissue inflammation | #1 |
| cd43expressing cells | #1 |
| specific cii | #1 |
| ncf1 nos2 | #1 |
| partial advanced intercross | #1 |
| ox8 monoclonal | #1 |
| socalled collagen antibody | #1 |
| caia effects | #1 |
| suppression collagen arthritis | #1 |
| specific antibody protection | #1 |
| incidence arthritis | #1 |
| p47phoxv232 | #1 |
| l012 vivo imaging | #1 |
| peritonitis sod3 | #1 |
| induced arthritis cia | #1 |
| induced relapsing | #1 |
| arthritis pnipaam | #1 |
| ros immunohistochemistry implants | #1 |
| ncf1 mutant mice | #1 |
| animal genetic predisposition | #1 |
| congenic polymorphism | #1 |
| p47phox ncf1 | #1 |
| riiis segment chromosome | #1 |
| mhc‐congenic mouse strains | #1 |
| cii dendritic cells | #1 |
| ciiglycopeptides | #1 |
| rats clec4b | #1 |
| emerging glyco‐based strategies | #1 |
| strains nodq | #1 |
| cia9 | #1 |
| prevents arthritis | #1 |
| transgenic tolerance tlymphocytes | #1 |
| cia collagen | #1 |
| ciispecific monoclonal | #1 |
| mgpi325 | #1 |
| c57bl 10q | #1 |
| animal epitopes injections | #1 |
| chronic intervention | #1 |
| susceptible collagen | #1 |
| pia experimental arthritis | #1 |
| joint proteins | #1 |
| chromosome 17 mhc | #1 |
| dba 1 mouse | #1 |
| c3hnb | #1 |
| 17βestradiolregulation | #1 |
| chromosome caia | #1 |
| data act389949 | #1 |
| b10qnss1 | #1 |
| type collagen cia | #1 |
| topoisomerase antagonist | #1 |
| rt1l haplotypes | #1 |
| downregulating oestradiol | #1 |
| cxi cii | #1 |
| b10dr4ncf1 mice cii | #1 |
| complex cia | #1 |
| psoriasis single locus | #1 |
| ncf1m1j m1j mice | #1 |
| h2r h2q | #1 |
| chronic arthritis development | #1 |
| serum interferon activity | #1 |
| cia12 pia4 | #1 |
| beta 812 | #1 |
| cii260 | #1 |
| model rheumatoid | #1 |
| extraarticular cartilage | #1 |
| b10q dba 1f1 | #1 |
| dth mice trait | #1 |
| arthritis qtl chip | #1 |
| locus cia development | #1 |
| arthritis collagen arthritis | #1 |
| dapia3 | #1 |
| caia experimental arthritis | #1 |
| position ciilysdnp | #1 |
| haplotypes h2q | #1 |
| serum chromosome | #1 |
| carbohydrates cii | #1 |
| animal histocompatibility | #1 |
| human cii cartilage | #1 |
| immunological transmitter | #1 |
| nonglycosylated epitope | #1 |
| position mouse cii | #1 |
| concentrations cii | #1 |
| rat rt1ba genes | #1 |
| rt1ba | #1 |
| ftirm mice | #1 |
| pepsin lewis | #1 |
| arthritis mhc | #1 |
| eae3 chromosome | #1 |
| ciif4 ciic1 | #1 |
| b10qbalb | #1 |
| cii severity | #1 |
| obs electrophoresis | #1 |
| bcell activities | #1 |
| marginal ankylosis | #1 |
| endos hydrolyzed igg | #1 |
| arthritis humans | #1 |
| mrl mice estrogen | #1 |
| acpas specificity | #1 |
| cii epitope | #1 |
| wt ncf1 | #1 |
| tcell congenic arthritis | #1 |
| inbred dba prolactin | #1 |
| h2w3 | #1 |
| region eae2 | #1 |
| congenic cia40 | #1 |
| ncf1 mutated | #1 |
| mab ecm | #1 |
| major epitopes patients | #1 |
| publication animals arthritis | #1 |
| cii recognition | #1 |
| expression liver receptor | #1 |
| arthritis protection | #1 |
| dba 1jpfp cia | #1 |
| methods | #1 |
| reactivity cii | #1 |
| cia rheumatoid arthritis | #1 |
| rat congenic data | #1 |
| cell recognition cii | #1 |
| genes arthritis | #1 |
| cii carbohydrates | #1 |
| new therapy arthritis | #1 |
| autoimmune priming | #1 |
| arthritis ncf1 allele | #1 |
| b10q mice authors | #1 |
| mouse cii | #1 |
| single monoclonal | #1 |
| minor cartilage proteins | #1 |
| arthritis genetics | #1 |
| sialadenitis cell phenotypes | #1 |
| recombinant vaccine inflammation | #1 |
| mhc genetic region | #1 |
| antibodies citrullinated peptide | #1 |
| wo2012127214 | #1 |
| severity arthritis | #1 |
| arthritis driven | #1 |
| cia oestrogen | #1 |
| ifa cii ifa | #1 |
| 1 ncf1 | #1 |
| ncf1mutation | #1 |
| tumor models ncf1 | #1 |
| region eae3 | #1 |
| igg response cii | #1 |
| ccp2 negative | #1 |
| rats rt1f mhc | #1 |
| monoclonal arthritis arthritis | #1 |
| liver contributes hfdmets | #1 |
| new loci controlling | #1 |
| c3bireceptors | #1 |
| autoimmune arthritis activation | #1 |
| features arthritis | #1 |
| animal models acpa | #1 |
| critical restriction site | #1 |
| joint inflammatory phase | #1 |
| eae39 | #1 |
| ftirm cii | #1 |
| functional nox2 | #1 |
| caia cii | #1 |
| cia rheumatoid autoantibodies | #1 |
| collagen arthritis hyaluronanreceptor | #1 |
| regulates severity | #1 |
| cia ul1 mab | #1 |
| mice ros | #1 |
| genes antibodies | #1 |
| polyi pia rats | #1 |
| cii ros | #1 |
| ciic1 antibody | #1 |
| b10q strain | #1 |
| cia swr mouse | #1 |
| daxlewf1 | #1 |
| swr nfr | #1 |
| c3hq | #1 |
| therapeutic cleavage igg | #1 |
| epitope type | #1 |
| cii immunization mice | #1 |
| glycosylation cell recognition | #1 |
| mhv runting neonates | #1 |
| native cii | #1 |
| arthritis injection | #1 |
| driven psoriatic arthritis | #1 |
| cii articular cartilage | #1 |
| peptide characterisation | #1 |
| pparγ cbrh7919 cells | #1 |
| rat comp | #1 |
| anti type | #1 |
| cii arthritis | #1 |
| maintenance arthritis | #1 |
| pepsin cii | #1 |
| scarce clinical samples | #1 |
| arthritis onset severity | #1 |
| locus arthritis | #1 |
| autoimmunogenic hydrocarbon oils | #1 |
| isolated fragment chromosome | #1 |
| cii rat cii | #1 |
| h2q mice | #1 |
| estrogen manifestations | #1 |
| w33t | #1 |
| macrophage ros | #1 |
| h‐2q mice | #1 |
| loci sialadenitis | #1 |
| saline arthritis | #1 |
| b10q | #1 |
| ciic1scfv | #1 |
| sialadenitis nodq | #1 |
| rat type collagen | #1 |
| ros antigens | #1 |
| citrullinated collagen | #1 |
| effects cia | #1 |
| functional ncf1 | #1 |
| cia animal models | #1 |
| cia induced arthritis | #1 |
| cii sera | #1 |
| type cii | #1 |
| congenic strains cia | #1 |
| antibodies pc4 | #1 |
| terpenes toll | #1 |
| oestrogen cia | #1 |
| synovial membranes joints | #1 |
| disease arthritis | #1 |
| pristane tlr3 expression | #1 |
| cells chronic arthritis | #1 |
| inbred dba cii | #1 |
| b10b | #1 |
| skg mutation | #1 |
| mbq mouse macrophages | #1 |
| hufcgammariia | #1 |
| experimental arthritis articular | #1 |
| inflammatory tissue attack | #1 |
| dba 1 | #1 |
| cix disease | #1 |
| cii cells | #1 |
| environments mice | #1 |
| anti comp | #1 |
| b10q h2q | #1 |
| tolerance arthritis protection | #1 |
| peripheral cells alphachains | #1 |
| cia40 | #1 |
| cii259273 peptide | #1 |
| experimental chromosomes | #1 |
| urokinase enzyme | #1 |
| beta haplotype | #1 |
| dapia6 | #1 |
| presence mhv | #1 |
| polymorphism mitochondrial genome | #1 |
| arthritis ncf1 | #1 |
| ncf4 mip | #1 |
| arthritis males | #1 |
| spe acute phase | #1 |
| tlr3 expression tnfα | #1 |
| heterologous cii | #1 |
| rats ncf1 allele | #1 |
| damage type collagen | #1 |
| chronic arthritis rats | #1 |
| cii cross reactivity | #1 |
| genome b10riii | #1 |
| induction phase cia | #1 |
| cii chronic | #1 |
| mice salt intake | #1 |
| rats mhc genes | #1 |
| ros nox2 complex | #1 |
| beta 10b beta | #1 |
| oestrogen treated | #1 |
| b10qc5δ | #1 |
| collagen antibody arthritis | #1 |
| single bout hiit | #1 |
| collagen type‐ii epitope | #1 |
| cells galactosylated peptide | #1 |
| tumors immunosuppressive leukocytes | #1 |
| lewis rats pepsin | #1 |
| ciipeptide | #1 |
| ccp positive patients | #1 |
| injection mannan | #1 |
| development aureus arthritis | #1 |
| day ciispecific cells | #1 |
| patients china cohort | #1 |
| sle‐prone mrl | #1 |
| cii cb fragments | #1 |
| arthritis congenic | #1 |
| cii anticd4 treatment | #1 |
| ncf4 gene | #1 |
| rats congenic arthritis | #1 |
| mabs cii | #1 |
| ala261gly262 | #1 |
| act389949 fpr | #1 |
| cii256−270 | #1 |
| sterically privileged | #1 |
| denatured cii | #1 |
| clec4b ncf1 | #1 |
| citc1iiip | #1 |
| transgenic nadph | #1 |
| mice ncf1m1j mutation | #1 |
| cia22 | #1 |
| arthritis caia | #1 |
| severe arthritis | #1 |
| mice th1 cytokines | #1 |
| kgf treatment onset | #1 |
| ciispecific cell responses | #1 |
| mir144 tlr2 expression | #1 |
| flss polyi | #1 |
| role major epitopes | #1 |
| hfdmets expression | #1 |
| hydrolyzed igg | #1 |
| pc117 | #1 |
| tolerance cia | #1 |
| macrophages autoimmune priming | #1 |
| homologous type pia | #1 |
| position ros production | #1 |
| cia locus | #1 |
| ciic1 m2139 | #1 |
| surface redox levels | #1 |
| ncf1deficient mice | #1 |
| ros autoimmune diseases | #1 |
| tregs ros | #1 |
| genetic variants ncf1 | #1 |
| induction postpartum flare | #1 |
| development chronic arthritis | #1 |
| nod nss1 loci | #1 |
| nod incidence | #1 |
| anticlever1 antibody treatment | #1 |
| arthritis b10q mice | #1 |
| toxin‐1‐producing staphylococci | #1 |
| kgf thymus | #1 |
| cii monoclonal arthritis | #1 |
| cia2 arthritis | #1 |
| rats rt1 | #1 |
| cii response | #1 |
| cia vivo priming | #1 |
| arthritis locus | #1 |
| ncf1m1j | #1 |
| cia development | #1 |
| mice salt concentrations | #1 |
| eae39 locus cia | #1 |
| cii comp | #1 |
| collagen iiinduced arthritis | #1 |
| mumt mice oestrogen | #1 |
| antibody ciic1 | #1 |
| ltabncr3 | #1 |
| type disease | #1 |
| mice deficient ncf1 | #1 |
| dnp epitopes lysine | #1 |
| compia | #1 |
| glycosylated epitope | #1 |
| cartilage collagen type | #1 |
| incidence nod | #1 |
| cartilage explants m2139 | #1 |
| experimental arthritis antibodies | #1 |
| autoantibodies cii | #1 |
| estrogenmediated suppression | #1 |
| bb2bb3 regulation | #1 |
| comp lack | #1 |
| cia comp | #1 |
| active arthritis complex | #1 |
| mhc class injections | #1 |
| arthritis darkness | #1 |
| animal models arthritis | #1 |
| mice burkholderia cepacia | #1 |
| ciif4 cartilage damage | #1 |
| mbq mouse | #1 |
| positional identification | #1 |
| selfcii | #1 |
| ciiinduced | #1 |
| e3xda | #1 |
| cii antigen presentation | #1 |
| established pia disease | #1 |
| rheumatoid arthritis complexity | #1 |
| m1j mice | #1 |
| tlr3 synovium | #1 |
| cii development | #1 |
| da1f | #1 |
| induction cii | #1 |
| f1 males influence | #1 |
| neonatal mortality milk | #1 |
| arthritis mutant strains | #1 |
| severe polyarthritis | #1 |
| ciic1 mabs | #1 |
| homologous type collagen | #1 |
| ul1 ciif4 mab | #1 |
| abetachains | #1 |
| cxi | #1 |
| arthritis multiple | #1 |
| cxi rats | #1 |
| arthritis naive mice | #1 |
| lew avridineinduced arthritis | #1 |
| gia expansion | #1 |
| immunization lathyritic cii | #1 |
| ul1 ciif4 | #1 |
| oxazolone inflammatory response | #1 |
| cii human | #1 |
| fecq3 locus | #1 |
| function single | #1 |
| rheumatoid arthritis cii | #1 |
| dependent autoimmune arthritis | #1 |
| strains b10q | #1 |
| pc4 pc8 | #1 |
| mhc cii | #1 |
| dth dba 1 | #1 |
| immunization mouse cii | #1 |
| phagocytic nox2 complex | #1 |
| new arthritis | #1 |
| autoantibodies collagen | #1 |
| cii peptide molecules | #1 |
| pia3 chromosome | #1 |
| collagen langerhans cells | #1 |
| psicoch2 | #1 |
| restricted role fcγr | #1 |
| snat proteins | #1 |
| g6pi chronic arthritis | #1 |
| innate rats | #1 |
| comp cii | #1 |
| cii heterologous cii | #1 |
| cartilage specific | #1 |
| mutated ncf1 | #1 |
| new arthritis therapy | #1 |
| antibody binding vivo | #1 |
| arthritis mcaia | #1 |
| native comp | #1 |
| confers arthritis susceptibility | #1 |
| epitopes collagen | #1 |
| proteolipoprotein peptide | #1 |
| ciispecific cells day | #1 |
| m1j | #1 |
| cii cell | #1 |
| arthritis b6n mice | #1 |
| region ncf1 | #1 |
| cii specific | #1 |
| arthritis gene regions | #1 |
| cia12 | #1 |
| congenic c57bl mice | #1 |
| cnbr‐fragment | #1 |
| pristaneinduced arthritis rats | #1 |
| rat recombinants | #1 |
| disease lew | #1 |
| nod nss1 | #1 |
| increased incidence cia | #1 |
| arthritogenic mab ciic1 | #1 |
| arthritis tlr3 upregulation | #1 |
| methodspurified | #1 |
| rat cii response | #1 |
| mediating arthritis | #1 |
| cii antibodies | #1 |
| cii h2q | #1 |
| cii immunization | #1 |
| tnfα tlr3 expression | #1 |
| cii histocompatibility complex | #1 |
| greater osteoclasts | #1 |
| molecule aq | #1 |
| nodq nod | #1 |
| administration antibodies hyaluronanreceptor | #1 |
| drb10401 col2259 | #1 |
| rheumatoid collagen | #1 |
| tracheolaryngeal | #1 |
| cxi 6 | #1 |
| pia disease | #1 |
| anticii autoantibodies | #1 |
| swr mice immunization | #1 |
| multiple sclerosis rabeximod | #1 |
| cia animal epitopes | #1 |
| chromosome f1 males | #1 |
| dba1 mice | #1 |
| mice ncf4 | #1 |
| arthritis rheumatoid arthritis | #1 |
| caia gene segments | #1 |
| respiratory burst severity | #1 |
| cells arthritogenicity | #1 |
| cia oia | #1 |
| gergaagiagpk | #1 |
| caia lps | #1 |
| dancf1da rats | #1 |
| cii antibody | #1 |
| celldependent disease | #1 |
| pia model | #1 |
| cxiia | #1 |
| susceptible strain cross | #1 |
| cd2 human cells | #1 |
| ncf1 ptpn22 | #1 |
| idiotype‐specific binding | #1 |
| acpa discriminate | #1 |
| cii caia | #1 |
| arthritismodulating | #1 |
| ncf1 | #1 |
| activation cii | #1 |
| qa2 ncf1 | #1 |
| pregq2 fragment | #1 |
| arthritis encephalomyelitis | #1 |
| cells synthetic glycopeptides | #1 |
| visual signs arthritis | #1 |
| mannan immune | #1 |
| arthritogenic mabs | #1 |
| epitopes arthritis | #1 |
| myeloid effector functions | #1 |
| genetic crossbreeding | #1 |
| mice chronic arthritis | #1 |
| modified glycopeptides | #1 |
| function ncf1 gene | #1 |
| cii vivo | #1 |
| selected anti‐t‐cell | #1 |
| nox2 complex–derived ros | #1 |
| δ228 | #1 |
| inflammation living mice | #1 |
| immunization autologous peptide | #1 |
| 22 variant r620w | #1 |
| cii lewis rats | #1 |
| rats severity | #1 |
| igg1 igg2b isotypes | #1 |
| pepsin immunization | #1 |
| non‐mhc genes | #1 |
| cia31 | #1 |
| cii ncf1 | #1 |
| rheumatoid arthritis immunization | #1 |
| ciid3 | #1 |
| cia chromosome | #1 |
| rheumatoid arthritis eae | #1 |
| tracheolaryngeal cartilage | #1 |
| increase ncf1 | #1 |
| u1 epitope | #1 |
| rat cii arthritis | #1 |
| arthritis rabeximod | #1 |
| insulitis nodq | #1 |
| protective alleles eae2 | #1 |
| ifnbeta experimental arthritis | #1 |
| biodegradation cryogels | #1 |
| tcell hybridomas cells | #1 |
| pia4 chromosome | #1 |
| cell recognition carbohydrates | #1 |
| chemical collagen | #1 |
| pia4 | #1 |
| comp disease monitoring | #1 |
| antibody induced | #1 |
| ncf1 allele | #1 |
| ciif4 adverse effects | #1 |
| loci cia2 | #1 |
| arthritis development cross | #1 |
| models collagen | #1 |
| g6pi acute arthritis | #1 |
| comp arthritis models | #1 |
| congenic fragments | #1 |
| oxidases receptors | #1 |
| proteins gay | #1 |
| severity ides | #1 |
| formation arthritis | #1 |
| ncf1m1j mutation | #1 |
| cii259 | #1 |
| collagens antibody | #1 |
| mice cii epitopes | #1 |
| thymectomy transgenes | #1 |
| eae2 resistant locus | #1 |
| development collageninduced arthritis | #1 |
| antitlr3 antibody | #1 |
| immune cartilage | #1 |
| rats antibody response | #1 |
| csfspecific | #1 |
| congenic polymorphism illness | #1 |
| arthritis incidence | #1 |
| eae2 eae3 | #1 |
| nox2complex | #1 |
| inflammatory arthritis assessment | #1 |
| substrains ztmrhd | #1 |
| immunization cii | #1 |
| 371115tetramethyl2hexadecene1ol | #1 |
| arthritis animal mice | #1 |
| h2q h2r | #1 |
| interacting subloci | #1 |
| ox8 antibodies | #1 |
| b10dr4ncf1 | #1 |
| oestrogen‐induced suppression | #1 |
| engagement fcgammar | #1 |
| antigenic adjuvant | #1 |
| olive oil arthritis | #1 |
| evokes peptide | #1 |
| cix cii | #1 |
| cii triple | #1 |
| elevated th17 cells | #1 |
| protein ncf1m1j mice | #1 |
| adjuvanticity autoimmunity | #1 |
| onset animals arthritis | #1 |
| innate immunity mip | #1 |
| cia caia model | #1 |
| cia molecular basis | #1 |
| animal epitopes | #1 |
| cia21 lymph nodes | #1 |
| cii mabs | #1 |
| h2q haplotype | #1 |
| argltgrpgda | #1 |
| cartilage‐specific antibodiesis | #1 |
| cii rats | #1 |
| ncf1 deficient | #1 |
| cb11 sequence cii | #1 |
| glycosylated cii259 | #1 |
| ym1 alternative activation | #1 |
| type collagens rats | #1 |
| autoimmunity mineral oils | #1 |
| myelomonocytic arthritis interleukin2 | #1 |
| ciipeptide cells | #1 |
| cii swr mice | #1 |
| citrullination cii | #1 |
| qa2 gene clusters | #1 |
| immunisation cells | #1 |
| nodq nod nodp | #1 |
| susceptibility cia | #1 |
| fpr act389949 | #1 |
| collageninduced arthritis loci | #1 |
| ciic1 fab | #1 |
| m1s1a | #1 |
| arthritis immunization | #1 |
| genetic background rats | #1 |
| eae chromosomes | #1 |
| autoimmune response cii | #1 |
| h‐2b | #1 |
| sod3 peritonitis | #1 |
| oxidases polymers | #1 |
| position 264 | #1 |
| major antigenic epitope | #1 |
| idd5 loci | #1 |
| collagen ii‐induced | #1 |
| inbred dba pepsin | #1 |
| maintained pregnancy levels | #1 |
| b10qnfr | #1 |
| ncf1 spread | #1 |
| suppressive development | #1 |
| ros glucose transporter | #1 |
| rfig lambda | #1 |
| arthritis suppression | #1 |
| fcbinding | #1 |
| mice c3h background | #1 |
| ncf1 p47phox | #1 |
| heterologous peptide response | #1 |
| antigen presentation cii | #1 |
| recombinants rt1u | #1 |
| ncf1 ncf1m1j mutation | #1 |
| cia reduction | #1 |
| cia5 cia21 | #1 |
| cells arthritis progression | #1 |
| pia cia | #1 |
| cia cells | #1 |
| autologous cii | #1 |
| alphachains cell surface | #1 |
| heterologous cii cells | #1 |
| congenic arthritis | #1 |
| anti collagen | #1 |
| ecm mab | #1 |
| collagen cxi | #1 |
| deficient neonatal | #1 |
| fls ppt medium | #1 |
| cii polymer | #1 |
| cartilage cii | #1 |
| estrogeninduced suppression | #1 |
| function p47phox | #1 |
| collagen‐induced | #1 |
| cii immunization treatment | #1 |
| day acute arthritis | #1 |
| lpr mice granulocytes | #1 |
| arthritis male | #1 |
| nox2 complex ncf4 | #1 |
| early onset development | #1 |
| cii induced arthritis | #1 |
| presentation cii | #1 |
| bal cells work | #1 |
| tissue attack | #1 |
| plasminogen deficiency cia | #1 |
| peritonitis transgenic | #1 |
| mice cii immunization | #1 |
| nod loci genes | #1 |
| cii matrix protein | #1 |
| cii peptides | #1 |
| controlling onset | #1 |
| vivo imaging l012 | #1 |
| presentation arthritis | #1 |
| arthritis autoantibody | #1 |
| rats rheumatoid | #1 |
| h2p mice cia | #1 |
| oestrogen‐induced | #1 |
| igg2a vivo | #1 |
| rt1f haplotype | #1 |
| disease th1 immunity | #1 |
| antibody response cii | #1 |
| arthritis adjuvants | #1 |
| transgenic mice mhcii | #1 |
| 339 polymorphism | #1 |
| cryogel column antibodies | #1 |
| homologous cii | #1 |
| cia model strains | #1 |
| chronic stage arthritis | #1 |
| arthritis experimental | #1 |
| arthritis development immunisation | #1 |
| rats phytol | #1 |
| congenic arthritis rats | #1 |
| ros adaptive immunity | #1 |
| cii ecm | #1 |
| dominant susceptibility loci | #1 |
| ncf1 mice wt | #1 |
| rats synthetic peptide | #1 |
| arthritis susceptibility rats | #1 |
| ftirm ciic1 | #1 |
| da1u rat liver | #1 |
| etoposide topoisomerase antagonist | #1 |
| cia lysine | #1 |
| phytol molecular pathways | #1 |
| 270 peptide | #1 |
| keratinocytes dth reaction | #1 |
| targeted deletion ncf1 | #1 |
| large numbers hybridomas | #1 |
| nox2 complex | #1 |
| cii256 | #1 |
| cia32 | #1 |
| cii mab | #1 |
| pristane hydrocarbon oils | #1 |
| cells ncf1 | #1 |
| pia2–8 | #1 |
| nox2 agonists | #1 |
| oxa backcrosses | #1 |
| autologous peptide cells | #1 |
| cia experimental autoantibodies | #1 |
| ciiderived | #1 |
| tlr3 rna interference | #1 |
| clever1 type macrophages | #1 |
| injection lewis rat | #1 |
| collagen reactive | #1 |
| collagen cii | #1 |
| established sialadenitis | #1 |
| act389949 fpr2 | #1 |
| concentrations rat cii | #1 |
| chromosome cia | #1 |
| hdac3 pparγ | #1 |
| pia eae | #1 |
| type collagen cii256−270 | #1 |
| rabeximod arthritis | #1 |
| cii responsiveness | #1 |
| cii molecule | #1 |
| comp mabs | #1 |
| anticd4 treatment immunization | #1 |
| clonal expansion arthritis | #1 |
| ncf1 m1j | #1 |
| genetic association ncf1 | #1 |
| cell determinants cii | #1 |
| ciilysdnp mice | #1 |
| ncf1 sle | #1 |
| cells caia | #1 |
| chick cii cii | #1 |
| collagen induced | #1 |
| vivo treatment | #1 |
| pia8 | #1 |
| nephritis nodq | #1 |
| genetic control sialadenitis | #1 |
| oestradiol dth | #1 |
| polymer adjuvant activity | #1 |
| c3hnb h2p | #1 |
| enhanced autoimmunity arthritis | #1 |
| diagnostic accuracy acpa | #1 |
| acute phase arthritis | #1 |
| ncf1 ncf1 mice | #1 |
| cells dba mouse | #1 |
| inflammation caia | #1 |
| humans animals arthritis | #1 |
| rs201802880 | #1 |
| developed severe | #1 |
| 2 nox2 | #1 |
| dominant suppressive | #2 |
| prophylactic treatment linomide | #2 |
| multiple sclerosis maps | #2 |
| lymphocytelike | #2 |
| anticcp2negative presence | #2 |
| nadph oxidase 2 | #2 |
| cii311 | #2 |
| ciif4 | #2 |
| cpg2088 | #2 |
| antibodies cartilage | #2 |
| fibβ36 | #2 |
| circulating medium | #2 |
| disease humanized mice | #2 |
| agonist fpr2 | #2 |
| hladr2dq6 | #2 |
| neuroendocrine profile | #2 |
| fibß62 | #2 |
| granulomas macrophages | #2 |
| monodeoxygenation | #2 |
| species susceptible haplotypes | #2 |
| antibodies fibß62 | #2 |
| antileukoproteinase modulation | #2 |
| autoimmunity autoantibodies | #2 |
| sera rheumatoid arthritis | #2 |
| mitochondria polymorphism | #2 |
| oestrogen pregnancy | #2 |
| c129s mutant disulfide | #2 |
| b10g | #2 |
| rats disease onset | #2 |
| dxeb strain immunization | #2 |
| cia disease | #2 |
| heterologous collagens arthritis | #2 |
| cartilage proteins sera | #2 |
| endoglycosidase treatment | #2 |
| anticii antibody | #2 |
| sialadenitis animals | #2 |
| ncf1 oxidation | #2 |
| increased severity development | #2 |
| snp position | #2 |
| eae protein rna | #2 |
| oestrogen myelin | #2 |
| l10d9 | #2 |
| functional ncf1 variants | #2 |
| dxea strain | #2 |
| l10d9 antibody cartilage | #2 |
| cia monkeys | #2 |
| animal granulomatous disease | #2 |
| immunological requirements | #2 |
| cell tolerance c5a | #2 |
| liver mice rna | #2 |
| disease development presence | #2 |
| sle cgd | #2 |
| fibα580 | #2 |
| arthritogenic | #2 |
| ß62 | #2 |
| arthritogenic capacity | #2 |
| mab cii | #2 |
| rheumatoid binding | #2 |
| h2q response | #2 |
| mice genistein treatment | #2 |
| tregs mph ros | #2 |
| ptpn22 c129s | #2 |
| osteoclastogenesis endogenous dna | #2 |
| redox regulation ptpn22 | #2 |
| cii injection | #2 |
| multiple antibody reactivities | #2 |
| raloxifene estradiol treatment | #2 |
| nadph oxidase elevations | #2 |
| ros peroxide | #2 |
| b10qf1 | #2 |
| ptpn22 ncf1 | #2 |
| citcii311 | #2 |
| pia rats | #2 |
| mice bacterial infections | #2 |
| immunization sch | #2 |
| mbp peptides immunization | #2 |
| das28 24 months | #2 |
| pia rat | #2 |
| sialadenitis mice | #2 |
| arthritis development rats | #2 |
| lymphocytes animals | #2 |
| mhciii | #2 |
| antibody‐mediated arthritis | #2 |
| elastaseinduced emphysema nox2 | #2 |
| wildtype mice macrophages | #2 |
| animal model arthritis | #2 |
| igke | #2 |
| igkeegfp lentivirus | #2 |
| arthritis mice | #2 |
| caia eae | #2 |
| ean6 | #2 |
| igsecretors | #2 |
| disease promoting | #2 |
| tgfbeta spinal cord | #2 |
| symptoms antibodies | #2 |
| ciic1 | #2 |
| oestradiol induction phase | #2 |
| psoriatic disease models | #2 |
| pristane rats | #2 |
| cell dependent | #2 |
| transgenic oxidases zymosan | #2 |
| intrinsic tolerance | #2 |
| mice collagen | #2 |
| adjuvant rats | #2 |
| collagen ii‐induced arthritis | #2 |
| cia anti | #2 |
| nox2 macrophages | #2 |
| oestradiol cia | #2 |
| h12919 | #2 |
| osteoclasts flow cytometry | #2 |
| arthritis g6pi | #2 |
| diseases collagen | #2 |
| transgenic protein processing | #2 |
| cii citrullination | #2 |
| antibody cartilage | #2 |
| citcii | #2 |
| gender rats | #2 |
| tracheolaryngeal cartilage rp | #2 |
| glycopeptides histocompatibility | #2 |
| analyses comp | #2 |
| implanted melanoma | #2 |
| w3 13 | #2 |
| maintenance induced resistance | #2 |
| eae caia | #2 |
| mice susceptible | #2 |
| mhc iii | #2 |
| tlymphocyte arthritis arthritis | #2 |
| 18ffluoromannan | #2 |
| collagen antibody | #2 |
| das28 values p001 | #2 |
| cd19 cells egfp | #2 |
| ala261 | #2 |
| mph ros | #2 |
| chronic autoimmune polyarthritis | #2 |
| sequence analysis indel | #2 |
| re04 | #2 |
| tregs mph | #2 |
| autoimmune membrane proteins | #2 |
| c2ta genetic | #2 |
| i‐a molecule | #2 |
| symptoms anti ccp2 | #2 |
| suggestive locus | #2 |
| early onset severity | #2 |
| cells arthritis | #2 |
| human lung nox2 | #2 |
| cia mechanisms | #2 |
| synovial immune reactions | #2 |
| single nucleotide rats | #2 |
| human animal models | #2 |
| incidence nephritis | #2 |
| murine locus eae2 | #2 |
| cytosolic ros production | #2 |
| epitope glycosylation | #2 |
| vaccination strategy c5a | #2 |
| ptpn22 disulfide | #2 |
| antibody response development | #2 |
| percentage peripheral cells | #2 |
| liver histone | #2 |
| arthritis raloxifene | #2 |
| dxeb | #2 |
| arthritis fb | #2 |
| oxidation increased severity | #2 |
| oxidation c129s | #2 |
| fpr1 agonist | #2 |
| antibodies development | #2 |
| titres ccp2 | #2 |
| ere activation treatment | #2 |
| h2q mice mice | #2 |
| hiit skeletal muscle | #2 |
| arthritogenic challenge | #2 |
| ros source | #2 |
| g6pi arthritis | #2 |
| mycobacteria granulomas | #2 |
| antibodies cep1 | #2 |
| apc naïve cells | #2 |
| tcells recognition | #2 |
| rats da1u | #2 |
| knockout illness | #2 |
| nodq | #2 |
| kinloch | #2 |
| rats polymorphism | #2 |
| acpa reactivities | #2 |
| dancf1da | #2 |
| autoimmune congenic arthritis | #2 |
| salt intake vivo | #2 |
| fpr1 signaling | #2 |
| mhcii experimental arthritis | #2 |
| cii depletion | #2 |
| tolerance cii | #2 |
| ptpn22 protein disulfide | #2 |
| binding cartilage | #2 |
| mbp peptide eae | #2 |
| arthritis ethanol | #2 |
| b10qncf1 mice cia | #2 |
| cxi l10d9 antibody | #2 |
| congenic polychondritis | #2 |
| lack functional nox2 | #2 |
| sle nadph oxidase | #2 |
| matrilin 1 | #2 |
| staphylococcal infections mice | #2 |
| vivo cii | #2 |
| da1u rats | #2 |
| sequences mbp89 | #2 |
| rats da1u rats | #2 |
| citc1359 | #2 |
| iaexpressing cells | #2 |
| c2ta genetic polymorphisms | #2 |
| paws mice | #2 |
| neutrophil fpr2 | #2 |
| skg model | #2 |
| cartilage respiratory | #2 |
| nox2 complex sle | #2 |
| arthritis heterologous cia | #2 |
| microscopic scoring arthritis | #2 |
| oestrogen ean | #2 |
| mhc congenic | #2 |
| chitosanagarosegelatin | #2 |
| animal haplotypes | #2 |
| granulomas cgd mice | #2 |
| type collagen cii | #2 |
| arthritis antibody response | #2 |
| putative vulnerability locus | #2 |
| dxea strain tgfbeta | #2 |
| mrl joints stages | #2 |
| congenic mice autoimmune | #2 |
| castrated mice day | #2 |
| selective fpr1 | #2 |
| exclusive reactivity | #2 |
| antitoxin immunoglobulin | #2 |
| α3xi | #2 |
| hkatpasecontaining vesicles | #2 |
| pnipaam vpba | #2 |
| igke promoter | #2 |
| ccp2 diagnostic accuracy | #2 |
| incidence insulitis | #2 |
| enhanced arthritis | #2 |
| antibody fine | #2 |
| fil307 | #2 |
| arthritis progression | #2 |
| psychosocial stress hpaaxis | #2 |
| myelin ppd | #2 |
| genotypes ovx | #2 |
| disease 111 | #2 |
| glycan activation | #2 |
| anti cii | #2 |
| rt1bb | #2 |
| egfp cd19 cells | #2 |
| shared epitope cxi | #2 |
| das28 acpa reactivities | #2 |
| m2139 | #2 |
| lack ifngamma | #2 |
| 18fbicyclo610nonyne | #2 |
| disease cyclosporin treatment | #2 |
| new immunomodulatory drug | #2 |
| mabs collagen | #2 |
| collageninduced arthritis mice | #2 |
| chain l10d9 antibody | #2 |
| b10qncf1 mice | #2 |
| immunization mbp89 | #2 |
| derived ros | #2 |
| chronic arthritis treatment | #2 |
| igg glycosylation arthritis | #2 |
| genetic regions psoriasis | #2 |
| allelic variant type | #2 |
| chronic relapsing disease | #2 |
| positive anticcp2 test | #2 |
| integrin‐binding‐domain | #2 |
| cms eae | #2 |
| nadph oxidase deficiency | #2 |
| ncf1gene | #2 |
| igkeegfp lentivirus expression | #2 |
| anticd4 treatment | #2 |
| eno5 | #2 |
| cii ciic1 | #2 |
| ability arthritis | #2 |
| immunization mouse collagen | #2 |
| fpr1 neutrophils | #2 |
| mbp89 | #2 |
| ncf1 ean6 | #2 |
| rats utility | #2 |
| rats arthritogenic challenge | #2 |
| macrophages enhances | #2 |
| c1epitope | #2 |
| cia day | #2 |
| antibodies disease onset | #2 |
| antipan | #2 |
| eae dxea strain | #2 |
| influence chromosome | #2 |
| ros granulomas | #2 |
| ncf1 mutants | #2 |
| bmd caia | #2 |
| cd8 cells incidence | #2 |
| mannan induced | #2 |
| clever1 tumor | #2 |
| cartilage respiratory tract | #2 |
| granulomas ros | #2 |
| caia | #2 |
| suppressive oestrogen | #2 |
| epitope‐specific recognition | #2 |
| models autoimmune | #2 |
| lew mol | #2 |
| collagen arthritis cii | #2 |
| galactosyl moiety | #2 |
| induction p47phoxmutated mph | #2 |
| chromosome rats | #2 |
| agonist study | #2 |
| micro dams transgenic | #2 |
| mrl mice stages | #2 |
| caia effector phase | #2 |
| wtc5a | #2 |
| p47phoxmutated | #2 |
| induction cia | #2 |
| alterations neuroendocrine profile | #2 |
| collagen citrullination adhesion | #2 |
| l10d9 antibody | #2 |
| glut4dependent | #2 |
| ros tregs | #2 |
| cia mice mice | #2 |
| arthritogenic mab cii | #2 |
| rp animal ear | #2 |
| c5ay35 | #2 |
| severity collagen | #2 |
| cartilage‐specific autoimmunity | #2 |
| comp titers | #2 |
| autoimmune recognition | #2 |
| macrophagespecific nox2 | #2 |
| fibα563 | #2 |
| development combination | #2 |
| ifngamma spinal cord | #2 |
| conditions igke promoter | #2 |
| macrophagespecific nox2 development | #2 |
| higher levels anas | #2 |
| immunocap isac performance | #2 |
| rats lymphocytes | #2 |
| utility comp | #2 |
| alp monoclonal arthritis | #2 |
| arthritis oia | #2 |
| c57bl 10 background | #2 |
| arthritis gender | #2 |
| anticcp2negative | #2 |
| mbp89 peptides | #2 |
| hydroxyethylene | #2 |
| receptor‐specific manner | #2 |
| toe stiffness | #2 |
| arthritis scoring | #2 |
| cia arthritis | #2 |
| 12 590 | #2 |
| mph induction | #2 |
| rats ifngamma | #2 |
| homologous cia | #2 |
| matrilin cartilage proteins | #2 |
| design glycopeptides | #2 |
| da1u | #2 |
| ides treatment | #2 |
| class immunoenzyme | #2 |
| dr4 cii259 | #2 |
| hiit skeletal | #2 |
| comp cia | #2 |
| citrullinated peptides development | #2 |
| immunosuppressive leukocytes | #2 |
| biologicals 24 months | #2 |
| linomide homologous cia | #2 |
| h2q | #2 |
| fibroblast induced | #2 |
| transgenic osteoporosis oestradiol | #2 |
| pathogenic igg antibodies | #2 |
| 111 vivo treatment | #2 |
| terpenes animals | #2 |
| aetiology2–4 | #2 |
| mog rats | #2 |
| collagen arthritis immunization | #2 |
| eosinophilia arthritis | #2 |
| nox2 neuropathological alterations | #2 |
| mbp 87110 peptide | #2 |
| pristane injection | #2 |
| flow cytometry ovx | #2 |
| experimental cloning | #2 |
| matrilin vivo | #2 |
| altered formation | #2 |
| rno12 | #2 |
| binding sites autoimmune | #2 |
| glycopeptide complexes | #2 |
| lymphoproliferative gene | #2 |
| epitopes rat | #2 |
| arthritis female | #2 |
| oestrogen suppressive | #2 |
| granulocytes alp | #2 |
| l10d9 antibody cxi | #2 |
| cep1 fibß62 | #2 |
| celldependent phase | #2 |
| rats heterologous cii | #2 |
| adjuvant oils arthritis | #2 |
| control subjects samples | #2 |
| cgd mice kynurenine | #2 |
| caia oestradiol | #2 |
| m2139 ciif4 | #2 |
| comp cartilage | #2 |
| cia animals | #2 |
| injection w3 13 | #2 |
| eae cia | #2 |
| raloxifene oestradiol | #2 |
| snecs neutrophils | #2 |
| beta 10b | #2 |
| disease genotype hybridization | #2 |
| ovx ncf1 mice | #2 |
| severity collagen arthritis | #2 |
| arthritis models rats | #2 |
| mog79 | #2 |
| peptides chronic eae | #2 |
| arthritis treatment | #2 |
| igke promoter expression | #2 |
| mabs comp | #2 |
| genetic encephalomyelitis | #2 |
| etoposide serum concentrations | #2 |
| 034positive | #2 |
| c2ta mhcii expression | #2 |
| smash recommendations | #2 |
| neutrophil functions modulation | #2 |
| antileukoproteinase alp | #2 |
| cii species | #3 |
| multiple sclerosis hladr2 | #3 |
| h2p mice | #3 |
| type c2ta | #3 |
| animal glycosylation humans | #3 |
| hdac1 rheumatoid arthritis | #3 |
| acpa subspecificities | #3 |
| eae5 ncf1 | #3 |
| lew1f | #3 |
| disease immunization | #3 |
| hdac1 pathogenesis | #3 |
| arthritis levels | #3 |
| cd4∶cd8 lineage commitment | #3 |
| cep1 filaggrin | #3 |
| presence drb104 | #3 |
| nox2 cgd | #3 |
| c57bl mice illness | #3 |
| ctla4 adult mice | #3 |
| levels fibα591 | #3 |
| arthritis susceptibility | #3 |
| dxea | #3 |
| disease risk subsets | #3 |
| cia strains | #3 |
| induced immunospecific tolerance | #3 |
| fibα573 fibα591 | #3 |
| disease genotype immunity | #3 |
| cii reactive | #3 |
| points acs | #3 |
| autoimmune models | #3 |
| antibodies citrullinated | #3 |
| hladrb104 cochranmantelhaenszel test | #3 |
| fibα591 | #3 |
| apc cia | #3 |
| citrullinated peptides multiplex | #3 |
| subspecificities occurrence | #3 |
| disease height | #3 |
| antigen presentation mhcii | #3 |
| osteoclasts release | #3 |
| lupus nets | #3 |
| minimal adjuvant requirement | #3 |
| ros deficiency | #3 |
| immuniozation | #3 |
| advanced intercross eae5 | #3 |
| allopregnancy | #3 |
| fibβ74 | #3 |
| patients monoclonal chimeric | #3 |
| cvrelated death | #3 |
| ncf4 rs729749 | #3 |
| ifnbetadeficient mice | #3 |
| antibodies vim60 | #3 |
| macrophages involvement | #3 |
| lew ztm | #3 |
| dthreaction | #3 |
| acpa specificities presence | #3 |
| female preponderance | #3 |
| antibodies citc1iii | #3 |
| rats disease | #3 |
| genes disease development | #3 |
| carriers hladrb104 | #3 |
| mca ean | #3 |
| disease anti lymphocyte | #3 |
| disease w3 13 | #3 |
| eae16 | #3 |
| eae5 pia4 | #3 |
| cd8 cells ean | #3 |
| treatment arthritis | #3 |
| hladrb104 mann whitney | #3 |
| species lymphocytes | #3 |
| occurrence subspecificities | #3 |
| mnc salivary glands | #3 |
| fibβ62 81b | #3 |
| citrullinated peptides time | #3 |
| cd4∶cd8 lineage | #3 |
| rs729749 ncf4 | #3 |
| arthritis susceptible | #3 |
| neutrophils eae | #3 |
| immunization addition | #3 |
| glycosylated type | #3 |
| h2qbearing | #3 |
| eae17 chromosome | #3 |
| cia animals arthritis | #3 |
| eae31 | #3 |
| binding aq | #3 |
| c2ta | #3 |
| arthritis effects | #3 |
| cartilage proteins | #3 |
| rheumatoid arthritis complement | #3 |
| acpa titers | #3 |
| rodents6 | #3 |
| h2aalpha | #3 |
| anticollagen antibody | #3 |
| combination acpa | #3 |
| type collagen vivo | #3 |
| arthritis model | #3 |
| anticollagen antibodies | #3 |
| genetic influence susceptibility | #3 |
| processing cii | #3 |
| incidence antinuclear antibodies | #3 |
| development collagen arthritis | #3 |
| cii elisa | #3 |
| disease disease development | #3 |
| arthritogenic mab | #3 |
| ncf1 cldn4 | #3 |
| crossreactive idiotope | #3 |
| loci antibodies | #3 |
| oxidases reactive | #3 |
| oxidase 2 | #3 |
| rt1a tap2 | #3 |
| acpas plasma | #3 |
| ifngammali | #3 |
| rs729749 | #3 |
| eae1 | #3 |
| dce spe | #3 |
| cvrelated death association | #3 |
| isotypes acpas | #3 |
| common mouse model | #3 |
| mmc mice | #3 |
| ciic1 cii | #3 |
| transgenic osteoporosis | #3 |
| keratinocytes langerhans cells | #3 |
| antibodies induce | #3 |
| twins acpas | #3 |
| response immune response | #3 |
| ifngamma neurons | #3 |
| human cii | #3 |
| db1 treatment | #3 |
| early phase disease | #3 |
| spe dce | #3 |
| rats mog | #3 |
| mice environments | #3 |
| reactive idiotope | #3 |
| sialadenitis | #3 |
| antigen monoclonal arthritis | #3 |
| ean mca | #3 |
| aureus arthritis mice | #3 |
| rheumatoid autoimmune | #3 |
| pathogenesis pia | #3 |
| mhc class betachain | #3 |
| acpas twins | #3 |
| mice constant light | #3 |
| bcg ros | #3 |
| vivo control mice | #3 |
| differences citrullinated peptides | #3 |
| acpa combination | #3 |
| major cell epitope | #3 |
| development arthritis | #3 |
| citcii355 | #3 |
| dancf1e3 | #3 |
| eae17 genetic heterogeneity | #3 |
| acpas human serum | #3 |
| anti‐type | #3 |
| hfdmets rats | #3 |
| cvrelated death adjustment | #3 |
| day disease duration | #3 |
| activated cells mice | #3 |
| cbrh7919 cells | #3 |
| twins acpapositive | #3 |
| endogenous ifnbeta | #3 |
| pristane‐induced arthritis | #3 |
| rheumatoid cloning | #3 |
| hydrocarbon oils | #3 |
| development acpas | #3 |
| mice development | #3 |
| natural alleles genes | #3 |
| antibodies specific sets | #3 |
| arthritis resistance | #3 |
| arthritis review | #3 |
| role ros | #3 |
| vim60 | #3 |
| models arthritis | #3 |
| allogeneic pregnancy | #3 |
| experimental arthritis | #3 |
| autoimmunity cartilage | #3 |
| experimental cell | #3 |
| cryogel bioreactor | #3 |
| citc1iii filaggrin | #3 |
| pia6 | #3 |
| cyp7a1 abca1 | #3 |
| antigens keratinocytes | #3 |
| acpas genetic factors | #3 |
| stroke cvrelated death | #3 |
| mice copolymers | #3 |
| inflamed synovial tissues | #3 |
| rheumatoid crosses | #3 |
| 81b | #3 |
| nerve terminallike profiles | #3 |
| ctla4 deletion | #3 |
| eae5r1 | #3 |
| rt11 rats | #3 |
| igl genes | #3 |
| rats rheumatoid arthritis | #3 |
| dnfb ears | #3 |
| swedish patients antibodies | #3 |
| clever1 macrophages | #3 |
| height disease | #3 |
| citc1iii | #3 |
| wildtype mice granulomas | #3 |
| chronic collagen | #3 |
| nadph oxidase complex | #3 |
| pnippam | #3 |
| acpa multiplex | #3 |
| neutrophil cytosolic factor | #3 |
| targeting toll | #3 |
| antigens collagen | #3 |
| fibβ74 onset | #3 |
| fibα573 fibβ74 | #3 |
| db1 treatment day | #3 |
| ifngammali neurons | #3 |
| citrulline inflammation | #3 |
| genotype knowledge | #3 |
| citc1iii fibα573 | #3 |
| complex genetic control | #3 |
| model arthritis | #3 |
| citrullinated cyclic | #3 |
| onset combination | #3 |
| rtlu | #3 |
| total abrogation | #3 |
| subspecificities associations | #3 |
| cystatin cdeficient mice | #3 |
| low production | #3 |
| chromosome eae17 | #3 |
| cells naïve mice | #3 |
| recombination rt1a | #3 |
| restricted role | #3 |
| autoimmunity pia | #3 |
| arthritis animal model | #3 |
| cdk6 padi4 | #3 |
| nox2 pathogenesis | #3 |
| mice rheumatoid | #3 |
| eae17 | #3 |
| fibα573 | #3 |
| cia hdac1 | #3 |
| 95 cvrelated death | #3 |
| fibα591 vim60 | #3 |
| pfp mice | #3 |
| complex autoimmune diseases | #3 |
| arthritogenicity | #3 |
| monoclonal cartilage sections | #3 |
| female immunoenzyme | #3 |
| dual manner | #3 |
| acpapositive twins | #3 |
| pia | #3 |
| arthritis autoimmunity | #3 |
| acpas fine specificities | #3 |
| origin suggestive linkage | #3 |
| class antigens keratinocytes | #3 |
| macroporous gel particles | #3 |
| cytotoxic t‐lymphocyte | #3 |
| disease development contribution | #3 |
| knowledge genetic association | #4 |
| glend2 | #4 |
| parathyroid antibodies | #4 |
| strain eae | #4 |
| krönke | #4 |
| type collagen autoimmunity | #4 |
| antitype collagen antibodies | #4 |
| α1ii chain | #4 |
| ethylene isosteres | #4 |
| autoimmune experimental phenotype | #4 |
| congenic rats rats | #4 |
| epitope collagen | #4 |
| macrophages mycobacteria | #4 |
| mutation ncf1 | #4 |
| pathogenic antibody | #4 |
| strains arthritis | #4 |
| smoking antibodies | #4 |
| mip mice | #4 |
| citrullinated peptides autoantibodies | #4 |
| multispecific antibodies | #4 |
| cia mouse | #4 |
| mhc eae | #4 |
| lxrα pparγ | #4 |
| response arthritis | #4 |
| tsc mice | #4 |
| fcγr regulation | #4 |
| cryogel matrix | #4 |
| estrogen cia | #4 |
| il‐4‐deficient mice | #4 |
| autoimmunity rats | #4 |
| autoimmune mrl | #4 |
| dth reaction | #4 |
| cia6 | #4 |
| elevated th1 | #4 |
| inbred dba peptides | #4 |
| immune response cii | #4 |
| fpr2 recognition | #4 |
| cell response immunization | #4 |
| collagen glycopeptides | #4 |
| acpas serum | #4 |
| arthritis severity | #4 |
| sh3gl1 | #4 |
| pathogenesis histone | #4 |
| mrl b6 | #4 |
| collagen rheumatoid | #4 |
| cii ifa | #4 |
| citrullinated protein antibodies | #4 |
| inpp4b474r 548p | #4 |
| peptide mbp | #4 |
| mice etoposide | #4 |
| cells maternal origin | #4 |
| collagen type | #4 |
| estrogen levels levels | #4 |
| antigen sequence deletion | #4 |
| cells cryogel | #4 |
| fibβ62 | #4 |
| pristane‐induced | #4 |
| interaction monoclonal antibody | #4 |
| experimental genetic | #4 |
| elimination cd8 cells | #4 |
| cyclic software | #4 |
| dth mrl | #4 |
| dead cell remnants | #4 |
| affinity case | #4 |
| lnchc | #4 |
| ox8 | #4 |
| cia lia | #4 |
| rp sle | #4 |
| development sialadenitis | #4 |
| positional cloning genes | #4 |
| cia b10q mice | #4 |
| vav1 rheumatoid arthritis | #4 |
| placental mhc | #4 |
| mp‐lpr | #4 |
| cia suppression | #4 |
| rheumatoid arthritis rats | #4 |
| cii animal epitopes | #4 |
| cellular transfer | #4 |
| antibodies citrullinated peptides | #4 |
| bxsb chromosome | #4 |
| genetic association vav1 | #4 |
| collagen immune | #4 |
| c129s | #4 |
| k8 k8 mice | #4 |
| genistein addition | #4 |
| rs12979659 | #4 |
| experimental cattle cells | #4 |
| arthritis collageninduced arthritis | #4 |
| cii peptide | #4 |
| catabolism kynurenine | #4 |
| dae3 | #4 |
| species regulate | #4 |
| antibody response mog | #4 |
| arthritis mouse | #4 |
| subsets presence | #4 |
| treg cells ctla4 | #4 |
| experimental arthritis humans | #4 |
| cells cryogel column | #4 |
| type collagen arthritis | #4 |
| cytosolic ros | #4 |
| tnfα p38 mapk | #4 |
| onset clinical arthritis | #4 |
| estrus cycling | #4 |
| cb10 fragment | #4 |
| autoantibodies type collagen | #4 |
| endos igg | #4 |
| experimental arthritis cii | #4 |
| anti‐t‐cell | #4 |
| normal mouse igg | #4 |
| congenic c57bl | #4 |
| immunodominant cell | #4 |
| synovial endothelium | #4 |
| arthritis comp | #4 |
| rs682626 | #4 |
| glands sialadenitis | #4 |
| shared autoimmunity | #4 |
| type collagen rat | #4 |
| immunoglobulin deficient | #4 |
| cd4 cells stage | #4 |
| variance animals arthritis | #4 |
| potent immunomodulator | #4 |
| adjuvant oil | #4 |
| diseases rheumatoid | #4 |
| type‐ii collagen | #4 |
| arthritis defined | #4 |
| candidate genes rats | #4 |
| mrl dth | #4 |
| tcell activation development | #4 |
| stages disease development | #4 |
| locus mouse chromosome | #4 |
| cathelicidins ll37 | #4 |
| collagen anti | #5 |
| mrvalues | #5 |
| chick cii | #5 |
| oia | #5 |
| o2• h2o2 nox | #5 |
| pineal gland development | #5 |
| recovery ean | #5 |
| streptococcus pyogenes ides | #5 |
| rats developed | #5 |
| raloxifene disease activity | #5 |
| multiplex analyses | #5 |
| apc cii | #5 |
| c‐glycoside analogue | #5 |
| collageninduced arthritis cia | #5 |
| asparaginelinked glycan | #5 |
| measurement nox activity | #5 |
| aureus arthritis | #5 |
| avridineinduced arthritis | #5 |
| lipidomic remodeling | #5 |
| symptoms rheumatoid arthritis | #5 |
| smoking prior | #5 |
| egfp flow cytometry | #5 |
| exercise hiit | #5 |
| oestradiol vehicle | #5 |
| glycopeptide fragment | #5 |
| cgd mice | #5 |
| epitope cii | #5 |
| cia model | #5 |
| antibodies filaggrin | #5 |
| antileukoproteinase | #5 |
| type collagen cix | #5 |
| cbrh7919 | #5 |
| glycopeptidomimetics | #5 |
| ii‐induced | #5 |
| overexpression hdac3 | #5 |
| citrullinated peptides | #5 |
| cia type collagen | #5 |
| severe sialadenitis | #5 |
| immunization type collagen | #5 |
| nox complex | #5 |
| position type collagen | #5 |
| ros mca | #5 |
| autoimmune disease models | #5 |
| immunization male | #5 |
| monoclonal antibody alpha | #5 |
| commonly model | #5 |
| mice acpa | #5 |
| congenic nod | #5 |
| oxidative radicals | #5 |
| igg endos | #5 |
| glycopeptide | #5 |
| severe arthritis mice | #5 |
| tsst1producing | #5 |
| patients acpa levels | #5 |
| backcrossed | #5 |
| arthritis rats | #5 |
| il4deficient mice | #5 |
| swr mouse | #5 |
| hydroxynorvaline | #5 |
| resistance cia | #5 |
| multiplex array | #5 |
| symptom onset frequency | #5 |
| classical adjuvant | #5 |
| lew1n | #5 |
| field nox | #5 |
| dba mouse | #5 |
| development acpa | #5 |
| tlr3 macrophages | #5 |
| cd8 deficiency | #5 |
| nox o2• h2o2 | #5 |
| painlike behavior | #5 |
| citrullinated peptides ccp | #5 |
| experimental breeding | #5 |
| interaction cartilage | #5 |
| subsets rheumatoid arthritis | #5 |
| chromosome cia7 | #5 |
| tbb infection | #5 |
| dba 1 mice | #5 |
| nox animal models | #5 |
| α10i | #5 |
| osteoclasts stromal cells | #5 |
| multiparous mice | #5 |
| tubule cells kidney | #5 |
| immunized animals controls | #5 |
| autologous type | #5 |
| ly female | #5 |
| tlr3 expression | #5 |
| ros macrophages | #5 |
| arthritogenic cells | #5 |
| tcell mrl | #5 |
| ovalbumin pepsin | #5 |
| rt1eu | #5 |
| immunological involvement | #5 |
| cgd hyperinflammation | #5 |
| beta 11 cells | #5 |
| symptoms development | #5 |
| wellknown role | #5 |
| regulating rat | #5 |
| low dose tolerance | #5 |
| arthritis onset | #5 |
| eae5 | #5 |
| cartilage type | #5 |
| puccetti | #5 |
| higher levels melatonin | #5 |
| tcell hybridomas | #5 |
| delayed immunization rats | #5 |
| absence c5 | #5 |
| uterus cells | #5 |
| b‐cell epitope | #5 |
| lethal inflammatory disorder | #5 |
| biomarkers 2 polyradiculoneuropathy | #5 |
| pathogenesis autoimmune arthritis | #5 |
| metabolic nuclear receptors | #6 |
| l3t4positive cells | #6 |
| collagen cia | #6 |
| collagen cells | #6 |
| mice investigated | #6 |
| cell recognition | #6 |
| arthritis antibodies | #6 |
| heterogeneous stock mice | #6 |
| nox2 mediates | #6 |
| anti ccp2 | #6 |
| k8 mice | #6 |
| rheumatoid arthritis model | #6 |
| acpa specificities | #6 |
| dominant suppression | #6 |
| macrophages mph | #6 |
| cartilage collagens | #6 |
| b10 mouse | #6 |
| data ros | #6 |
| cd4∶cd8 | #6 |
| joints rats | #6 |
| active arthritis | #6 |
| pathogenic events | #6 |
| erosive polyarthritis | #6 |
| c57bl 6 background | #6 |
| acpa anti | #6 |
| rcramp | #6 |
| autoimmunity arthritis | #6 |
| pv loss | #6 |
| igg autoantibodies sera | #6 |
| murine loci | #6 |
| cia26 | #6 |
| disease protective | #6 |
| experimental postmenopausal | #6 |
| contrasting roles | #6 |
| isotypes patients | #6 |
| glycoproteins nadph | #6 |
| glycopeptide specificity | #6 |
| complex mhc | #6 |
| collagen arthritis | #6 |
| knockout receptors igg | #6 |
| loci controlling | #6 |
| tsst1 mice | #6 |
| rheumatoid arthritis collagen | #6 |
| relapsing polychondritis rp | #6 |
| hdac1 class | #6 |
| mhcii alleles | #6 |
| cia cd4 cells | #6 |
| pyramidal neurons loss | #6 |
| cells affinity surface | #6 |
| mrna tgfbeta | #6 |
| recombinant rat interferongamma | #6 |
| arthritis autoantibodies | #6 |
| affinity ligand protein | #6 |
| immunization peptides | #6 |
| mice sialadenitis | #6 |
| pristane squalene | #6 |
| ccp2 positive | #6 |
| lys270 | #6 |
| controls arthritis | #6 |
| ltab | #6 |
| activity neuroinflammation | #6 |
| betaoestradiol | #6 |
| monoclonal encephalomyelitis autoimmune | #6 |
| develop arthritis | #6 |
| staphylococcus aureus arthritis | #6 |
| transgenic mice arthritis | #6 |
| arthritis models | #6 |
| autoimmune experimental genes | #6 |
| animal genetic | #6 |
| rheumatoid arthritis comp | #6 |
| eae mhc | #6 |
| female lymphocyte | #6 |
| mice congenic | #6 |
| peptides arthritis | #6 |
| treatment oestradiol | #6 |
| functional selective | #6 |
| induced psoriasis | #6 |
| nonarthritogenic | #7 |
| protective influences | #7 |
| region syntenic | #7 |
| glycosylated collagen | #7 |
| ean animals | #7 |
| hydrolases polymorphism | #7 |
| impaired induction | #7 |
| autoantibodies lymphocytes | #7 |
| symptoms disease onset | #7 |
| collagen arthritis cia | #7 |
| cii apc | #7 |
| locus chromosome | #7 |
| congenic strains | #7 |
| arthritis strains | #7 |
| mbp peptide | #7 |
| congenic mouse | #7 |
| animal immunization injections | #7 |
| arthritis genes | #7 |
| transgenic class | #7 |
| cia mice | #7 |
| aplec | #7 |
| autoimmune human | #7 |
| autoantibodies citrullinated peptides | #7 |
| 3xi | #7 |
| cii anti | #7 |
| analysis crosses | #7 |
| cryogel column | #7 |
| regulatory cells macrophages | #7 |
| g6pi | #7 |
| mediated vasculitis | #7 |
| periodontitis arthritis | #7 |
| oestrogen rats | #7 |
| snecs | #7 |
| macrophages alternative activation | #7 |
| castrated females | #7 |
| cia5 | #7 |
| mouse collagen | #7 |
| effector phase | #7 |
| yaa gene | #7 |
| ciireactive cells | #7 |
| cab3 | #7 |
| role raloxifene | #7 |
| strains disease | #7 |
| psoriasiform skin disease | #7 |
| rheumatoid arthritis role | #7 |
| chronic experimental | #7 |
| mice constant darkness | #7 |
| autoimmunity collagen | #7 |
| rats phases | #7 |
| isomerase peptide | #7 |
| type collagen | #7 |
| antibodyinduced arthritis | #7 |
| responses cii | #7 |
| collagen arthritis rats | #7 |
| induction arthritis | #7 |
| antigens differentiation arthritis | #7 |
| collagen epitope | #7 |
| response immunization | #7 |
| raassociated molecules | #7 |
| impact cia | #7 |
| cognate activation | #7 |
| conventional environment | #7 |
| chronic phase arthritis | #7 |
| citrullinated peptide antigens | #7 |
| antibodies citrullinated antigens | #7 |
| acpa titres | #7 |
| polychondritis relapsing | #7 |
| arthritis type collagen | #7 |
| murine psoriasis | #7 |
| antigenspecific priming | #8 |
| eae3 | #8 |
| autoimmune congenic mice | #8 |
| haematogenously | #8 |
| fcγr2b | #8 |
| persistent joint pain | #8 |
| mice techniques | #8 |
| autoantibodies subset | #8 |
| rheumatoid chromosome | #8 |
| parathyroid glands receptors | #8 |
| antibody vivo | #8 |
| rats mhc | #8 |
| diseases loci | #8 |
| b10 background | #8 |
| medium mem | #8 |
| rt1f | #8 |
| α1‐microglobulin | #8 |
| t‐cell priming | #8 |
| sialadenitis mrl | #8 |
| hdac3 expression | #8 |
| mbp mog | #8 |
| hladrb11001 | #8 |
| eae genetic encephalomyelitis | #8 |
| mumt mice | #8 |
| 297 cases | #8 |
| induced neuropathology | #8 |
| mice ifnbeta | #8 |
| typeii collagen | #8 |
| hybridomas antibodies | #8 |
| polymeric cryogels | #8 |
| patients type collagen | #8 |
| experimental autoimmune disease | #8 |
| 42 rats | #8 |
| murine locus | #8 |
| autologous peptide | #8 |
| inflamed synovia | #8 |
| ifa cii | #8 |
| experimental binding | #8 |
| heterologous peptide | #8 |
| humans experimental arthritis | #8 |
| cia animal model | #8 |
| expression hdac3 | #8 |
| illness igg | #8 |
| cia2 | #8 |
| lyme arthritis severity | #8 |
| dominant cell epitope | #8 |
| chromosomes loci | #8 |
| supermacroporous cryogel | #8 |
| antibodies acpas | #8 |
| oia2 | #8 |
| ptpn22620w | #8 |
| rheumatoid autoimmunity | #8 |
| treatment monoclonal | #8 |
| destructive effects | #8 |
| clinical signs ean | #8 |
| onset day day | #8 |
| ros interplay | #8 |
| neutrophil cytosolic | #8 |
| arthritis lymphocytes | #8 |
| non‐mhc | #8 |
| hlase alleles | #8 |
| cosphox | #8 |
| oxidized peptides | #8 |
| incidence cia | #8 |
| murinised | #8 |
| autoantibodies collagen type | #8 |
| chronic autoimmune arthritis | #8 |
| onset incidence | #8 |
| underlying genes | #8 |
| experimental genes | #9 |
| experimental arthritis rats | #9 |
| development autoimmune arthritis | #9 |
| arthritis skg mice | #9 |
| avridine | #9 |
| antibody alpha | #9 |
| differentiation autoimmune | #9 |
| collagen complement | #9 |
| oil adjuvants | #9 |
| b10riii mice | #9 |
| bovine cii | #9 |
| collagen female | #9 |
| alpha1inhibitor3 | #9 |
| autoimmunogenic | #9 |
| hgpi325 | #9 |
| effects mabs | #9 |
| specific nox2 | #9 |
| cia transgenic mice | #9 |
| eae immunization | #9 |
| posttranslational glycosylation | #9 |
| hitr | #9 |
| acpas patients | #9 |
| rheumatoid joints | #9 |
| rheumatoid autoantibodies | #9 |
| intranasal animals arthritis | #9 |
| reduced arthritis | #9 |
| specific sets | #9 |
| ean myelin | #9 |
| response mouse | #9 |
| serum interferon | #9 |
| rats rat | #9 |
| human immunopeptidome | #9 |
| 2 nadph | #9 |
| ox19 | #9 |
| early joint erosions | #9 |
| adaptive inflammation | #9 |
| mouse peptide | #9 |
| inbred lew tlymphocytes | #9 |
| animal models urgent | #9 |
| psychological tyrosine | #9 |
| oligomeric matrix | #9 |
| arthritis cross | #9 |
| variants acpa | #9 |
| bound carbohydrates | #9 |
| mammalian disease models | #9 |
| class allele | #9 |
| acpas | #9 |
| antibodies vivo | #9 |
| pristane | #9 |
| induced metabolic syndrome | #9 |
| histone 1 hdac1 | #9 |
| inbred dba mice | #9 |
| loci rats | #9 |
| illness receptor | #9 |
| nodp | #9 |
| il10 role | #9 |
| disease strains | #9 |
| murine collagen | #9 |
| rt1u | #9 |
| patients acpas | #9 |
| idiotype‐specific | #9 |
| postmenopausal arthritis | #9 |
| reactivity acpas | #10 |
| axotomized motor neurons | #10 |
| pain animal models | #10 |
| o2• h2o2 | #10 |
| inbred dba | #10 |
| rheumatoid arthritis dr4 | #10 |
| mice genistein | #10 |
| tertbutylacrylamide | #10 |
| native collagen type | #10 |
| genetic experiments | #10 |
| endogenous collagen | #10 |
| monoclonal arthritis | #10 |
| severe erosive | #10 |
| cartilage oligomeric | #10 |
| activation male | #10 |
| nih heterogeneous stock | #10 |
| prl effects | #10 |
| immunization rats | #10 |
| monoclonal antigens rats | #10 |
| rats lewis rats | #10 |
| cells increased production | #10 |
| stock mice | #10 |
| mice cii | #10 |
| acpa diagnosis | #10 |
| cells development | #10 |
| development severity | #10 |
| animal models | #10 |
| knockout nadph | #10 |
| presence acpa | #10 |
| experimental cartilage | #10 |
| antibodies specific | #10 |
| hlase smoking | #10 |
| cartilage arthritis | #10 |
| beta 11 | #10 |
| acutephase response rats | #10 |
| extracellular cartilage | #10 |
| mutated mice | #10 |
| dense fractions | #10 |
| mbp peptides | #10 |
| abp gene | #10 |
| cii mice | #10 |
| oestrogen | #10 |
| cartilage collagen fibrils | #10 |
| mice nadph | #10 |
| alpha collagen chains | #10 |
| ifnbeta mice | #10 |
| cd4 cells spleen | #10 |
| onset chromosome | #10 |
| collagen autoimmunity | #10 |
| h2ap | #10 |
| passive transfer experiments | #10 |
| autoimmune disease humans | #10 |
| citrullinated antigen | #10 |
| cell‐deficient | #10 |
| antibody collagen | #10 |
| chronic arthritis | #11 |
| antigen variability | #11 |
| dss wt | #11 |
| stromal cells macrophages | #11 |
| cia7 | #11 |
| cells pia | #11 |
| 2xi | #11 |
| 84–102 | #11 |
| antibodies association | #11 |
| potential autoantigens | #11 |
| loci regulating | #11 |
| rat collagen | #11 |
| ptpn22 smoking | #11 |
| chondrocytes ecm | #11 |
| rat arthritis | #11 |
| mhc control | #11 |
| species respiratory | #11 |
| mice cd1 | #11 |
| naïve cells cells | #11 |
| nodb10h2b mice | #11 |
| inflammatory arthritis role | #11 |
| isotypes | #11 |
| antibody type collagen | #11 |
| rat liver rats | #11 |
| individuals onset | #11 |
| tailbase | #11 |
| cia30 | #11 |
| gad6 | #11 |
| lentiviral vector expression | #11 |
| arthritis absence | #11 |
| fragments anti | #11 |
| liver receptor lxrα | #11 |
| monoclonal rheumatoid factors | #11 |
| mice mhc | #11 |
| development rheumatoid | #11 |
| mutated mouse | #12 |
| associations antibodies | #12 |
| role arthritis | #12 |
| antibodies structures | #12 |
| type collagen immunization | #12 |
| α1ii | #12 |
| psoriasis arthritis | #12 |
| bovine type collagen | #12 |
| natural loss | #12 |
| animal immunohistochemistry | #12 |
| cross rats | #12 |
| immunodominant | #12 |
| fpr2 agonists | #12 |
| autoimmune monoclonal antigens | #12 |
| mutation nadph | #12 |
| rats cia | #12 |
| myelin ean | #12 |
| chronic erosive arthritis | #12 |
| structure antibodies | #12 |
| riiis | #12 |
| major haplotype | #12 |
| icmediated | #12 |
| natural polymorphism | #12 |
| treatment experimental arthritis | #12 |
| study arthritis | #12 |
| onset symptoms | #12 |
| frequencies antibodies | #12 |
| reduces severity | #12 |
| pia1 | #12 |
| rats expression | #12 |
| encephalomyelitis induced | #12 |
| serum concentrations comp | #12 |
| stages pathogenesis | #12 |
| loci disease | #12 |
| stage cia | #12 |
| increased litter size | #12 |
| matrilin | #12 |
| peptide study | #12 |
| illness sex characteristics | #12 |
| lung macrophages mice | #12 |
| backgroundantibodies | #12 |
| cii patients | #12 |
| psoriasis mouse model | #12 |
| qa2 | #12 |
| nonselfdiscrimination | #12 |
| mbp response | #12 |
| genetic contamination | #12 |
| lymphoid cells development | #12 |
| hydroxylysines | #12 |
| cell responses cii | #12 |
| mice comp | #12 |
| levels nabs | #13 |
| arthritis knowledge | #13 |
| anticii | #13 |
| hladrb1 ptpn22 | #13 |
| rfigg | #13 |
| idd5 | #13 |
| l012 | #13 |
| factor isotypes | #13 |
| cyclic citrullinated | #13 |
| citrullinated | #13 |
| macroscopic scoring | #13 |
| dr1 transgenic | #13 |
| strains incidence | #13 |
| mannan | #13 |
| ccp2 antibodies | #13 |
| nos2derived | #13 |
| species deficiency | #13 |
| development type collagen | #13 |
| mouse strains | #13 |
| cell epitope | #13 |
| bcelldeficient mice | #13 |
| native type collagen | #13 |
| sequence collagen | #13 |
| b10p | #13 |
| t‐cell epitope | #13 |
| behavioral alterations rats | #13 |
| expression egfp | #13 |
| genes mouse chromosome | #13 |
| nonobese diabetic mouse | #13 |
| antibodies citrullinated proteins | #13 |
| major loci | #13 |
| dba molecular | #13 |
| complement complement activation | #13 |
| mtec aire | #13 |
| 24dinitro1fluorobenzene | #13 |
| cells salivary glands | #13 |
| epitope immunization | #13 |
| immunohistochemistry interferon | #13 |
| oxidative regulation | #13 |
| oxidase nox2 | #13 |
| ho4 | #13 |
| μ chain | #13 |
| lew1w | #13 |
| multispecific | #13 |
| doses ici | #13 |
| advanced intercross | #13 |
| joints blood | #13 |
| collagen comp | #14 |
| aggregated nets | #14 |
| protein collagen | #14 |
| b6n mice | #14 |
| thr233 | #14 |
| nasal inhalation | #14 |
| blymphocyte female humans | #14 |
| specific inflammation | #14 |
| arthritic paws | #14 |
| antifilaggrin antibodies | #14 |
| arlacel | #14 |
| sirt1 mmp9 | #14 |
| gut protection | #14 |
| mhc class region | #14 |
| molecular disease models | #14 |
| presence mcv | #14 |
| deficient production | #14 |
| cia expression | #14 |
| collagen disease | #14 |
| humans nadph | #14 |
| involvement cells | #14 |
| macrophages immune response | #14 |
| experimental interferon | #14 |
| smallmolecule compound | #14 |
| loci rheumatoid | #14 |
| candidate autoantigens | #14 |
| immune regulators | #14 |
| peptides anti | #14 |
| efficient promotion | #14 |
| loci interaction | #14 |
| autoimmune arthritis | #14 |
| osteoclasts vivo | #14 |
| autoimmunity animals | #14 |
| murine collageninduced arthritis | #14 |
| immunized rat | #14 |
| treatment cia | #15 |
| monoclonal arthritis rats | #15 |
| apcs macrophages | #15 |
| ros cii | #15 |
| exaggerates | #15 |
| neuritis rats | #15 |
| 2 weight | #15 |
| murine cia | #15 |
| dcii | #15 |
| rheumatoid arthritis presence | #15 |
| type collagen development | #15 |
| rat genetics | #15 |
| cdr regions | #15 |
| raloxifene estradiol | #15 |
| immune complex formation | #15 |
| congenic rats | #15 |
| osteoporosis development | #15 |
| anticollagen | #15 |
| antibodies arthritis | #15 |
| rats monoclonal antigens | #15 |
| tflask | #15 |
| rt1a | #15 |
| regulation adaptive immunity | #15 |
| nodb10h2b | #15 |
| integrated bioprocess | #15 |
| mhc class molecule | #15 |
| aire mtec | #15 |
| mice immunization | #15 |
| antigenic epitope | #15 |
| translationally modified | #15 |
| experimental allergic neuritis | #15 |
| monolithic cryogel | #15 |
| citrullinated peptides patients | #15 |
| lentiviral gene delivery | #15 |
| amps development | #15 |
| mice type collagen | #15 |
| arthritis role | #15 |
| cultured human chondrocytes | #15 |
| involvement pathogenesis | #15 |
| presence anticarp antibodies | #15 |
| polychondritis | #15 |
| arthritis development | #15 |
| cep1 | #16 |
| hla–drb1 shared epitope | #16 |
| mumt | #16 |
| congenic mice mice | #16 |
| class transplantation | #16 |
| arthritis severity mice | #16 |
| rt1 | #16 |
| disease mice mice | #16 |
| mhc genes | #16 |
| lethal inflammatory | #16 |
| nonglycosylated form | #16 |
| oligomeric matrix protein | #16 |
| rheumatoid arthritis genes | #16 |
| rats experimental arthritis | #16 |
| lew1 | #16 |
| rno10 | #16 |
| anti‐t | #16 |
| males onset | #16 |
| arthritis cii | #16 |
| levels natural antibodies | #16 |
| genes animals | #16 |
| mhcii ciita | #16 |
| epitopes mice mice | #16 |
| h2p | #16 |
| matrilin proteins | #16 |
| subspecificities | #16 |
| staphylococcal arthritis | #16 |
| fewer osteoclasts | #16 |
| autologous collagen | #16 |
| pparγ lxrα | #16 |
| indirect genetic predisposition | #16 |
| acute inflammation mice | #16 |
| development rheumatoid arthritis | #16 |
| n305 | #16 |
| rheumatoid factor production | #16 |
| antinuclear autoimmunity | #16 |
| spleen peyers patches | #17 |
| ethanol development | #17 |
| periodontitis antibodies | #17 |
| cab4 | #17 |
| inbred lew | #17 |
| genistein mice | #17 |
| cells collagen | #17 |
| arthritis rheumatoid autoantibodies | #17 |
| triplehelical conformation | #17 |
| collagen specific | #17 |
| onset rheumatoid arthritis | #17 |
| cartilage collagen | #17 |
| collagen induced arthritis | #17 |
| mice rheumatoid arthritis | #17 |
| progesterone development | #17 |
| cells presenting cells | #17 |
| rheumatoid arthritis subsets | #17 |
| strains lymphocytes | #17 |
| leuphe | #17 |
| human fcγriia | #17 |
| nox2 derived | #17 |
| polyphosphate4 | #17 |
| animals congenic | #17 |
| skg | #17 |
| rats lewis | #17 |
| cells female mice | #17 |
| rt1av1 | #17 |
| native denatured | #17 |
| allergic neuritis | #17 |
| clever1 | #17 |
| defined epitope | #18 |
| expression lxrα | #18 |
| humanized transgenic mice | #18 |
| h2z | #18 |
| ros data | #18 |
| keratinocytes induction | #18 |
| genes spleen | #18 |
| collagen autoantibodies | #18 |
| arthritis anti | #18 |
| cartilage type collagen | #18 |
| short‐term administration | #18 |
| autoimmune illness | #18 |
| day immunization | #18 |
| adjuvant arthritis rats | #18 |
| phenotypic feature | #18 |
| purified anti | #18 |
| joint inflammatory | #18 |
| hybridomas mice mice | #18 |
| ealkene | #18 |
| day arthritis | #18 |
| langerhans cells cells | #18 |
| galactose moiety | #18 |
| cuiiida | #18 |
| moginduced eae | #18 |
| dra0101 | #18 |
| anti cd44 | #18 |
| salivary glands mice | #18 |
| addition ros | #18 |
| disease duration onset | #18 |
| mice develop | #19 |
| citrullinated proteins acpa | #19 |
| future utility | #19 |
| mrl mp mice | #19 |
| mice congenic mice | #19 |
| inflammatory attack | #19 |
| patients polychondritis | #19 |
| gly262 | #19 |
| protective alleles | #19 |
| tbetarii gene | #19 |
| peyers patches spleen | #19 |
| new avenues | #19 |
| trimolecular complex | #19 |
| blood monocytes neutrophils | #19 |
| suppression dth | #19 |
| rats snp | #19 |
| cia eae | #19 |
| castrated female rats | #19 |
| protein comp | #19 |
| supermacroporous | #19 |
| single intradermal injection | #19 |
| beta oestradiol | #19 |
| elisa cia | #19 |
| collagen response | #19 |
| vivo elimination | #19 |
| three‐dimensional culture | #19 |
| cd4 transgenic | #19 |
| glycosylated | #20 |
| pvg1av1 | #20 |
| 5p14 | #20 |
| loci chromosomes | #20 |
| enhanced tcr | #20 |
| matrilin1 | #20 |
| ncr3 | #20 |
| mhc class alleles | #20 |
| nox1deficient mice | #20 |
| response mbp | #20 |
| monkeys rodents | #20 |
| mice cia | #20 |
| imaging reactive | #20 |
| rt1d | #20 |
| ciita mhcii | #20 |
| human rheumatoid arthritis | #20 |
| antibody treatment | #20 |
| littermate | #20 |
| prominent infiltration | #20 |
| 5r5 | #20 |
| development disease | #20 |
| serm raloxifene | #20 |
| fls tnfα | #20 |
| progesterone oestrogen | #20 |
| experimental autoimmunity | #20 |
| role nox | #20 |
| underlying gene | #20 |
| knockout mice transgenic | #20 |
| highly susceptible | #20 |
| stress phospholipids | #20 |
| mbp rats | #20 |
| inflammation mice | #20 |
| triplehelical peptides | #21 |
| experimental rheumatoid | #21 |
| arthritis pregnancy | #21 |
| muscle ros | #21 |
| nitratenitriteno pathway | #21 |
| individual acpa | #21 |
| cells adaptive immune | #21 |
| n141 | #21 |
| granule mobilization | #21 |
| nox2 activity | #21 |
| linomide treatment | #21 |
| conserved haplotype | #21 |
| igg fcgammar | #21 |
| diseases lymphocytes | #21 |
| positional cloning | #21 |
| illness autoimmune | #21 |
| onset severity | #21 |
| rats development | #21 |
| cia treatment | #21 |
| drb11001 | #21 |
| mice mutant strains | #21 |
| serum levels comp | #21 |
| pathogenesis rheumatoid | #21 |
| olahsd | #21 |
| ean rats | #21 |
| n286 | #21 |
| genes controlling | #21 |
| suppressor cytotoxic cells | #21 |
| chronic relapsing | #21 |
| nox2 mice | #21 |
| α1acidglycoprotein | #21 |
| supermacroporous cryogels | #21 |
| mice independent | #22 |
| antiidiotypic antibody | #22 |
| rats loss | #22 |
| ccp negative | #22 |
| association pv | #22 |
| response myelin | #22 |
| cultured hepatic cells | #22 |
| 81a | #22 |
| c57bl mice subfamily | #22 |
| identification susceptibility genes | #22 |
| ul1 | #22 |
| samples onset | #22 |
| 270 | #22 |
| induced eae | #22 |
| experimental phenotype | #22 |
| vh j558 | #22 |
| rats nonalcoholic steatohepatitis | #22 |
| determinant selection | #22 |
| animal epitopes humans | #22 |
| semiallogenic | #22 |
| peptide activation | #23 |
| citrullinated antigens | #23 |
| tgfbeta resistance | #23 |
| inflammation absence | #23 |
| anti‐cd5 | #23 |
| monoclonal antigens autoimmune | #23 |
| cells presentation | #23 |
| onset cia | #23 |
| loss collagen | #23 |
| phage clones | #23 |
| arthritis type | #23 |
| mace association | #23 |
| mbp eae | #23 |
| b10r | #23 |
| 4npa | #23 |
| cells b10 | #23 |
| experimental chromatography | #23 |
| animal genes | #23 |
| immunopeptides | #23 |
| citrullinated protein | #23 |
| experimental autoimmune diseases | #23 |
| antibodies acpa | #23 |
| complex influences | #23 |
| rats inbred lew | #23 |
| comp | #23 |
| castration rats | #23 |
| diseases autoimmunity | #23 |
| cryogel beads | #23 |
| citrullinated epitopes | #23 |
| 17 betaoestradiol | #23 |
| lymphocytes amino | #23 |
| experimental lupus | #24 |
| animal epistasis | #24 |
| severity chronicity | #24 |
| experimental cells | #24 |
| postpartum flare | #24 |
| 339 | #24 |
| controls anti | #24 |
| y35 | #24 |
| secondary immune response | #24 |
| new mouse | #24 |
| mice nox2 | #24 |
| antinuclear apoptosis | #24 |
| flss patients | #24 |
| autoantibodies rheumatoid | #24 |
| levels comp | #24 |
| severity ali | #24 |
| ftirm | #24 |
| inflammation arthritis | #24 |
| chronic autoimmune diseases | #24 |
| monoclonal anti | #24 |
| rat induction | #24 |
| cells c3h | #24 |
| mediated arthritis | #24 |
| c57bl 10 mice | #24 |
| loci chromosome | #24 |
| mouse models development | #24 |
| subloci | #24 |
| autoimmune messenger | #25 |
| interleukin2 mice receptors | #25 |
| complex male | #25 |
| autoantibody response | #25 |
| proteinarginine deiminase type | #25 |
| murine lyme arthritis | #25 |
| massive infiltration | #25 |
| common autoimmune disease | #25 |
| beta lymphocytes | #25 |
| relapsing polychondritis | #25 |
| tolerized rats | #25 |
| arthritis experimental arthritis | #25 |
| specific epitopes | #25 |
| immunodominant epitope | #25 |
| cells immunization | #25 |
| arginine arthritis | #25 |
| parasitemia survival | #25 |
| rno4 | #25 |
| collagen cartilage | #25 |
| rat mhc | #25 |
| cell hybridomas | #25 |
| production monoclonal | #25 |
| bnda | #25 |
| congenic animals | #25 |
| monocytes nadph | #25 |
| ros | #25 |
| inbred lew rats | #25 |
| immunization development | #25 |
| 8 antibodies | #25 |
| cix | #25 |
| autoimmune diseases humans | #25 |
| b6 balb | #25 |
| eae development | #26 |
| mice gammadelta cells | #26 |
| helperinducer animals antibodies | #26 |
| polychondritis rp | #26 |
| granulocytes cells | #26 |
| igg2a mice | #26 |
| hydrocarbon oil | #26 |
| post translationally | #26 |
| cb11 | #26 |
| glutamax | #26 |
| nitrophenylalanine | #26 |
| autoantibodies citrullinated proteins | #26 |
| gene regions | #26 |
| anti citrullinated | #26 |
| viable chondrocytes | #26 |
| cells joints | #26 |
| local exposure | #26 |
| intercrossed | #27 |
| individuals antibodies | #27 |
| trypsination | #27 |
| antibodies type | #27 |
| immunospecific | #27 |
| rheumatoid factor isotypes | #27 |
| disease immunoglobulin | #27 |
| pannus tissue | #27 |
| interleukin21 tlymphocytes | #27 |
| perforin deficiency | #27 |
| nonmhc genes | #27 |
| innate interleukin10 | #27 |
| ccp2 | #27 |
| c1i | #27 |
| immunodominant response | #27 |
| physiological level | #27 |
| pointmutation | #27 |
| hladrb1 shared epitope | #27 |
| rat strain | #28 |
| antibodies mab | #28 |
| ros induction | #28 |
| w3 25 | #28 |
| antily6g | #28 |
| eae susceptibility | #28 |
| cartilage vivo | #28 |
| protein peptides | #28 |
| anti rat | #28 |
| antigenspecific tolerance | #28 |
| chronicity | #28 |
| mediated effects | #28 |
| mrna ifngamma | #28 |
| severity day | #28 |
| cia3 | #28 |
| lysine position | #28 |
| upregulation cytokines | #28 |
| animal models neurodegeneration | #28 |
| onset day | #28 |
| nr8383 | #28 |
| autoimmune inflammatory | #28 |
| glucose transport capacity | #29 |
| smoking presence | #29 |
| chronic dss | #29 |
| ls2616 | #29 |
| hiit exercise | #29 |
| rfigm | #29 |
| acpa | #29 |
| 246trinitrophenyl | #29 |
| peptide anti | #29 |
| phenomes | #29 |
| cfa cia | #29 |
| suboptimal doses | #29 |
| parotid secretory protein | #29 |
| immunopathogenicity | #29 |
| presence synovial fluid | #29 |
| mice mab | #29 |
| ros production macrophages | #29 |
| antibody producing cells | #29 |
| absence inflammation | #29 |
| membrane lymphocytes | #29 |
| linkage disease | #30 |
| disease immunity | #30 |
| 11 cells | #30 |
| alphabetat | #30 |
| acpa fine | #30 |
| variable heavy chain | #30 |
| increased salt | #30 |
| development experimental | #30 |
| plasminogendeficient mice | #30 |
| paws | #30 |
| metabolic syndrome rats | #30 |
| cultivation cells | #30 |
| translational rats | #30 |
| chain collagen | #30 |
| chronic autoimmune | #30 |
| vpba | #30 |
| synovial cells patients | #30 |
| ctla4 mice | #30 |
| vivo exercise | #30 |
| treatment raloxifene | #30 |
| hlase | #30 |
| adult thymectomy | #30 |
| vgenes | #30 |
| dba mice | #30 |
| common chain | #31 |
| drugs addition | #31 |
| acute‐phase response | #31 |
| trimolecular | #31 |
| immunization | #31 |
| comparative genetic analysis | #31 |
| human type collagen | #31 |
| rats autoimmune | #31 |
| monoclonal antibody production | #31 |
| phytol | #31 |
| pristaneinduced lupus | #31 |
| hiit training | #31 |
| nox2 nox1 | #31 |
| disease development | #31 |
| psoriasis model | #31 |
| apc development | #31 |
| littermate controls | #31 |
| selfprotein | #31 |
| synovial fluid blood | #31 |
| expressing cells | #31 |
| ige cd23 | #31 |
| perpetuated | #31 |
| bound peptides | #32 |
| presence acpas | #32 |
| hladrb104 | #32 |
| rt11 | #32 |
| differentiation arthritis | #32 |
| steen | #32 |
| acpa rheumatoid arthritis | #32 |
| influence genes | #32 |
| caia mice | #32 |
| 11 cell | #32 |
| h2aq | #32 |
| type antibody | #32 |
| nonb cells | #32 |
| arthritis therapy | #32 |
| nodes mice | #32 |
| specificity function | #32 |
| congenic mice | #32 |
| ra33 | #32 |
| polymorphic genes | #32 |
| nadph oxidases nox | #32 |
| ros rns | #32 |
| mucosal tolerance | #32 |
| cell ratio | #32 |
| receptor preference | #32 |
| beta mice | #32 |
| epitope antibodies | #32 |
| genomewide genotyping | #32 |
| role osteoclastogenesis | #32 |
| methods serum samples | #32 |
| cells uterus | #32 |
| tolerance immunization | #33 |
| modified collagen | #33 |
| rheumatoid joint | #33 |
| epitopes antibodies | #33 |
| antigenpresenting cells cells | #33 |
| induced immunization | #33 |
| role vav1 | #33 |
| tcell receptor | #33 |
| autoimmune demyelinating disease | #33 |
| cytosolic factor | #33 |
| autoantibody activity | #33 |
| delayed type | #33 |
| skews | #33 |
| multiplex analysis | #33 |
| arthritic mice | #33 |
| type cross | #33 |
| patients animal models | #34 |
| c4bp | #34 |
| cells dendritic cells | #34 |
| interferon activity | #34 |
| joint pathology | #34 |
| promiscuous expression | #34 |
| nox2 deficiency | #34 |
| heterogeneous stock | #34 |
| natural antibodies nabs | #34 |
| neurodegeneration role | #34 |
| fpr1 | #34 |
| chronic polyarthritis | #34 |
| hybridomas | #35 |
| destructive arthritis | #35 |
| arthritis disease | #35 |
| antiarthritis | #35 |
| infectious disease models | #35 |
| phagotope | #35 |
| 1xi | #35 |
| autoreactive | #35 |
| nets neutrophils | #35 |
| acs stroke | #35 |
| major regulators | #35 |
| vdr cells | #35 |
| accessible sites | #35 |
| plasminogen deficiency | #35 |
| psoriasiform skin | #35 |
| antirat | #35 |
| monoclonal rheumatoid | #35 |
| development chronic | #35 |
| triple helical | #35 |
| complex arthritis | #35 |
| patients populations | #35 |
| tolerance tlymphocytes | #36 |
| arthritis cartilage | #36 |
| flow cytometry expression | #36 |
| specificity sera | #36 |
| phagocyte | #36 |
| female histocompatibility | #36 |
| nk cells recognition | #36 |
| cii cfa | #36 |
| h2g7 | #36 |
| animals antigen | #36 |
| techniques mice | #36 |
| comparative genetics | #36 |
| oxidases rna | #36 |
| h2r | #36 |
| variance animals antibodies | #36 |
| cartilage joints | #36 |
| induction tregs | #36 |
| protein specific | #36 |
| dth | #36 |
| dinitro1 | #36 |
| lymphocytes disease | #37 |
| role gamma interferon | #37 |
| recombinant vaccine | #37 |
| spontaneous arthritis | #37 |
| c129 | #37 |
| dba1 | #37 |
| encephalomyelitis | #37 |
| genetic control | #37 |
| acpa positive | #37 |
| susceptibility autoimmune diseases | #37 |
| immunopathological features | #37 |
| mif pathogenesis | #37 |
| oxidases oxidation | #37 |
| peptides binding | #37 |
| synthetic glycopeptides | #37 |
| joint cartilage | #37 |
| rich lipid | #37 |
| cii protein | #37 |
| cochranmantelhaenszel test | #38 |
| animal models pain | #38 |
| innovative tools | #38 |
| cldn4 | #38 |
| human blood neutrophils | #38 |
| nitrogen species | #38 |
| sialophorin | #38 |
| target autoantigens | #38 |
| antibodies animals | #38 |
| snat | #38 |
| acpa response | #39 |
| autoreactive cells | #39 |
| endoβnacetylglucosaminidase | #39 |
| allogeneically | #39 |
| benoist | #39 |
| nzw | #39 |
| oestrogen treatment | #39 |
| cell tolerance | #39 |
| nfr | #39 |
| ym1 | #39 |
| b6n | #39 |
| wasting syndrome | #39 |
| resultsrats | #39 |
| ccia | #39 |
| clonal expansion cells | #39 |
| data myelin | #39 |
| measurement activity | #39 |
| genetic complexity | #40 |
| disease animal models | #40 |
| antigens arthritis | #40 |
| isostere | #40 |
| rt1c | #40 |
| addition impact | #40 |
| positive rheumatoid | #40 |
| peptide cell | #40 |
| polyclonal cell activation | #40 |
| adjuvant induced | #40 |
| severity incidence | #41 |
| rats anti | #41 |
| aq | #41 |
| mhc haplotype | #41 |
| genes loci | #41 |
| autoimmune inflammatory diseases | #41 |
| congenic mapping | #41 |
| autoimmune | #41 |
| rat myelin | #41 |
| priming phase | #41 |
| ncii | #41 |
| effects experiments | #41 |
| immunocap isac | #41 |
| fibroblasts mice | #42 |
| spleen weight | #42 |
| species receptors | #42 |
| th17 axis | #42 |
| articular collagen | #42 |
| antibody isotypes | #42 |
| p38 mapk nfκb | #42 |
| mhc class class | #42 |
| ptpn22 locus | #42 |
| drb1 shared | #42 |
| cartilage bone destruction | #42 |
| pineal gland melatonin | #42 |
| expected onset | #42 |
| anticitrullinated | #43 |
| rats sex | #43 |
| lew rats | #43 |
| arthritis data | #43 |
| congeneic | #43 |
| treatment autoimmune diseases | #43 |
| spinal glia | #43 |
| crosses genetic | #43 |
| anticyclic | #43 |
| pc8 | #43 |
| type‐ii | #43 |
| autoreactive cell | #43 |
| kgf treatment | #43 |
| lew lymphocytes | #43 |
| mice autoimmune | #43 |
| cd11bly6g | #43 |
| collagen | #43 |
| immunodominant epitopes | #43 |
| defensins humans | #44 |
| inflammation animals | #44 |
| neuritis ean | #44 |
| homozygous form | #44 |
| c4bbinding protein c4bp | #44 |
| addition order | #44 |
| mice mice autoimmune | #44 |
| genetic linkage analysis | #44 |
| mathis | #44 |
| provocations | #44 |
| mice adulthood | #44 |
| chloro23 | #44 |
| peptide induced | #44 |
| epitopes lymphocyte | #44 |
| genetic encoding | #45 |
| susceptibility arthritis | #45 |
| potent suppression | #45 |
| relapsing disease | #45 |
| phagotopes | #45 |
| disease histocompatibility | #45 |
| nzb | #45 |
| outbred rats | #45 |
| chromosome development | #45 |
| locus controlling | #46 |
| affinity purified | #46 |
| lower severity | #46 |
| alphachains | #46 |
| c227 | #46 |
| cocrystallisation | #46 |
| neuritis autoimmune | #46 |
| carp antibodies | #46 |
| mhc class humans | #46 |
| isosteres | #46 |
| eae mbp | #46 |
| posttranslationally | #46 |
| disease induction | #46 |
| specific tolerance | #46 |
| rat2 | #46 |
| posttranslational rats receptors | #47 |
| f1 hybrid mice | #47 |
| association hladrb1 alleles | #47 |
| intercrosses | #47 |
| antibody reactivities | #47 |
| protective allele | #47 |
| idiotypic antibody | #47 |
| diagnostic accuracy diagnosis | #47 |
| rheumatoid factors | #47 |
| complex mediated | #47 |
| tlr12 | #48 |
| collagen peptide | #48 |
| peptide recognized | #48 |
| cia rats | #48 |
| mice carrying | #48 |
| experimental arthritis mice | #48 |
| lupus disease | #48 |
| acetylchitobiose | #48 |
| γchains | #48 |
| synovial lining layer | #48 |
| collagen glycosylation | #48 |
| mice nzb | #48 |
| antibody specificity | #48 |
| humanized model | #48 |
| f1 crosses | #48 |
| experimental crosses | #49 |
| bystander activation | #49 |
| class major | #49 |
| histone hdacs | #49 |
| mouse cartilage | #49 |
| polyvinylcaprolactam | #49 |
| tcell stimulation | #49 |
| comp levels | #49 |
| sex genes | #49 |
| immune nervous | #49 |
| monoclonal autoimmune diseases | #49 |
| mice caia | #49 |
| glutamine uptake | #50 |
| ciiia | #50 |
| loci animals | #50 |
| parathyroid cells | #50 |
| inflammation kynurenine | #50 |
| cytometry analyses | #50 |
| glycosylated form | #50 |
| complex region | #50 |
| anticarbamylated protein | #50 |
| mice tolerance | #50 |
| monoclonal epitopes | #50 |
| disease rats | #50 |
| antigenantibody | #50 |
| alagly | #50 |
| dependent chronic | #50 |
| animal cell culture | #50 |
| autoantibodies rheumatoid arthritis | #51 |
| tolerized | #51 |
| rheumatoid factor activity | #51 |
| derived type | #51 |
| aire mice | #51 |
| evidence animal models | #51 |
| runting | #51 |
| inbred c57bl autoimmune | #51 |
| lentiviral particles | #51 |
| fewer cells | #51 |
| tracheal cartilage | #51 |
| delayed immunization | #51 |
| antibodies cells | #51 |
| cells ova | #51 |
| c57bl 6j background | #51 |
| ptpn22 | #52 |
| macrophages skin | #52 |
| antigenpresenting cells | #52 |
| matrix protein | #52 |
| model collagen | #52 |
| xor activity | #52 |
| melatonin day | #53 |
| protein antibodies | #53 |
| production reactive | #53 |
| physiological doses | #53 |
| carbamylated proteins | #53 |
| triple helical structure | #53 |
| lysosomal compartments | #53 |
| antibodies epitopes | #53 |
| gastric parietal cell | #53 |
| cartilage erosion | #53 |
| patients rheumatic conditions | #53 |
| induced autoimmunity | #53 |
| arthritis induction | #53 |
| aged peptides | #53 |
| melatonin animals | #54 |
| animals autoimmune | #54 |
| major epitope | #54 |
| nodes lymphocyte | #54 |
| strain rats | #54 |
| imitating | #54 |
| carbamylated protein | #54 |
| predating | #54 |
| antigens myelomonocytic arthritis | #54 |
| yaa | #54 |
| development individuals | #54 |
| rats social isolation | #54 |
| crossbreeding | #54 |
| autoimmune reactions | #55 |
| arthritis genetic | #55 |
| inflammatory manifestations | #55 |
| macrophage mannose receptor | #55 |
| complex genetic disease | #55 |
| autoimmune nzb | #55 |
| susceptibility autoimmune disease | #55 |
| labels superoxide | #56 |
| alpha1microglobulin | #56 |
| new animal | #56 |
| mhc | #56 |
| selfreactive cells | #56 |
| animals antibody | #56 |
| cells salivary | #56 |
| vivo depletion | #57 |
| antibodies | #57 |
| igg abs | #57 |
| collagen sequence | #57 |
| animals antirheumatic | #57 |
| cd1 mice | #57 |
| arthritis pathogenesis | #57 |
| antibodies bind | #57 |
| development autoimmune | #57 |
| urokinase activity | #58 |
| schafer | #58 |
| rat type | #58 |
| oestrogen progesterone | #58 |
| peptide response | #58 |
| chronic eae | #58 |
| genes mhc | #59 |
| articular joints | #59 |
| anticarp antibodies | #59 |
| anti cell | #59 |
| hydroxylase diet | #59 |
| anti cd8 | #59 |
| encephalitogenicity | #59 |
| oligoclonal igg bands | #59 |
| resistance eae | #59 |
| cartilage matrix protein | #59 |
| assay epitopes | #60 |
| protein peptide | #60 |
| immunohistopathology | #60 |
| alternative activation macrophages | #60 |
| inflammatory cells macrophages | #60 |
| joint erosions | #60 |
| dichotomous effects | #60 |
| macrophage mannose | #60 |
| hpaaxis | #60 |
| species reactive | #61 |
| experimental rats rats | #61 |
| cells innate immune | #61 |
| alpha1m | #61 |
| major histocompatibility | #61 |
| differentiation myelomonocytic arthritis | #61 |
| experimental evoked potentials | #61 |
| epitope spreading | #61 |
| serum comp | #61 |
| incidence severity | #61 |
| adaptive immune | #62 |
| antigens class histocompatibility | #62 |
| cyclic sensitivity | #62 |
| syngeneically | #62 |
| interferon‐β | #62 |
| autoantibody formation | #62 |
| basic characterization | #62 |
| reduced oxidative | #62 |
| fpr2 | #62 |
| toxin1 | #62 |
| placenta uterus | #62 |
| mice susceptibility | #62 |
| mog1 | #63 |
| induced experimental | #63 |
| protein disease | #63 |
| specificity tumor | #63 |
| rats strain | #63 |
| delayed interferon | #63 |
| glycoprotein myelin | #63 |
| peptide specific | #63 |
| nadph oxidases | #63 |
| post‐partum | #63 |
| transfer animals | #63 |
| mice polyi | #63 |
| specific stages | #63 |
| hypersensitivity dth | #63 |
| collagen cell | #63 |
| constant darkness | #63 |
| igaproducing cells | #63 |
| duval | #63 |
| lower capacity | #64 |
| secondary immune | #64 |
| role apc | #64 |
| tolerance model | #64 |
| maternal origin | #64 |
| freund adjuvant | #64 |
| model chronic | #65 |
| major subset | #65 |
| histocompatibility complex | #65 |
| hindpaws | #65 |
| flss | #65 |
| autoimmunity humans | #65 |
| induced suppression | #65 |
| weight variation | #65 |
| phagocytosis oxidative burst | #66 |
| hladr2 | #66 |
| negative rheumatoid | #66 |
| experimental lymphocytes | #66 |
| rheumatoid synovial cells | #66 |
| peripheral joints | #66 |
| acute arthritis | #66 |
| thy1 antigen | #66 |
| spontaneous disease | #66 |
| chromosomes mammalian | #66 |
| resemblances | #66 |
| multispecificity | #66 |
| dendritic cells epitopes | #67 |
| myelomonocytic arthritis | #67 |
| fibrinogen genotype | #67 |
| key interactions | #67 |
| endos | #67 |
| rheumatoid arthritis susceptibility | #67 |
| experimental allergic | #67 |
| development cell | #67 |
| strains susceptible | #67 |
| experimental encephalomyelitis | #67 |
| mice induced | #67 |
| mice cell | #67 |
| iggrf | #68 |
| rheumatoid chromosomes | #68 |
| tolerized mice | #68 |
| cells mhc class | #68 |
| sodium diethyldithiocarbamate | #68 |
| individuals positive | #68 |
| frequent infections | #68 |
| female sex hormones | #68 |
| class region | #68 |
| helper phenotype | #68 |
| anti carp | #68 |
| complex class | #68 |
| severity periodontitis | #68 |
| zap‐70 | #69 |
| frequency antibodies | #69 |
| vertebrate immune | #69 |
| direct damage | #69 |
| lymphocytes chronic | #69 |
| cells mouse | #69 |
| rheumatoid disease | #69 |
| relapsing | #69 |
| role cells | #70 |
| mrl mice | #70 |
| response type | #70 |
| presence rheumatoid factor | #70 |
| immunoglobulin interferon | #70 |
| translationally | #70 |
| prolonged graft survival | #70 |
| isolated rats | #71 |
| cartilage mice | #71 |
| susceptibility female | #71 |
| human psoriasis | #71 |
| expression pparγ | #71 |
| cb10 | #71 |
| ztm | #71 |
| swr | #71 |
| napdh | #72 |
| dark agouti rats | #72 |
| antibodies binding | #72 |
| interphalangeal joints | #72 |
| study antibodies | #72 |
| lathyritic | #72 |
| naïve mice | #72 |
| delayedtype hypersensitivity dth | #72 |
| autoimmunity lymphocytes | #72 |
| membrane animals | #73 |
| knockout protein processing | #73 |
| bovine type | #73 |
| treatment stages | #73 |
| mrl lpr | #73 |
| environmental lighting | #73 |
| species ros | #73 |
| type ifn signature | #73 |
| oxidase complex | #73 |
| pregnancyinduced | #74 |
| hypersensitivity delayed | #74 |
| peptides sequences | #74 |
| igarf | #74 |
| antigens class | #74 |
| cartilage explants | #74 |
| effects development | #75 |
| acpapositive | #75 |
| cell reactivity | #75 |
| genetic disease models | #75 |
| dth mice | #75 |
| diabetes arthritis | #75 |
| inbred dba receptors | #75 |
| oestradiol | #75 |
| peptide mhc | #76 |
| anti carbamylated | #76 |
| rat splenocytes | #76 |
| type collagens | #76 |
| disease rheumatoid arthritis | #76 |
| lpr mrl | #77 |
| cell deficient | #77 |
| regulatory vaccines | #77 |
| cyp7a1 | #77 |
| rt1n | #77 |
| pain inflammation | #77 |
| collagen chains | #77 |
| new animal model | #77 |
| rats eae | #77 |
| development insulitis | #77 |
| inbred mouse strains | #77 |
| eae induced | #77 |
| nerve conduction velocity | #77 |
| oligomeric | #77 |
| pythons | #78 |
| autoantigenic | #78 |
| cartilage integrity | #78 |
| pathogenesis rheumatoid arthritis | #78 |
| clinical arthritis | #78 |
| rats respiratory | #78 |
| mhc expression | #78 |
| 1ii | #79 |
| mononuclear lung | #79 |
| autoimmune experimental epitopes | #79 |
| inflammatory autoimmune | #79 |
| shared epitope | #79 |
| susceptibility disease | #79 |
| oxidases | #80 |
| detection autoantibodies | #80 |
| erosive arthritis | #80 |
| chromosome study | #80 |
| aspartic acid position | #81 |
| mog mbp | #81 |
| inflammatory phase | #81 |
| mrl mp | #81 |
| hnrnpa2 | #81 |
| mhcii expression | #81 |
| induced leukocyte | #81 |
| estrogen suppression | #81 |
| spleen study | #81 |
| sex linkage | #81 |
| arthritis cells | #81 |
| expression ll37 | #81 |
| type macrophages | #81 |
| dr1 antigen | #81 |
| class antigen expression | #81 |
| nadphoxidase | #82 |
| 14weeks | #82 |
| pannus formation | #82 |
| mice igg | #83 |
| tlymphocyte genes | #83 |
| cell independent | #83 |
| expression mhc | #83 |
| bcg infection | #83 |
| drug encephalomyelitis | #83 |
| rat cardiac allografts | #84 |
| reactive cells | #84 |
| strains animals | #84 |
| multiple sclerosis evidence | #84 |
| arthritis day | #84 |
| epidermal cells | #84 |
| naïve cells | #84 |
| spontaneous development | #84 |
| cells recognize | #85 |
| inflammation joints | #85 |
| homopentamer | #85 |
| antiifngamma | #85 |
| class molecule | #85 |
| inflammation joint | #85 |
| knockout receptors | #85 |
| classical humans | #86 |
| contribution genes | #86 |
| gfoger | #86 |
| preclinical stage | #86 |
| monoclonal antibodies mab | #86 |
| phagocyte nadph | #86 |
| severe eae | #86 |
| animal humans | #86 |
| mutant strains | #86 |
| anti cd4 | #86 |
| alpha1acid glycoprotein | #87 |
| inbred rat strains | #87 |
| estrogen induced | #87 |
| smash | #87 |
| mhc class gene | #87 |
| narac | #88 |
| thps | #88 |
| copy variation | #88 |
| fine specificities | #88 |
| levels anti | #88 |
| inguinal lymph nodes | #88 |
| mabs mab | #89 |
| depletion cd8 cells | #89 |
| peptide immunization | #89 |
| experimental autoimmune | #89 |
| genetic quantitative | #89 |
| arthritic | #89 |
| mice antibodies | #89 |
| genistein treatment | #90 |
| susceptible | #90 |
| ilc2 activation | #90 |
| mediated mechanisms | #90 |
| pineal hormone melatonin | #90 |
| arthritis compared | #90 |
| adjuvant arthritis | #90 |
| monkeys mice | #90 |
| rheumatoid arthritis cells | #90 |
| autoimmune inbred c57bl | #90 |
| synovial fluid serum | #91 |
| backgroundan | #91 |
| activation cd4 cells | #91 |
| protein induced | #91 |
| histological sections | #91 |
| cattle collagen | #91 |
| cells apc | #91 |
| difco | #92 |
| abdominal region | #92 |
| experimental mouse models | #92 |
| humans immunodominant | #92 |
| anticitrullinated protein | #92 |
| nod mhc | #92 |
| knockout myelin | #93 |
| animals autoantibodies | #93 |
| cellspecific | #93 |
| natural polymorphisms | #93 |
| 290 patients | #93 |
| mice melatonin | #93 |
| xor | #93 |
| galactosylated | #94 |
| endosomal acidification | #94 |
| fcγrs | #94 |
| activated cells cells | #94 |
| autosomal genes | #94 |
| macrophages development | #94 |
| induced sarcoma | #95 |
| binding integrins | #95 |
| chronic phase disease | #95 |
| moderateintensity exercise | #95 |
| lung emphysema | #96 |
| cell alpha | #96 |
| fetal rejection | #96 |
| romani | #96 |
| macrophages stimulation | #96 |
| pregnancy disease | #96 |
| nonglycosylated | #96 |
| messenger tolllike receptor | #96 |
| data rats | #96 |
| ifnbeta | #96 |
| cathelicidins | #97 |
| complex mice | #97 |
| hydroxylysine | #97 |
| genetic female genes | #97 |
| antiimmunoglobulin | #97 |
| il33r | #97 |
| citrullinated fibrinogen | #97 |
| rheumatoid lymphocytes | #97 |
| macrophages fibroblasts | #97 |
| autoimmune experimental | #98 |
| acpa igg | #98 |
| rheumatoid cartilage | #98 |
| swr mice | #98 |
| ean | #98 |
| autoimmune rats | #98 |
| rat chromosomes | #99 |
| interleukin‐4 | #99 |
| collagen cytokines | #99 |
| alternative pathways | #99 |
| thy1 antigens | #100 |
| invading pathogens | #100 |
| peptides cells | #100 |
| rats monoclonal antibodies | #100 |
| tlymphocyte immunity | #100 |
| ccp anti | #100 |
| inducer animals | #100 |
| cultured crosses | #100 |
| tap2 | #100 |
| protein antibody | #100 |
| bone degradation | #101 |
| diarthrodial | #101 |
| cell determinants | #101 |
| susceptible strain | #101 |
| singlenucleotide polymorphism | #101 |
| fprs | #101 |
| eira | #101 |
| safety drugs | #101 |
| findings treatment | #102 |
| mouse monoclonal antibodies | #102 |
| brucei infection | #102 |
| candidate autoantigen | #102 |
| eae animal encephalomyelitis | #102 |
| drb10401 | #103 |
| pathogenesis emphysema | #103 |
| agalactosyl | #103 |
| hla dr1 | #103 |
| ros homeostasis | #103 |
| oxidative burst | #103 |
| nonarthritic | #104 |
| haplotypes histocompatibility | #104 |
| skg mice | #104 |
| arthritic disease | #104 |
| mhcii | #104 |
| thelper cells | #104 |
| f1 males | #104 |
| synchrotron infrared | #104 |
| male mice mice | #104 |
| mutation mice | #104 |
| osteoclasts mice | #105 |
| fcγr | #105 |
| dmaam | #105 |
| type 22 | #105 |
| development antibodies | #105 |
| vivo macrophages | #105 |
| hybridoma cell | #105 |
| autoreactivity | #105 |
| proteoglycan loss | #106 |
| primed cells | #106 |
| 273 | #106 |
| arthritis hla | #106 |
| limited cross | #106 |
| disease dose | #106 |
| tcell immunity | #106 |
| nzb mice | #107 |
| c3h mice | #107 |
| cells synovial | #107 |
| littermates | #108 |
| study tolerance | #108 |
| fpr | #108 |
| development autoimmune disease | #108 |
| reactive cell | #109 |
| type hypersensitivity | #109 |
| structural polymorphism | #109 |
| enthesophytes | #109 |
| citrullinated proteins | #109 |
| presentation cells | #109 |
| delayedtype hypersensitivity | #109 |
| monoclonal igg | #109 |
| autoantibodies autoantigens | #109 |
| carcinoma tumors | #110 |
| autoimmune encephalomyelitis | #110 |
| backcross | #111 |
| inbred dba microscopy | #111 |
| female hypersensitivity | #111 |
| experimental female | #111 |
| streptococcal cell wall | #111 |
| dba 1j mice | #111 |
| cartilage | #111 |
| mog eae | #111 |
| toxic shock syndrome | #111 |
| presymptomatic individuals | #112 |
| humoral autoimmunity | #112 |
| extensive literature search | #112 |
| amide bond | #112 |
| alphabeta receptors antigen | #112 |
| anti idiotypic antibodies | #112 |
| autoimmune c57bl mice | #113 |
| db1 | #113 |
| tcra | #113 |
| xid mice | #113 |
| mice collageninduced arthritis | #113 |
| restricted cell | #113 |
| oligoclonality | #113 |
| adjuvant properties | #113 |
| trait loci | #113 |
| ifngammaproducing cells | #114 |
| adjuvantinduced arthritis | #114 |
| autoantigens autoimmunity | #115 |
| anti mcv | #115 |
| mice disease | #115 |
| proinflammatory cytokine | #115 |
| drb10402 | #115 |
| rats collagen | #115 |
| immunosorbents | #116 |
| transgenic peptides receptors | #116 |
| glyco | #116 |
| pathogenesis autoimmune diseases | #116 |
| lutz | #116 |
| experimental epitopes | #116 |
| glycopeptides | #116 |
| ccp patients | #116 |
| lymphocyte female | #116 |
| susceptibility eae | #116 |
| congenic lines | #117 |
| antibodies reactive | #117 |
| tolerance induced | #117 |
| fluorescence nf | #117 |
| mice type | #117 |
| encephalomyelitis autoimmune | #117 |
| antiarthritic | #117 |
| myelin oligodendrocyte | #118 |
| pineal hormone | #118 |
| α enolase | #118 |
| alpha1acid | #118 |
| rats immunized | #118 |
| samples individuals | #118 |
| psoriasiform dermatitis | #118 |
| class expression | #118 |
| rheumatoid arthritis review | #119 |
| 05m | #119 |
| psa rheumatoid arthritis | #119 |
| response cells | #119 |
| radiological damage | #119 |
| cd4 tcells | #119 |
| protein mbp | #120 |
| neutrophils nets | #120 |
| vivo animal models | #121 |
| experimental animal models | #121 |
| chondrocyte cultures | #121 |
| acpa negative | #122 |
| transgenic neurons receptors | #122 |
| pharmacological potential | #122 |
| transfer arthritis | #122 |
| genes age | #122 |
| patients acpa | #122 |
| treatment progesterone | #122 |
| immune complex deposition | #122 |
| t‐lymphocyte | #122 |
| alphabeta cells | #123 |
| cell monoclonal | #123 |
| nox2 activation | #123 |
| c5b | #123 |
| type cytokines | #123 |
| symptoms associations | #123 |
| cartilage surface | #124 |
| tlr4 stimulation | #124 |
| inbred mouse | #124 |
| oxidases neutrophils | #125 |
| qtl genes | #125 |
| helperinducer | #125 |
| disease mechanisms | #125 |
| preimmunized | #125 |
| genetic rats | #125 |
| cryogel | #125 |
| immunodominant peptide | #125 |
| allelic variations | #125 |
| general mechanisms | #125 |
| blocking antigens | #125 |
| nonobese diabetic | #126 |
| nzb nzw | #126 |
| pnipaam | #126 |
| cyclic polymorphism | #126 |
| female immunization | #126 |
| knockout murine | #127 |
| animal enzyme | #127 |
| absence cells | #127 |
| microarray detection | #127 |
| atp8 | #127 |
| chronic inflammatory disease | #128 |
| dominant epitope | #128 |
| lining layer | #128 |
| anticitrullinated peptide | #128 |
| deiminases | #128 |
| multiple epitopes | #129 |
| rats patients | #129 |
| bxsb | #129 |
| spleen rats | #129 |
| oestradiol testosterone | #130 |
| cells eae | #130 |
| nos2 | #130 |
| vivo absence | #130 |
| disease induced | #130 |
| psd1 | #130 |
| onset arthritis | #131 |
| epitope specific | #131 |
| lipomannan | #131 |
| disease cgd | #132 |
| pronociceptive | #132 |
| induction regulatory cells | #132 |
| mineral oils | #132 |
| kgf | #132 |
| intercross | #132 |
| linomide | #132 |
| reduced severity | #133 |
| ggaa | #133 |
| leukosialin | #133 |
| rat chromosome | #133 |
| interstitial collagens | #134 |
| mice estrogen | #134 |
| plasma synovial fluid | #134 |
| eae | #134 |
| species animals | #134 |
| knockout receptors antigen | #134 |
| myocellular | #134 |
| patients cytokines | #134 |
| accentuate | #134 |
| peptides cyclic | #135 |
| igg immune complexes | #135 |
| spinal glial | #135 |
| immunizing | #136 |
| intracellular reactive | #136 |
| macrophages dendritic | #136 |
| chronic autoimmune disease | #136 |
| receptor upregulation | #137 |
| innate lymphocytes | #137 |
| immunopathological | #137 |
| stimulated muscle | #137 |
| mice deficient | #138 |
| ditiocarb | #138 |
| autoimmune mice | #139 |
| immunomodulatory drug | #139 |
| control development | #139 |
| dmannitol | #139 |
| tcrdelta | #140 |
| oligoclonal expansion | #141 |
| thermoresponsive polymer | #141 |
| producing cell | #141 |
| or113 | #142 |
| smfish | #142 |
| genetic factors development | #142 |
| phadia | #142 |
| rejection tolerance | #142 |
| interferon‐γ | #142 |
| single subcutaneous injection | #142 |
| gamma lymphocyte | #142 |
| mice beta | #143 |
| class haplotypes | #143 |
| cell hybridoma | #143 |
| tcell alphabeta receptors | #143 |
| phosphate isomerase | #143 |
| rat strains | #144 |
| synovial hyperplasia | #144 |
| rheumatoid arthritis | #144 |
| mhc haplotypes | #144 |
| inbred buf rats | #145 |
| lyme arthritis | #145 |
| severe chronic | #145 |
| syngenic | #145 |
| treatment ici | #145 |
| tnf production | #145 |
| tcr gamma delta | #145 |
| rats induced | #146 |
| neonatal growth | #146 |
| cellular heterogeneity | #147 |
| systemic challenge | #147 |
| pregnancy levels | #147 |
| function cells | #147 |
| gammainterferon | #147 |
| ccp antibodies | #147 |
| cell surface antigen | #148 |
| α2i | #148 |
| redox regulation | #148 |
| interestingly | #148 |
| autoimmune disease | #148 |
| phagocyte nadph oxidase | #148 |
| human autoimmune diseases | #149 |
| complex diseases | #149 |
| mhc binding | #150 |
| larsen score | #150 |
| drb104 | #150 |
| epicutaneously | #151 |
| humans hybridomas | #151 |
| mice animals | #151 |
| receptor rats | #151 |
| differential gene expression | #151 |
| levels antibodies | #151 |
| alphabeta receptors | #152 |
| mononuclear cells | #153 |
| arthritic animals | #153 |
| pepsin | #153 |
| levels pregnancy | #153 |
| key player | #153 |
| expression class | #154 |
| fcgammar | #154 |
| critical event | #154 |
| immune priming | #154 |
| selfpeptides | #154 |
| joint inflammation | #154 |
| daf1 | #154 |
| male rats rats | #154 |
| c4bbinding protein | #154 |
| infiltrating cells | #155 |
| serum synovial fluid | #155 |
| f1 mice | #155 |
| mace acs | #155 |
| autoantibodies autoimmune | #155 |
| arthritis rheumatoid | #155 |
| padi4 | #155 |
| mhc region | #156 |
| suppressive role | #156 |
| stabilin1 | #156 |
| specificities | #156 |
| adjuvanticity | #157 |
| murine keratinocytes | #157 |
| downstream signals | #157 |
| genetic diabetes mellitus | #158 |
| analysis structure | #158 |
| parentals | #158 |
| hypersensitivity reaction | #158 |
| systemic mice mice | #159 |
| meaib | #159 |
| animals autoimmunity | #159 |
| arthritis infectious | #159 |
| inbred c3h mice | #159 |
| consensus motif | #159 |
| knockout severity | #161 |
| specific autoimmunity | #161 |
| nursed | #161 |
| gamma interferon | #161 |
| benzylated | #161 |
| day onset | #161 |
| factors anti | #161 |
| βarrestin recruitment | #162 |
| anti ccp | #162 |
| arthritis inflammation | #162 |
| rheumatoid autoantigens | #162 |
| epitope | #162 |
| psors1 | #162 |
| binding collagen | #162 |
| cd152 | #162 |
| chains humans | #163 |
| onset disease | #163 |
| laboratory rats | #163 |
| mouse type | #163 |
| endobetanacetylglucosaminidase | #164 |
| striking similarities | #164 |
| progesterone effects | #164 |
| rats induction | #164 |
| autoantibody responses | #164 |
| genes qtl | #164 |
| agalactosyl igg | #164 |
| mrl | #164 |
| animal humans immunity | #165 |
| cells macrophages | #165 |
| pathogenic pathways | #166 |
| melatonin mice mice | #166 |
| epitope alleles | #166 |
| tolerance induction | #166 |
| nonimmunized | #166 |
| class mice | #167 |
| seronegative | #167 |
| nox2 | #167 |
| human autoimmunity | #167 |
| tlymphocyte humans | #167 |
| ag7 | #167 |
| mice cd4 cells | #168 |
| cd1 | #168 |
| phase disease | #168 |
| genetic backgrounds | #168 |
| oxazole | #169 |
| denoted | #169 |
| acpa levels | #169 |
| p12 | #169 |
| experimental animal | #170 |
| inherited disorder | #170 |
| joints male | #170 |
| lymph node cells | #170 |
| mirp | #170 |
| pathogenesis arthritis | #170 |
| cryogels | #170 |
| oxazolone | #171 |
| encephalomyelitis eae | #171 |
| ros nitric oxide | #171 |
| peripheral lymphoid organs | #172 |
| single nucleotide polymorphism | #172 |
| lst1 | #172 |
| autoimmune eae | #172 |
| autoimmunity cell | #172 |
| rat placenta | #172 |
| rheumatoid | #172 |
| monoclonal autoantibodies | #173 |
| sod3 | #173 |
| inbred dba models | #173 |
| nasal cartilage | #174 |
| presence autoantibodies | #174 |
| class gene | #174 |
| studies pain | #174 |
| resistant rats | #174 |
| maternal decidua | #175 |
| understanding pathogenesis | #175 |
| mice mutation | #175 |
| ifn signature | #175 |
| skin disease | #176 |
| new mouse model | #176 |
| strains molecular | #176 |
| mammalian crosses | #176 |
| moab | #176 |
| tryptophan catabolism | #176 |
| secondary challenge | #176 |
| lymphotoxinα | #177 |
| histocompatibility | #178 |
| ctla‐4 | #178 |
| hladrb1 alleles | #178 |
| alternative pathway complement | #179 |
| nod genes | #179 |
| immunized | #179 |
| mice role | #179 |
| dextran sulphate sodium | #179 |
| protein anti | #179 |
| arthritis methods | #180 |
| epitopes female | #180 |
| complex disease | #180 |
| cgd patients | #180 |
| alleles arthritis | #181 |
| genetic influence | #181 |
| molecular adaptations | #181 |
| autoimmunity disease | #181 |
| arginine deiminases | #182 |
| hormone melatonin | #182 |
| immunoglobulin mice mice | #185 |
| cells lymph nodes | #186 |
| multistep process | #186 |
| antigen processing presentation | #186 |
| rats reactive | #186 |
| drb1 chains | #187 |
| b10 | #187 |
| dba | #187 |
| tcell recognition | #187 |
| molecular peptide | #188 |
| substrains | #188 |
| chondritis | #188 |
| mtec | #189 |
| cells disease | #189 |
| synovial membranes | #190 |
| inflamed joint | #190 |
| positionally | #190 |
| hnrnpa2b1 | #190 |
| oligodendrocyte glycoprotein | #191 |
| autoantibody profiles | #192 |
| ly1 | #192 |
| cross‐reactivity | #192 |
| fmlf | #193 |
| passive mice mice | #193 |
| glycoprotein peptide | #194 |
| cyclic predictive | #194 |
| proteins myelin | #194 |
| mhv | #195 |
| chapter 16 | #195 |
| perpetuate | #195 |
| mice mutant | #195 |
| mhc class expression | #196 |
| oophorectomized | #196 |
| lewis rat | #196 |
| myelin glycoprotein | #196 |
| tcell response | #196 |
| acutephase response | #197 |
| multiplex assay | #197 |
| evidence development | #197 |
| pannus | #197 |
| genetic links | #198 |
| swedish patients | #198 |
| igmrf | #198 |
| early appearance | #198 |
| rat genome | #199 |
| interleukin17 | #199 |
| dr4 antigen | #199 |
| hla association | #200 |
| citrullinated peptide | #200 |
| cell collagen | #200 |
| pathogenesis autoimmune | #201 |
| dendritic cells macrophages | #202 |
| acpa status | #202 |
| instigation | #202 |
| myelin proteolipid protein | #202 |
| myelin proteins myelin | #202 |
| mice cells | #203 |
| complete elimination | #203 |
| class molecules | #204 |
| immunization immunoglobulin | #204 |
| spleen staining | #204 |
| 2 complex | #204 |
| macrophages mice | #205 |
| dth response | #205 |
| suppresses | #205 |
| native collagen | #205 |
| ides | #205 |
| nonparametric tlymphocytes | #205 |
| defb4 | #206 |
| wild rats | #206 |
| betaestradiol | #206 |
| mice peptide | #207 |
| parental strains | #207 |
| induced upregulation | #207 |
| intranasal challenge | #207 |
| desmoglein 3 | #207 |
| noxs | #207 |
| interleukin4 mice mice | #207 |
| alternative complement pathway | #207 |
| insulitis diabetes | #207 |
| vivo patients | #208 |
| antigen presenting | #208 |
| highest probability | #208 |
| naive mice | #208 |
| immunization mice | #208 |
| severity disease | #208 |
| disease rheumatoid | #209 |
| cotwins | #209 |
| immunoglobulin vh | #209 |
| highfatdiet | #210 |
| susceptible strains | #210 |
| specific antibodies | #210 |
| valuable tools | #210 |
| citrullinated vimentin | #210 |
| vav1 | #210 |
| diseases genetic | #211 |
| glucose6 phosphate | #211 |
| purified protein derivative | #211 |
| hla dr4 | #211 |
| natural antibodies | #211 |
| cells immobilized | #212 |
| association rheumatoid arthritis | #212 |
| large numbers | #212 |
| psoriasiform | #213 |
| mice injected | #213 |
| antibody binding | #213 |
| tsst1 | #214 |
| antigen induced | #215 |
| inbred rat | #215 |
| triethylsilane | #215 |
| cytofluorometric | #215 |
| central tolerance | #215 |
| mhc class antigens | #215 |
| lower level | #216 |
| dissect | #216 |
| training hiit | #216 |
| induced autoimmune | #217 |
| lentiviral vector | #217 |
| resistant strain | #217 |
| joints mice | #217 |
| rats immunization | #217 |
| inflammatory infiltrates | #217 |
| cd23 | #217 |
| treatment onset | #218 |
| antigen tcell | #218 |
| granuloma formation | #219 |
| autoimmunity | #219 |
| fcrγ | #219 |
| peptide antibodies | #219 |
| k8 | #219 |
| cells autoimmune | #220 |
| hyl | #220 |
| peptidylarginine deiminases | #220 |
| bone erosions | #220 |
| rheumatoid factor | #221 |
| agouti rats | #221 |
| pinealectomy | #221 |
| cells dendritic | #221 |
| targeted deletion | #221 |
| cyclosporin treatment | #221 |
| fine specificity | #221 |
| redox signaling | #221 |
| cybb | #222 |
| monoclonal antigens differentiation | #222 |
| wkymvm | #222 |
| thymectomized | #222 |
| cartilage damage | #222 |
| experimental autoimmune neuritis | #223 |
| igg2a | #223 |
| carbamylated | #223 |
| multiplex | #223 |
| inflammation vivo | #224 |
| expressing | #224 |
| lew | #225 |
| cells antigen | #225 |
| established disease | #225 |
| interleukin‐10 | #225 |
| clinical scoring | #225 |
| pathogenic antibodies | #226 |
| disease locus | #226 |
| macrophagelike cells | #227 |
| j1 | #227 |
| delayed type hypersensitivity | #228 |
| arthritis objective | #228 |
| presenting cells | #228 |
| presence anti | #229 |
| cell selection | #229 |
| site inflammation | #230 |
| eae rats | #230 |
| human rheumatoid | #231 |
| ls1 | #231 |
| monoclonal immunohistochemistry | #232 |
| reactive oxygen | #232 |
| lack expression | #233 |
| role eosinophils | #233 |
| production ros | #233 |
| ameliorated | #233 |
| synovial joints | #233 |
| centimorgan | #234 |
| lower numbers | #234 |
| chromosome 14 | #235 |
| staphylococcal infection | #235 |
| mhc gene | #235 |
| chronic psychosocial stress | #235 |
| immune complex | #236 |
| specificity animals | #236 |
| pathological mechanisms | #237 |
| control strain | #237 |
| progression arthritis | #238 |
| autoimmune chronic | #238 |
| c5 | #239 |
| trait locus | #239 |
| inbred dba tlymphocytes | #240 |
| study plasma | #241 |
| joint pain | #242 |
| strong influence | #242 |
| monoclonal antigen | #243 |
| hla drb1 | #243 |
| multicomponent | #243 |
| protected | #243 |
| class genetic | #243 |
| positive anti | #243 |
| cutaneous infection | #244 |
| common denominator | #244 |
| treatment autoimmune | #244 |
| crosses | #244 |
| inflammation cartilage | #244 |
| estrus cycle | #244 |
| binding antibodies | #245 |
| rt1l | #246 |
| development emphysema | #246 |
| allelic differences | #246 |
| florescence | #247 |
| normal cartilage | #247 |
| antibody response | #247 |
| new model | #247 |
| inbred strain | #247 |
| antibodies anti | #247 |
| activity assays | #248 |
| efficient expression | #248 |
| oxygen species | #249 |
| induced chronic | #249 |
| node cells | #250 |
| picryl | #250 |
| fragments rats | #250 |
| arthritic joints | #250 |
| mouse rat | #250 |
| inflammation score | #250 |
| conditional knockout mice | #251 |
| develops | #251 |
| treatment rats | #251 |
| hyperinflammation | #251 |
| nadph oxidase | #251 |
| role model | #252 |
| response disease | #252 |
| mice lymphocytes | #252 |
| mice lack | #252 |
| dark agouti | #252 |
| class mhc | #254 |
| onset clinical | #254 |
| cartilage matrix | #254 |
| lacking | #254 |
| lpr mice | #254 |
| dinitrofluorobenzene | #254 |
| proteins glycoproteins | #254 |
| autoimmune response | #255 |
| inbred c3h | #255 |
| specific neutralizing | #256 |
| postmenopausal bone | #256 |
| specific subgroups | #256 |
| inflammatory disorder | #256 |
| anti arthritic | #256 |
| disease cell | #257 |
| additive interaction | #258 |
| class mhc molecules | #259 |
| chronic granulomatous | #260 |
| mir144 | #260 |
| relationship immunologic | #260 |
| mediated suppression | #261 |
| autoimmune neuritis | #261 |
| denatured | #261 |
| secondary osteoporosis | #261 |
| mice expressing | #261 |
| lymphocytes helper | #261 |
| immunologic animals | #262 |
| selfantigen | #263 |
| primary immunization | #265 |
| crossreactive | #265 |
| mouse strain | #265 |
| tolerance mice | #265 |
| pregnancy mice | #265 |
| genetic techniques | #265 |
| antigen specific | #267 |
| rats animals | #267 |
| cysteine proteases | #267 |
| vim2 | #267 |
| posttranslational modifications | #268 |
| xid | #268 |
| lentiviral gene | #268 |
| pathogenic roles | #269 |
| mann whitney | #269 |
| oxpl | #270 |
| complement c5 | #270 |
| castrated | #271 |
| monosodium urate crystals | #271 |
| selfantigens | #271 |
| melatonin effects | #271 |
| amino acid transporters | #273 |
| experimental model | #273 |
| lewis rats | #274 |
| tcells | #275 |
| inhibitory peptide | #275 |
| synovial lining | #275 |
| hdac1 | #275 |
| nasally | #275 |
| fcgr3b | #276 |
| macrophages dendritic cells | #276 |
| viral female hepatitis | #277 |
| deiminase type | #277 |
| rheumatoid arthritis association | #277 |
| producing cells | #277 |
| metabolic properties | #278 |
| recognize | #278 |
| interferongamma | #279 |
| colon length | #279 |
| gp70 | #279 |
| induced tolerance | #280 |
| dinucleotide phosphate | #280 |
| inflammatory conditions | #281 |
| immunological receptors antigen | #281 |
| neonatal mice | #281 |
| recipient mice | #281 |
| passive transfer | #281 |
| hemiacetal | #282 |
| igg2b | #283 |
| isoflavone genistein | #283 |
| disease susceptibility | #283 |
| factor production | #283 |
| inbred nod | #283 |
| severe colitis | #284 |
| helper inducer | #284 |
| increased serum levels | #284 |
| aire | #284 |
| complete protection | #285 |
| publication animals antibodies | #285 |
| idiotope | #285 |
| theilovirus | #285 |
| aureus strain | #285 |
| maintained | #285 |
| endophilin | #285 |
| emulsified | #286 |
| hla dr2 | #287 |
| tlr9 mice | #288 |
| melatonin release | #288 |
| melatonin mice | #288 |
| antibody production | #288 |
| myelin basic protein | #288 |
| cells autoimmunity | #289 |
| mice immunized | #289 |
| disease cells | #291 |
| synovial cells | #291 |
| ctla4 expression | #291 |
| rheumatic conditions | #292 |
| autoimmune mechanisms | #292 |
| collagen receptors | #293 |
| induced ros | #293 |
| increased copy | #293 |
| cytokines disease | #293 |
| mouse genes | #294 |
| unique model | #294 |
| antigen processing | #295 |
| gastric parietal | #295 |
| c3h | #295 |
| c57bl 6 mice | #295 |
| tissue‐specific | #296 |
| nerve conduction | #296 |
| 6week | #296 |
| immunological receptors | #296 |
| dnfb | #297 |
| helical peptides | #297 |
| phosphopyruvate | #297 |
| murine dendritic cells | #297 |
| gene selection | #298 |
| ppad | #298 |
| vivo imaging | #298 |
| cd19 cells | #298 |
| solidphase synthesis | #299 |
| transplantation antigens | #299 |
| citrullination | #299 |
| tcr beta | #300 |
| neutrophil extracellular traps | #301 |
| posttranslational rats | #301 |
| alphabeta | #302 |
| extraembryonic tissues | #302 |
| peptide antibody | #302 |
| draining lymph | #302 |
| strains mice | #303 |
| 1 interferon | #303 |
| epidemiological investigation | #303 |
| animals antibodies | #303 |
| pathogeneses | #303 |
| conditioned disease models | #304 |
| autoimmune diseases | #304 |
| cgd | #304 |
| igg glycosylation | #304 |
| cells tcr | #305 |
| immunological function | #305 |
| mutant strains mice | #305 |
| cartilage development | #305 |
| gammaifn | #306 |
| αgalcer | #306 |
| hcdr3 | #306 |
| murine colitis | #306 |
| immunological studies | #306 |
| inpp4b | #307 |
| class histocompatibility | #307 |
| immunisation | #307 |
| basal metabolic rate | #308 |
| chromosome 10 | #309 |
| basal metabolic | #309 |
| arthritis study | #310 |
| articular cattle cells | #310 |
| multiple sclerosis eae | #311 |
| perpetuation | #311 |
| disease symptoms | #312 |
| synthetic peptide | #312 |
| alleles animals | #312 |
| inflamed joints | #312 |
| epitopes | #313 |
| exuberant | #313 |
| c3bi | #313 |
| activatory | #314 |
| induced colitis | #314 |
| intradermally | #315 |
| mice genes | #315 |
| r620w | #315 |
| trypanosoma brucei brucei | #316 |
| classical risk factors | #318 |
| onset rheumatoid | #318 |
| genetic interactions | #319 |
| tubule cells | #319 |
| galactosyl | #319 |
| genomewide linkage analysis | #320 |
| spleen bone marrow | #320 |
| deiminase | #320 |
| mice subjected | #320 |
| cells specific | #323 |
| il21r | #323 |
| ccp1 | #324 |
| impact disease | #324 |
| daf2 | #324 |
| expressing human | #324 |
| specific cell | #325 |
| expression cells | #325 |
| rat gene | #325 |
| surprisingly | #326 |
| resembles | #327 |
| mgps | #327 |
| allelic variant | #328 |
| c57bl mice | #328 |
| immunoenzyme | #329 |
| publication adjuvants | #329 |
| constant light | #329 |
| complex genes | #330 |
| early arthritis | #331 |
| glycoprotein mog | #332 |
| nucleotide polymorphism | #332 |
| fcgammariia | #332 |
| rheumatoid synovial | #332 |
| anticcp | #333 |
| mouse hepatitis virus | #333 |
| 35ssulfate | #334 |
| mrl lpr mice | #335 |
| susceptibility genes | #335 |
| joint tissues | #335 |
| autoimmune inflammation | #336 |
| cell response | #338 |
| delayed onset | #340 |
| epitope specificity | #340 |
| cells spleen | #340 |
| adjuvants immunologic | #341 |
| activation macrophages | #341 |
| ros oxygen species | #341 |
| erosive | #341 |
| rat | #341 |
| 6weeks | #342 |
| incident cardiovascular events | #342 |
| animal enzyme inhibitors | #342 |
| specific autoimmune | #342 |
| diabetic mouse | #343 |
| rats injection | #343 |
| drb1 alleles | #343 |
| sequence animals | #343 |
| rapid spread | #343 |
| monoclonals | #344 |
| 182780 | #344 |
| favor | #345 |
| acpa positivity | #345 |
| energetic costs | #346 |
| intraperitoneal injection | #347 |
| pemphigus vulgaris pv | #348 |
| reduced capacity | #349 |
| complement activity | #349 |
| neuritis | #349 |
| igg autoantibodies | #350 |
| phenotype rats | #351 |
| thymic selection | #352 |
| methylcholanthrene | #352 |
| anti cyclic | #353 |
| immunoregulation | #353 |
| mice induction | #353 |
| c3h hej | #353 |
| arthritis synovial | #354 |
| autoantigens autoimmune | #354 |
| mice cd4 | #354 |
| splenic macrophages | #355 |
| dsg3 | #357 |
| adjuvant activity | #358 |
| tbetarii | #358 |
| cells autoantibodies | #358 |
| injected | #359 |
| enos | #359 |
| neuritogenic | #359 |
| tcrbeta | #360 |
| freund | #361 |
| pvg | #361 |
| tlr3 | #361 |
| murine lupus | #362 |
| hla transgenic | #362 |
| mouse chromosome | #363 |
| determines | #363 |
| generation ros | #363 |
| allergic encephalomyelitis | #363 |
| identification genes | #363 |
| hladr4 | #364 |
| recognized | #364 |
| cells anti | #364 |
| european journal | #366 |
| glycoproteins mice | #366 |
| sex chromosomes | #366 |
| immune deviation | #366 |
| antiidiotypic antibodies | #367 |
| psychosocial stress | #367 |
| toxic shock | #368 |
| 100 micrograms | #368 |
| ncf2 | #368 |
| loci | #368 |
| affinity ligand | #368 |
| autoimmune responses | #368 |
| nasal administration | #369 |
| histocompatibility antigens | #369 |
| pentameric | #369 |
| increased production | #370 |
| immune pathogenesis | #370 |
| serum transfer | #371 |
| regulate | #371 |
| clinical onset | #371 |
| role mif | #372 |
| newborn antibodies | #372 |
| alternative activation | #373 |
| rheumatoid cell | #375 |
| autoantigens | #375 |
| undifferentiated arthritis | #376 |
| acutephase proteins | #376 |
| glucose6 | #377 |
| gia | #379 |
| reparixin | #380 |
| mouse monoclonal antibody | #381 |
| oxidase deficiency | #381 |
| induced lupus | #381 |
| fia | #382 |
| fragments immunoglobulin | #382 |
| granulomatous | #383 |
| naive rats | #384 |
| specific loci | #384 |
| c1a | #384 |
| granulomatous disease | #384 |
| postmenopausal bone loss | #385 |
| shock syndrome | #385 |
| cell specificity | #386 |
| pc4 | #386 |
| antioxid | #387 |
| filaggrin | #387 |
| backcrosses | #387 |
| ptpn22 gene | #387 |
| phase response | #388 |
| inbred nod receptors | #388 |
| downregulating | #389 |
| greater 50 | #390 |
| ovulation rate | #390 |
| deficient | #390 |
| peptidylarginine | #391 |
| radiological progression | #391 |
| anaphylatoxin c5a | #391 |
| finetune | #392 |
| rf1 | #394 |
| il4 il10 | #394 |
| ameliorating | #395 |
| draining | #397 |
| induced metabolic | #397 |
| autoantibody levels | #397 |
| juvenile chronic arthritis | #398 |
| regulation animals | #399 |
| protein myelin | #399 |
| immunized mice | #399 |
| inflammatory reactions | #400 |
| reactive oxygen species | #400 |
| genes cells | #401 |
| antibody formation | #401 |
| biacore | #403 |
| inflammation demyelination | #403 |
| immunopeptidome | #403 |
| fcγriib | #404 |
| beta chain | #404 |
| experimental | #405 |
| basic protein | #405 |
| n31 | #407 |
| rheumatoid case | #407 |
| effects models | #407 |
| pam3csk4 | #408 |
| major locus | #409 |
| immunogenetics | #409 |
| diabetes loci | #410 |
| intracellular processing | #410 |
| 3hproline | #410 |
| cell phenotypes | #412 |
| hladrb1 | #412 |
| cd43 | #412 |
| titres | #413 |
| susceptibility loci | #413 |
| characteristic feature | #414 |
| reproductive performance | #414 |
| igk | #415 |
| cultured collagen | #415 |
| female mice | #416 |
| levels autoantibodies | #416 |
| spontaneous mutation | #417 |
| lupus mice | #417 |
| synovial inflammation | #417 |
| genetically modified mice | #418 |
| molecular interactions | #419 |
| induced pain | #419 |
| wtccc | #419 |
| class hdacs | #419 |
| hiit | #420 |
| ameliorate | #420 |
| tcell | #421 |
| lower affinity | #422 |
| dr4 | #422 |
| lipidomic | #423 |
| subsets animals | #424 |
| restricted | #424 |
| hyaline cartilage | #425 |
| congenic strain | #426 |
| regulatory animals | #426 |
| inflammatory cells | #426 |
| carbohydrate moiety | #429 |
| epitopes humans | #430 |
| nonimmunogenic | #430 |
| nod mouse | #430 |
| postimmunization | #430 |
| immunoregulatory | #431 |
| patients healthy individuals | #433 |
| il10 mice | #433 |
| cells antibodies | #434 |
| factor 5 | #435 |
| spontaneous autoimmune | #435 |
| reactivities | #436 |
| cells beta | #436 |
| chromosomes chromosome | #437 |
| mass spectrometric analysis | #437 |
| decalcified | #437 |
| crystallizable | #437 |
| specific antigens | #438 |
| helperinducer tlymphocytes | #438 |
| immunised | #438 |
| mice effects | #438 |
| joint swelling | #439 |
| cells | #439 |
| nod | #440 |
| wildtype mice | #440 |
| female immunoglobulin | #441 |
| vitro techniques leukocytes | #441 |
| effector functions | #441 |
| normal rats rats | #441 |
| patients population | #442 |
| complete adjuvant | #442 |
| mice activation | #442 |
| methylβcyclodextrin | #443 |
| mhc class molecules | #443 |
| myelin basic | #444 |
| tlr2 expression | #444 |
| skeletal muscle function | #445 |
| genomewide scan | #445 |
| mice humans | #445 |
| systemic mice | #445 |
| mouse models | #445 |
| ros production | #447 |
| inbred strains receptors | #448 |
| induced mice | #448 |
| control mice | #448 |
| pain model | #448 |
| tcell responses | #449 |
| complement factor | #449 |
| synovial tissue | #449 |
| innate adaptive | #450 |
| igg anti | #451 |
| apcs | #451 |
| hybridoma cells | #452 |
| heterologous | #452 |
| reduced production | #452 |
| differs | #454 |
| cells chronic | #456 |
| lglutamine | #456 |
| inbred c57bl tlymphocytes | #457 |
| raloxifene | #457 |
| priming | #459 |
| resembling | #459 |
| eae cns | #459 |
| rheumatoid cells | #459 |
| lung macrophages | #459 |
| antibodies monoclonal | #460 |
| autoantigen | #462 |
| neutrophil functions | #462 |
| 256 | #462 |
| gilt | #463 |
| fab fragments | #464 |
| autoantibody production | #465 |
| receptor tcr | #466 |
| salivary glands | #466 |
| cells lymph | #467 |
| earlier onset | #469 |
| titers | #469 |
| disease mice | #474 |
| antibody mediated | #474 |
| anticyclic citrullinated peptide | #474 |
| arthritic rats | #474 |
| cartilage cells | #475 |
| human autoimmune | #476 |
| mice exhibited | #477 |
| cluster genes | #477 |
| therapeutic vaccination | #478 |
| mediated inflammation | #478 |
| laboratory rat | #479 |
| female hla | #479 |
| apoptosis arthritis | #479 |
| aggravated | #480 |
| deacetylase 1 | #480 |
| quantitative trait loci | #480 |
| polymorphonuclear cells | #482 |
| anti idiotypic | #482 |
| immune reactions | #484 |
| immunologists | #485 |
| immunoglobulin male | #486 |
| jca | #487 |
| oxyntic | #487 |
| controlling | #487 |
| tcralpha | #487 |
| invariant natural | #488 |
| insulitis | #488 |
| specific immune | #488 |
| gland animals | #489 |
| normal mice | #490 |
| cytoplasmic calcium | #494 |
| nacetylglucosaminidase | #495 |
| reactive nitrogen | #496 |
| conclude | #496 |
| h2b | #496 |
| gammadelta cells | #496 |
| early rheumatoid | #496 |
| mbp | #498 |
| small effects | #498 |
| receptor 9 | #499 |
| biologicals | #500 |
| autoreactive cd4 | #503 |
| immunoenzyme techniques | #503 |
| nadph | #503 |
| pathogenic | #506 |
| chondrocytes collagen | #507 |
| immunofluorescence analysis | #507 |
| isopropyl | #508 |
| mab mabs | #508 |
| persistent pain | #508 |
| mineral oil | #508 |
| gingipain | #509 |
| immunization passive | #509 |
| orosomucoid | #509 |
| mice knockout mice | #510 |
| mhc class | #510 |
| c3h hej mice | #511 |
| 812 | #511 |
| deficient mice | #511 |
| differential gene | #511 |
| systemic spread | #511 |
| blymphocytes | #512 |
| mrp8 | #515 |
| hydroxyquinolines | #517 |
| behavioral alterations | #517 |
| u1 | #518 |
| antibody complex | #518 |
| inflammation | #519 |
| suggestive linkage | #519 |
| chronic granulomatous disease | #519 |
| tcr recognition | #520 |
| modified form | #521 |
| ttg | #522 |
| dextran sulfate sodium | #522 |
| pcorr | #522 |
| inflammation role | #523 |
| data peptide | #523 |
| encephalitogenic | #524 |
| litter size | #524 |
| p47phox | #524 |
| neutrophil granulocytes | #525 |
| mnc | #526 |
| tconv | #526 |
| mechanical hypersensitivity | #526 |
| maternal antibodies | #527 |
| disease acute | #527 |
| spleen cells | #527 |
| larsen | #528 |
| tolonium | #528 |
| primed | #528 |
| vaccinates | #528 |
| tolllike receptor tlr4 | #529 |
| ifa | #529 |
| rat rats | #529 |
| displayed | #529 |
| cell antibodies | #530 |
| isac | #530 |
| antigen presentation | #530 |
| autoantibody | #530 |
| pathogenesis sle | #530 |
| ratg | #531 |
| bred | #532 |
| epistatic | #532 |
| lyt2 | #533 |
| complex role | #533 |
| posttranslational receptors | #534 |
| translational modification | #536 |
| resorptions | #536 |
| spleen lymphocytes | #536 |
| synovial | #537 |
| urokinase | #537 |
| experimental rats | #538 |
| animals | #538 |
| cells inflammatory | #538 |
| joints | #540 |
| antigen recognition | #540 |
| suppressive | #540 |
| fibroblast synoviocytes | #540 |
| membrane attack complex | #541 |
| rheumatoid humans | #543 |
| specific autoantibodies | #544 |
| protein tyrosine phosphatase | #545 |
| regulating | #545 |
| hypomorphic | #546 |
| tlymphocytes | #547 |
| animal gene | #547 |
| shortcut | #547 |
| entheses | #548 |
| formyl peptide receptors | #548 |
| immunohistochemical methods | #548 |
| mog | #550 |
| immunoglobulin fab | #552 |
| mixed lymphocyte reaction | #553 |
| nox activity | #554 |
| breeder | #555 |
| stronger association | #557 |
| beta animals | #557 |
| cell epitopes | #557 |
| cells control | #558 |
| early onset | #559 |
| healthy mice | #560 |
| elispot assay | #561 |
| transgenic molecular | #562 |
| ptdins3p | #563 |
| inbred strains | #563 |
| negative selection | #563 |
| neutrophil depletion | #564 |
| deeper layers | #565 |
| therapeutic treatment | #565 |
| target tissue | #566 |
| darkness | #566 |
| earlier | #566 |
| immunoglobulin heavy chains | #566 |
| crucial | #567 |
| outbred | #568 |
| interferon signature | #568 |
| disease loci | #568 |
| mycobacteria | #569 |
| neutrophilia | #569 |
| cells pathogenesis | #569 |
| concomitantly | #570 |
| mice compared | #571 |
| btla | #572 |
| transgenic mouse models | #572 |
| keratin8 | #573 |
| col2 | #574 |
| pepstatins | #576 |
| presenting | #576 |
| terpenes | #577 |
| estrogen treatment | #577 |
| prolactin prl | #578 |
| keratinocyte growth factor | #578 |
| ptm | #579 |
| sera patients | #579 |
| triple helix | #580 |
| methotrexate mice | #581 |
| f1 hybrids | #581 |
| hybridoma | #583 |
| production ifngamma | #583 |
| inflammatory joint | #583 |
| lymphocyte antigens | #584 |
| exaggerated | #584 |
| time onset | #584 |
| antibody reactions | #585 |
| traps nets | #590 |
| environmental triggers | #591 |
| antigen antibody | #591 |
| oligoclonal | #592 |
| immunological tolerance | #592 |
| lxrα | #592 |
| transgenic models | #593 |
| noncollagenous | #593 |
| autoimmune disorders | #594 |
| adaptive immunity | #594 |
| macrophages | #594 |
| clonal expansion | #595 |
| th1 cytokines | #595 |
| multiplexing | #595 |
| xanthine oxidoreductase | #596 |
| cells study | #599 |
| tcell activation | #599 |
| develop | #600 |
| augmented | #602 |
| n85 | #602 |
| th2 cytokines | #602 |
| spite | #602 |
| pemphigus vulgaris | #603 |
| common diseases | #603 |
| mouse monoclonal | #603 |
| cells involved | #604 |
| phagosomal | #604 |
| cells male | #604 |
| oxa | #606 |
| animal rats | #606 |
| mice inbred | #606 |
| class humans | #607 |
| genotype hla | #608 |
| frozen sections | #608 |
| spleen animals | #609 |
| inefficiently | #610 |
| regulatory role | #610 |
| production ifn | #611 |
| naive | #611 |
| positive individuals | #612 |
| quantitative trait locus | #615 |
| exponential phase | #616 |
| alpha chains | #616 |
| class antigens | #616 |
| acetophenones | #616 |
| autoantibodies | #616 |
| mutant strains receptors | #616 |
| th1 type | #616 |
| idiotypic | #616 |
| nonobese | #617 |
| oral immunization | #617 |
| beta type | #618 |
| day mice | #619 |
| wistar restraint | #620 |
| promiscuous | #620 |
| consequent | #621 |
| inflammatory role | #621 |
| receptor 3 | #621 |
| nicotinamide adenine | #622 |
| receptors antigen | #624 |
| fluorine18 | #624 |
| loci identified | #625 |
| chronic stage | #625 |
| animal mice | #628 |
| cytoplasmic ca2 | #628 |
| local injection | #629 |
| cross reactions | #630 |
| inflammatory disease | #630 |
| healthy rats | #632 |
| reactive antibodies | #632 |
| development eae | #633 |
| highintensity interval training | #634 |
| fibromodulin | #634 |
| vivo binding | #635 |
| langerhans cells | #635 |
| ifn beta | #637 |
| nabs | #637 |
| class genes | #638 |
| cells inhibition | #638 |
| inflammation autoimmunity | #640 |
| estrogens female | #640 |
| biotinylated | #643 |
| mouse lung | #644 |
| cell binding | #645 |
| immune serum | #646 |
| haplotype | #649 |
| patients sera | #650 |
| antigen specificity | #650 |
| genetic disease | #652 |
| hexadecane | #654 |
| idiotypic antibodies | #654 |
| antibody titres | #655 |
| interphalangeal | #655 |
| genetic linkage | #658 |
| new pathway | #658 |
| axotomized | #659 |
| cyba | #660 |
| sialoprotein | #660 |
| acute inflammation | #661 |
| peptide binding | #661 |
| inbred cba mice | #661 |
| mutated | #662 |
| cartilage destruction | #663 |
| ifng | #664 |
| animal ear | #665 |
| delayed hypersensitivity | #665 |
| receptors igg | #666 |
| reactive | #666 |
| superantigens | #666 |
| 264 | #666 |
| lymphoid organs | #666 |
| activation mice | #669 |
| drb1 | #670 |
| apeced | #670 |
| disease autoimmune | #671 |
| purified proteins | #673 |
| treatment protocol | #674 |
| cells induce | #674 |
| pyramidal neurons | #675 |
| genetic epistasis | #675 |
| desmoglein | #675 |
| strikingly | #676 |
| germinal center | #677 |
| idiotypes | #677 |
| adherent cells | #677 |
| china cohort | #678 |
| major genes | #679 |
| il12p70 | #679 |
| igg response | #679 |
| thelper | #680 |
| cells role | #682 |
| lymphocytes mice | #682 |
| inbred c57bl mice | #683 |
| normal animals | #683 |
| puzzle | #683 |
| helper cell | #684 |
| specific antibody | #684 |
| intradermal injection | #686 |
| transgenic receptors | #687 |
| βarrestin | #688 |
| foot joints | #689 |
| subsets | #689 |
| delayed | #689 |
| rendered | #690 |
| early rheumatoid arthritis | #690 |
| production autoantibodies | #691 |
| disease genes | #692 |
| muscle glucose | #695 |
| knockout polymorphism | #695 |
| paam | #696 |
| igg antibodies | #696 |
| luminex | #697 |
| anas | #697 |
| mice model | #698 |
| disease hla | #698 |
| uterus | #700 |
| heavy chain genes | #701 |
| microspectroscopy | #703 |
| inbred | #704 |
| quantitative trait | #704 |
| complete freund | #706 |
| histopathological analysis | #707 |
| fibroblastlike synoviocytes | #707 |
| extracellular trap | #708 |
| specific cells | #710 |
| estradiol female | #710 |
| igl | #712 |
| posttranslational | #713 |
| predetermined | #716 |
| spleens | #716 |
| mice lacking | #717 |
| acute bout | #718 |
| antibodies patients | #718 |
| lymphocyte depletion | #719 |
| proliferative response | #720 |
| regulatory function | #720 |
| buf | #721 |
| deficiency syndromes | #721 |
| surrounding tissues | #722 |
| th1 th17 | #723 |
| human hand | #725 |
| macrophages mice mice | #725 |
| cd1d | #728 |
| dmaema | #728 |
| th2 cytokine | #729 |
| ccps | #729 |
| mhc molecules | #729 |
| cdk6 | #730 |
| cns inflammation | #732 |
| animals antigens antigens | #732 |
| cholesterol metabolism | #732 |
| administrated | #732 |
| excessive inflammation | #734 |
| finding | #735 |
| net formation | #736 |
| rats treatment | #736 |
| locus | #737 |
| cheeks | #739 |
| operates | #740 |
| c57bl | #740 |
| species specificity | #741 |
| cd5 cells | #741 |
| tissue destruction | #742 |
| nkt | #742 |
| immunologic deficiency | #743 |
| vivo mice | #743 |
| cell responses | #743 |
| treatment anti | #744 |
| role disease | #746 |
| mycobacterial infections | #747 |
| autoantibodies autoimmunity | #749 |
| intensity interval | #749 |
| keratinocyte | #749 |
| nonobese diabetic mice | #749 |
| transferred | #751 |
| preclinical phase | #751 |
| control disease | #753 |
| hapten | #755 |
| tlr activation | #755 |
| metabolomic | #755 |
| ere | #755 |
| mice anti | #757 |
| disease protection | #758 |
| autoantibodies type | #758 |
| phenotypic differences | #758 |
| hyperinflammatory | #759 |
| reacted | #759 |
| linkage region | #760 |
| knockout tlymphocytes | #760 |
| ifngamma production | #761 |
| ccp | #761 |
| polycytidylic | #762 |
| immunocap | #763 |
| gamma ifn | #765 |
| glut4 translocation | #767 |
| periarticular | #772 |
| redox signal | #773 |
| hkexchanging | #773 |
| cells apcs | #773 |
| peripheral tolerance | #774 |
| afflicted | #777 |
| fab fragment | #778 |
| diseases cell | #778 |
| interacted | #779 |
| inbred nzb | #780 |
| acid transporters | #781 |
| nox1 | #782 |
| arthritis osteoarthritis | #782 |
| pathogenic role | #782 |
| development autoimmunity | #782 |
| arthritis psa | #783 |
| chronic colitis | #784 |
| clinical scores | #786 |
| transgenic mutation | #789 |
| peptide fragments | #790 |
| transgenic receptors antigen | #790 |
| inflammatory lesions | #790 |
| reduced incidence | #790 |
| pineal gland | #791 |
| polyarthritis | #792 |
| cell gamma | #793 |
| cell humans | #794 |
| antibodies directed | #794 |
| neutrophil function | #796 |
| interval training | #796 |
| neutrophil extracellular | #796 |
| pathogen free | #797 |
| lymphocyte proliferation | #798 |
| genes immunoglobulin | #798 |
| carbohydrate moieties | #800 |
| matrix proteins | #801 |
| polyi | #801 |
| monoclonal binding | #802 |
| blymphocyte chain genes | #802 |
| thy1 | #802 |
| innate adaptive immunity | #802 |
| helper cells | #805 |
| redox control | #805 |
| induces | #805 |
| count male | #805 |
| multinucleated giant cells | #808 |
| backcrossing | #809 |
| bone erosion | #810 |
| function mutation | #811 |
| catabolism | #811 |
| strains receptors | #812 |
| acc1 | #812 |
| resident cells | #812 |
| febuxostat | #813 |
| nonreceptor type | #815 |
| arginines | #817 |
| ctb | #817 |
| leads | #820 |
| auricle | #820 |
| collagen cross | #821 |
| cd8 antigens | #821 |
| leukocyte infiltration | #822 |
| piece | #823 |
| humoral immune response | #824 |
| colocalizes | #824 |
| electroporated | #824 |
| prominently | #825 |
| genetic environmental | #825 |
| psoriasis psoriatic arthritis | #825 |
| response animals | #826 |
| muscle training | #826 |
| chondroid | #827 |
| growth factor beta | #829 |
| class antigen | #829 |
| producing | #830 |
| effects immune | #830 |
| cross reactivity | #834 |
| lpr | #841 |
| inbred c57bl | #841 |
| immunoglobulin mice | #842 |
| peyers patches | #842 |
| therapeutic approaches | #844 |
| diabetic nod | #844 |
| il25 | #845 |
| chronic active | #845 |
| mice transgenic | #846 |
| inflammatory arthritis | #846 |
| induce | #848 |
| intermingled | #850 |
| macroscopically | #851 |
| antigen cell | #852 |
| lymphocyte | #852 |
| new possibilities | #854 |
| leukocyte migration | #854 |
| tcell receptors antigen | #855 |
| ms275 | #855 |
| alveolar mice mice | #856 |
| importantly | #856 |
| strongest association | #856 |
| mcv | #858 |
| post translational | #861 |
| immune defence | #862 |
| treatment reduced | #865 |
| lyme | #866 |
| factor anti | #867 |
| mediated inflammatory | #867 |
| knockin mice | #867 |
| mice reduced | #867 |
| cross reactive | #868 |
| strongest | #868 |
| hinge region | #869 |
| parietal cells | #869 |
| lentiviral | #869 |
| lnc | #872 |
| dextran sulfate | #873 |
| immune tolerance | #873 |
| parasitemia | #874 |
| lower expression | #874 |
| elisas | #875 |
| cells expressing | #876 |
| granulomas | #877 |
| fcγri | #878 |
| synovial fluid patients | #878 |
| arthritis inflammatory | #879 |
| antigen4 | #881 |
| adoptive | #881 |
| pregnancy animal | #882 |
| systemic autoimmune diseases | #882 |
| testosterone treatment | #883 |
| fluid synovial | #884 |
| cartilaginous | #888 |
| standard therapies | #890 |
| psoriasis vulgaris | #891 |
| genetic dissection | #891 |
| basic | #893 |
| regulator | #895 |
| completely | #896 |
| inflammation mediators | #897 |
| intranasal administration | #897 |
| interleukin1alpha | #898 |
| ctla4 antigen | #898 |
| phosphatase receptor | #902 |
| granulocytes | #904 |
| partly | #904 |
| inception cohort | #905 |
| infiltrations | #906 |
| γδ cells | #906 |
| rats inbred | #907 |
| lipocalins | #908 |
| extracellular traps | #909 |
| immunohistochemical analyses | #910 |
| single injection | #911 |
| liu | #911 |
| immunoglobulin levels | #911 |
| chromosome 16 | #912 |
| lectin pathway | #913 |
| mitochondrial ros | #913 |
| ciita | #914 |
| pneumonitis | #914 |
| enolase | #915 |
| proliferate | #915 |
| allelic variation | #915 |
| immunemediated diseases | #916 |
| cytokine response | #923 |
| antibodies antibody | #924 |
| psoriatic arthritis psa | #924 |
| neutrophil chemotaxis | #924 |
| chromosome mapping | #925 |
| fluorobenzene | #925 |
| cd200 | #925 |
| phenotypic analysis | #926 |
| nkt cells | #926 |
| repertoires | #929 |
| burst | #930 |
| tissue transglutaminase | #931 |
| data role | #932 |
| citrulline | #933 |
| hydratase | #933 |
| alpha animals | #935 |
| macropinocytosis | #936 |
| alters | #937 |
| arthritides | #938 |
| lymphocyte activation | #938 |
| 1040 | #939 |
| synovia | #939 |
| immune reactivity | #940 |
| rns | #940 |
| analysed | #940 |
| vitro stimulation | #941 |
| disease model | #941 |
| genetic analysis | #941 |
| collagen structure | #941 |
| mediated autoimmune | #944 |
| association hla | #945 |
| sciatic nerves | #945 |
| mice mice | #947 |
| fluid patients | #948 |
| inflammatory pathways | #948 |
| clinical observations | #948 |
| humanized mice | #949 |
| riii | #950 |
| vivo | #950 |
| l3t4 | #954 |
| environmental determinants | #955 |
| nos1 | #957 |
| carrying | #958 |
| differentiation tlymphocyte antigens | #959 |
| mhc peptide | #962 |
| levels ros | #962 |
| chronic disease | #963 |
| cellular immunization | #965 |
| monoclonal antigens | #967 |
| cells lymphocytes | #967 |
| animals cytokines | #967 |
| cytotoxic tlymphocytes | #967 |
| cell transfer | #969 |
| lower frequency | #969 |
| chromosome 15 | #971 |
| draining lymph nodes | #972 |
| secreting cells | #973 |
| susceptibility locus | #978 |
| cartilage articular | #979 |
| synovial membrane | #981 |
| w5 | #982 |
| genes chromosome | #982 |
| lymphocytes | #982 |
| binding peptides | #983 |
| pain behavior | #984 |
| tbb | #987 |
| tallele | #988 |
| microspectrophotometry | #990 |
| knockout models | #991 |
| macrophages cells | #991 |
| allergic contact dermatitis | #992 |
| immunodominance | #992 |
| cells reactive | #993 |
| transgenic expression | #994 |
| patients rp | #994 |
| 510 | #994 |
| cartilage bone | #995 |
| hej | #995 |
| formyl peptide | #997 |
| knee joints | #997 |
| spontaneously | #997 |
| laminin fibronectin | #998 |
| antigen expression | #999 |
| immunoglobulin fragments | #1000 |
| lymphocyte subpopulations | #1002 |
| multiple loci | #1003 |
| expands | #1004 |
| processing presentation | #1004 |
| aggravate | #1004 |
| protective role | #1007 |
| igg subclasses | #1011 |
| nrc | #1012 |
| cyclic peptides | #1012 |
| 95 stroke | #1013 |
| interleukin21 | #1013 |
| igg | #1015 |
| model multiple | #1015 |
| direct comparison | #1015 |
| nerve roots | #1016 |
| cellular composition | #1016 |
| cells mast | #1016 |
| aged arthritis | #1017 |
| melatonin levels | #1019 |
| patients early | #1019 |
| cd4 antigens | #1020 |
| immunoglobulin variable | #1022 |
| cysteine protease | #1025 |
| diseases animals | #1026 |
| genetic humans | #1027 |
| innate killer cells | #1028 |
| il4 | #1029 |
| baseline 24 months | #1031 |
| dr1 | #1031 |
| mice treated | #1032 |
| oxidase | #1034 |
| major regulator | #1036 |
| species production | #1039 |
| tramp | #1040 |
| arthritis psoriatic | #1041 |
| expression mrna | #1042 |
| complementary genes | #1043 |
| das28 | #1045 |
| myelin proteins | #1050 |
| parental strain | #1050 |
| patients rheumatoid | #1051 |
| chromosome 5 | #1052 |
| gamma delta | #1055 |
| inflammatory macrophages | #1055 |
| antigens differentiation | #1056 |
| immune defense | #1056 |
| mannans | #1057 |
| rat cells | #1060 |
| morula | #1062 |
| sterile inflammation | #1062 |
| lymphocytes cells | #1062 |
| transgenic | #1063 |
| tarsus | #1066 |
| role immune | #1069 |
| oxazoles | #1069 |
| decidua | #1069 |
| disease humans polymorphism | #1069 |
| synovial fluids | #1071 |
| transgenic cells | #1075 |
| fcγ | #1076 |
| radiological | #1077 |
| peptidylarginine deiminase | #1078 |
| epistasis | #1079 |
| adjuvant cfa | #1080 |
| key steps | #1080 |
| reestablishment | #1082 |
| lymphoid cells | #1082 |
| irf1 | #1086 |
| dependent regulation | #1087 |
| al2 | #1088 |
| haplotypes | #1089 |
| uppsala | #1089 |
| enlarged | #1091 |
| inflamed | #1092 |
| osteoclast formation | #1093 |
| 7 weeks | #1096 |
| oligodendrocyte | #1098 |
| inkt cells | #1102 |
| igs | #1103 |
| effector mechanisms | #1104 |
| cells increased | #1105 |
| arginine deiminase | #1114 |
| subdominant | #1115 |
| fibril | #1115 |
| molecular mimicry | #1115 |
| sclerosis myelin | #1116 |
| clinical disease | #1116 |
| deamidation | #1117 |
| disulfide | #1117 |
| genetic factors | #1117 |
| animal immunity | #1117 |
| cd5 | #1117 |
| antitoxin | #1117 |
| antigenic peptides | #1118 |
| pil | #1121 |
| lymphocytes regulatory | #1123 |
| recognizing | #1126 |
| primary immunodeficiency | #1127 |
| cells ifn | #1128 |
| isomerase | #1128 |
| foreign antigens | #1128 |
| humans lymphocyte | #1128 |
| predisposing | #1128 |
| dissected | #1130 |
| treatment day | #1132 |
| skeletal muscle fibers | #1132 |
| superantigen | #1134 |
| cryosections | #1135 |
| immune response | #1135 |
| overlapped | #1136 |
| vivo administration | #1136 |
| glucosyl | #1136 |
| c57 | #1137 |
| underline | #1138 |
| peptide sequence | #1138 |
| editorial | #1139 |
| anticardiolipin antibodies | #1139 |
| cd4foxp3 | #1142 |
| mice rats | #1146 |
| syntenic | #1147 |
| treatment animals | #1149 |
| helpers | #1149 |
| agonist | #1150 |
| cd4 cells | #1151 |
| subcloned | #1155 |
| disease onset | #1157 |
| antibody affinity | #1160 |
| inactivating | #1161 |
| lxr | #1161 |
| respiratory burst | #1163 |
| prolactin rats | #1164 |
| demonstrating | #1168 |
| stainings | #1168 |
| increased severity | #1170 |
| activated cells | #1171 |
| transduction toll | #1174 |
| gp91phox | #1175 |
| nadph oxidoreductases | #1176 |
| models disease | #1178 |
| inflamed tissues | #1178 |
| 10b | #1179 |
| preponderance | #1180 |
| recombinant interferon | #1180 |
| genetic background | #1181 |
| chemiluminescent | #1182 |
| destructive | #1182 |
| arginine residues | #1184 |
| objective investigate | #1186 |
| disease haplotypes humans | #1186 |
| synovial fibroblasts | #1188 |
| lymphocytes cell | #1188 |
| human type | #1190 |
| ileitis | #1191 |
| rat human | #1192 |
| splenic cells | #1192 |
| antiphospholipid | #1193 |
| primary sjögrens syndrome | #1195 |
| infiltrates | #1195 |
| cells rheumatoid | #1199 |
| susceptibility | #1200 |
| antibody | #1200 |
| basic mechanisms | #1200 |
| antibodies mabs | #1200 |
| somatically | #1201 |
| lung mice mice | #1204 |
| protein arginine | #1208 |
| identified loci | #1210 |
| h2k | #1211 |
| predisposition disease | #1212 |
| onset progression | #1212 |
| c5a | #1213 |
| singlecell | #1214 |
| rationales | #1214 |
| hdacs | #1217 |
| chronic inflammation | #1218 |
| critical issues | #1218 |
| igg subclass | #1220 |
| ilc2 | #1221 |
| adaptive immune response | #1223 |
| mononuclear | #1223 |
| compared wt | #1223 |
| subcellular fractionation | #1224 |
| adaptive immune responses | #1225 |
| tlymphocyte antigens | #1226 |
| chromosome 4 | #1227 |
| antimicrobial peptides amps | #1229 |
| linkage analysis | #1229 |
| analyse | #1230 |
| experimental models | #1231 |
| therapeutically | #1232 |
| subsets lymphocytes | #1233 |
| aps | #1233 |
| host defense | #1238 |
| immunological mechanisms | #1240 |
| human cd4 | #1241 |
| cell lymphocytes | #1244 |
| indel | #1247 |
| mouse | #1250 |
| immune inflammatory | #1251 |
| lining | #1252 |
| ltb | #1253 |
| animal | #1253 |
| dead cells | #1254 |
| animal doseresponse relationship | #1259 |
| mesenteric lymph nodes | #1263 |
| differentiation lymphocyte | #1263 |
| antigen presenting cells | #1264 |
| synovium | #1265 |
| pathogenic mechanisms | #1266 |
| adenine dinucleotide | #1269 |
| suppress | #1269 |
| suppressive function | #1270 |
| molecular pathogenesis | #1270 |
| rheumatoid arthritis patients | #1270 |
| synovial fluid | #1271 |
| rat mouse | #1273 |
| claudin4 | #1274 |
| eae model | #1274 |
| rats mice | #1275 |
| chromosomal regions | #1275 |
| inducer | #1279 |
| rattus norvegicus | #1282 |
| becn1 | #1282 |
| hla molecules | #1283 |
| staphylococcal | #1283 |
| c4a | #1283 |
| rodent models | #1284 |
| spreading | #1286 |
| joint destruction | #1287 |
| attacked | #1288 |
| disease response | #1290 |
| pathological processes | #1294 |
| immunochip | #1295 |
| suppressor cells | #1296 |
| day pregnancy | #1297 |
| serm | #1297 |
| peripheral cells | #1297 |
| nadph oxidase activity | #1299 |
| production anti | #1299 |
| data protein | #1300 |
| publication animals antigens | #1300 |
| restimulation | #1305 |
| model experimental | #1307 |
| hdac3 | #1307 |
| peptide library | #1309 |
| ali | #1310 |
| social isolation | #1310 |
| fab2 | #1312 |
| phagocytic cells | #1313 |
| generated | #1313 |
| introgressed | #1314 |
| permissive | #1315 |
| lymphoproliferation | #1315 |
| detailed characterization | #1316 |
| immune | #1316 |
| increased susceptibility | #1316 |
| protects | #1319 |
| estradiol treatment | #1320 |
| immunoglobulin isotypes | #1321 |
| hydrolyzes | #1321 |
| phagocytes | #1322 |
| intrathymic | #1322 |
| healthy human subjects | #1322 |
| submandibular | #1323 |
| collagen types | #1323 |
| aureus infections | #1325 |
| acute phase proteins | #1327 |
| valuable tool | #1327 |
| therapeutic antibodies | #1328 |
| dietary nitrate | #1329 |
| receptor 2 | #1330 |
| human igg | #1330 |
| immunological memory | #1332 |
| pockets | #1333 |
| thymectomy | #1335 |
| identically | #1335 |
| rats rats | #1336 |
| new therapies | #1336 |
| acute phase response | #1338 |
| induction phase | #1341 |
| cells mice | #1341 |
| adjuvants | #1344 |
| increasing evidence | #1348 |
| knockout mutation | #1349 |
| promiscuity | #1350 |
| galactosylceramides | #1356 |
| allergic contact | #1359 |
| elimination | #1361 |
| position | #1361 |
| alp | #1361 |
| regulatory genes | #1362 |
| disease activity score | #1364 |
| believed | #1364 |
| n44 | #1366 |
| hypersensitivity | #1367 |
| 590 | #1368 |
| bacterial arthritis | #1372 |
| ameliorates | #1374 |
| shared | #1375 |
| betad | #1375 |
| membrane glycoproteins | #1375 |
| trait | #1375 |
| rat spinal cord | #1379 |
| il1r | #1381 |
| abrogates | #1383 |
| immunogen | #1383 |
| surface cells | #1384 |
| rats humans | #1388 |
| exacerbation | #1388 |
| variable region | #1389 |
| suffer | #1389 |
| regulatory treg | #1390 |
| clinical signs | #1390 |
| cd2 | #1390 |
| squalene | #1392 |
| human patients | #1392 |
| phage display | #1393 |
| feto | #1393 |
| cd4cd8 | #1394 |
| effects rats | #1396 |
| disease outcomes | #1397 |
| inbred mice | #1397 |
| positional | #1399 |
| submandibular glands | #1400 |
| joint disease | #1403 |
| early patients | #1403 |
| mononuclear phagocytes | #1406 |
| linkage genetic | #1409 |
| disease phenotypes | #1412 |
| animals disease | #1413 |
| antigens humans | #1415 |
| enzymelinked immunosorbent | #1416 |
| humans immune | #1417 |
| activation neutrophils | #1417 |
| cytokine profile | #1424 |
| class switching | #1425 |
| bacterial infections | #1431 |
| genetic heterogeneity | #1436 |
| gene usage | #1438 |
| stages disease | #1439 |
| cells type | #1440 |
| peptide | #1441 |
| guillainbarré syndrome | #1451 |
| arthritis systemic | #1453 |
| inbred strains mice | #1454 |
| alpha1 | #1458 |
| cell activation | #1458 |
| monoclonal | #1460 |
| proinflammatory responses | #1461 |
| knockout rats | #1461 |
| expression genetic | #1462 |
| lupus | #1464 |
| salt concentrations | #1465 |
| ccr6 | #1467 |
| opens | #1467 |
| pfp | #1467 |
| cell origin | #1468 |
| inflammatory properties | #1469 |
| cells pregnancy | #1472 |
| activation status | #1473 |
| cartilage cell | #1474 |
| immune deficiency | #1474 |
| muscle muscle | #1476 |
| cells activated | #1478 |
| allelic variants | #1479 |
| allotype | #1480 |
| specific gene | #1482 |
| responses animals | #1482 |
| markers genetic | #1483 |
| blisters | #1483 |
| initiate | #1486 |
| genetic regulation | #1486 |
| inflammatory diseases | #1486 |
| cells lung | #1486 |
| stroke 95 | #1487 |
| host defence | #1489 |
| hormone release | #1489 |
| donated | #1490 |
| inbred rats | #1491 |
| human cartilage | #1491 |
| mice day | #1491 |
| humoral immune | #1497 |
| myelin | #1499 |
| emphysematous | #1499 |
| treatment inflammatory | #1504 |
| regulatory effects | #1504 |
| monocytes neutrophils | #1504 |
| specific monoclonal | #1505 |
| vivo vitro | #1505 |
| joint arthritis | #1507 |
| mimicking | #1507 |
| eluate | #1507 |
| fls | #1508 |
| mapped | #1509 |
| inflammatory cell | #1510 |
| hindlimbs | #1511 |
| chromosome 6 | #1512 |
| stimulates | #1515 |
| egfp | #1516 |
| induced ali | #1520 |
| human leukocyte antigen | #1524 |
| lia | #1525 |
| earlier studies | #1525 |
| genes dominant | #1528 |
| knockout mitochondria | #1530 |
| sex steroids | #1531 |
| streptococcus pyogenes | #1533 |
| glutamic acid | #1535 |
| malaise | #1536 |
| lysines | #1537 |
| downregulate | #1540 |
| net release | #1545 |
| protein rna | #1546 |
| production macrophages | #1547 |
| unexpectedly | #1547 |
| increased numbers | #1548 |
| acetylglucosaminidase | #1549 |
| chronic phase | #1554 |
| higher level | #1555 |
| mediated diseases | #1559 |
| intraperitoneally | #1560 |
| 4 humans | #1563 |
| copy variations | #1563 |
| neuroimmunomodulation | #1563 |
| activate | #1564 |
| intradermal | #1565 |
| vsg | #1566 |
| matrix components | #1567 |
| guerin | #1567 |
| mammalian embryo | #1568 |
| immunoglobulin humans | #1568 |
| formyl | #1569 |
| sufficient | #1573 |
| pineal | #1574 |
| cytotoxic lymphocyte | #1574 |
| cochran | #1577 |
| independent | #1577 |
| cathelicidin | #1578 |
| glycolipid | #1580 |
| collagens | #1585 |
| fab | #1592 |
| mac1 | #1593 |
| factor beta | #1597 |
| directed | #1597 |
| conserved | #1597 |
| defines | #1598 |
| twins | #1600 |
| f1 | #1600 |
| cell mediated | #1600 |
| adoptive transfer | #1600 |
| reactive nitrogen species | #1603 |
| autoantibodies biomarkers | #1604 |
| cell receptor | #1605 |
| estriol | #1607 |
| cells th17 | #1607 |
| helical | #1611 |
| stromal cells | #1615 |
| chondrocyte | #1616 |
| immunity animals | #1617 |
| chronic inflammatory diseases | #1617 |
| isosteric | #1619 |
| autoimmune diabetes | #1621 |
| anaphylatoxin | #1622 |
| c57bl 6 | #1622 |
| humans immunoglobulin | #1622 |
| differently | #1625 |
| unreactive | #1626 |
| antigen | #1626 |
| rat spinal | #1629 |
| iggs | #1630 |
| complement component | #1632 |
| c3b | #1635 |
| immunohistology | #1635 |
| collagen fibers | #1639 |
| lund | #1639 |
| type interferon | #1641 |
| mice increased | #1642 |
| p6 | #1644 |
| abrogated | #1644 |
| c4b | #1645 |
| aspartic acid | #1647 |
| intracellular ros | #1651 |
| sjl | #1652 |
| opsonization | #1653 |
| complement activation | #1657 |
| defence | #1658 |
| linked | #1658 |
| complement receptors | #1660 |
| commonly | #1660 |
| staphylococcal enterotoxin | #1661 |
| immune complexes | #1661 |
| transporter type | #1661 |
| enterotoxins | #1662 |
| mice knockout | #1664 |
| tcell receptors | #1665 |
| salt intake | #1668 |
| tumor vasculature | #1669 |
| coincided | #1670 |
| primary sjögren | #1671 |
| isopropylacrylamide | #1672 |
| immunologic epitopes | #1673 |
| pathogenic cells | #1673 |
| gamma production | #1678 |
| single nucleotide | #1683 |
| complement c5a | #1686 |
| cd206 | #1686 |
| auto | #1689 |
| cocktail | #1689 |
| igm antibodies | #1691 |
| method analysis | #1693 |
| agouti | #1694 |
| ido1 | #1694 |
| classical pathway | #1696 |
| transgenic mice | #1696 |
| severity | #1701 |
| 5 months | #1704 |
| triple | #1704 |
| animals autoantigens | #1704 |
| precede | #1704 |
| suppressors | #1706 |
| encoded | #1707 |
| treg cells | #1711 |
| disulfiram | #1711 |
| beta chains | #1712 |
| erosions | #1712 |
| mice neutrophils | #1714 |
| ankylosis | #1719 |
| sjögrens syndrome | #1719 |
| evoke | #1720 |
| tolerance | #1721 |
| pulmonary aspergillosis | #1721 |
| skewing | #1725 |
| oophorectomy | #1727 |
| showing | #1728 |
| mutant mice | #1729 |
| myelin proteolipid | #1729 |
| drug targets | #1732 |
| 369 | #1734 |
| analysis protein | #1734 |
| immune responses | #1734 |
| staphylococcal infections | #1736 |
| phagocytic | #1737 |
| sicca | #1737 |
| fmoc | #1739 |
| intranasally | #1740 |
| arthritis patients | #1742 |
| affinity binding | #1743 |
| 626 | #1744 |
| prophylactic treatment | #1744 |
| cd11 | #1745 |
| osteoclasts | #1746 |
| alternative pathway | #1748 |
| zap70 | #1748 |
| strain mice | #1748 |
| new loci | #1749 |
| responded | #1750 |
| neoplastic disease models | #1753 |
| peroxide | #1758 |
| infiltrating | #1762 |
| endoglycosidase | #1764 |
| dr2 | #1766 |
| inhibitory receptors | #1766 |
| triggering | #1770 |
| multiple genes | #1770 |
| higher frequency | #1770 |
| glycosylation | #1774 |
| peptide antigens | #1775 |
| operate | #1776 |
| blocking | #1781 |
| adoptively | #1782 |
| cnbr | #1783 |
| articular cell | #1784 |
| ll37 | #1784 |
| local administration | #1788 |
| immunohistological | #1789 |
| compartmentalized | #1791 |
| carbohydrates | #1792 |
| pathogenesis | #1793 |
| dogma | #1794 |
| render | #1794 |
| competed | #1797 |
| immune recognition | #1800 |
| disease pathogenesis | #1801 |
| polymorphism genetic | #1801 |
| rat models | #1802 |
| rechallenge | #1803 |
| cd19 antigens | #1803 |
| peyer | #1804 |
| obese diabetic | #1805 |
| aureus infection | #1808 |
| immunogenic | #1810 |
| predisposed | #1810 |
| elucidation | #1811 |
| complement pathway | #1811 |
| activated lymphocytes | #1811 |
| psoriatic | #1813 |
| recovery phase | #1814 |
| nonfunctional | #1817 |
| pregnancy rats | #1817 |
| ossification | #1818 |
| promoting | #1818 |
| il2r | #1818 |
| intravenously | #1819 |
| blymphocyte | #1819 |
| crossed | #1823 |
| katpase | #1824 |
| myelin sheath | #1825 |
| hydroxylated | #1825 |
| neurodegenerative diseases | #1827 |
| deplete | #1830 |
| female sex | #1833 |
| genetic susceptibility | #1836 |
| new treatments | #1839 |
| pathogenesis disease | #1841 |
| trif | #1843 |
| resolution inflammation | #1844 |
| clinical score | #1846 |
| subsequently | #1846 |
| inflammation macrophages | #1847 |
| estrogen | #1848 |
| cultured disease | #1849 |
| pyogenes | #1852 |
| specific immunity | #1854 |
| genetic variance | #1854 |
| cd8 lymphocytes | #1856 |
| macrophages neutrophils | #1856 |
| humoral | #1857 |
| rac2 | #1858 |
| barre | #1858 |
| cocktails | #1860 |
| haenszel | #1862 |
| secreting | #1863 |
| structural basis | #1864 |
| aggravation | #1864 |
| lacrimal apparatus | #1865 |
| silastic | #1871 |
| rats groups | #1871 |
| immunoadsorption | #1873 |
| inkt | #1874 |
| carries | #1875 |
| major | #1876 |
| cartilages | #1879 |
| subsequent development | #1879 |
| candidate | #1883 |
| antigen humans | #1890 |
| inflammation lung | #1892 |
| polyclonal | #1893 |
| bacterial clearance | #1894 |
| ovalbumin | #1897 |
| cyanogen | #1900 |
| striking | #1902 |
| lymphatics | #1903 |
| tcr repertoire | #1903 |
| indicating | #1905 |
| complexity | #1905 |
| proteins rats | #1907 |
| model rats | #1908 |
| gammadelta | #1910 |
| mediated | #1910 |
| enzyme linked | #1911 |
| cells neutrophils | #1912 |
| cell maturation | #1912 |
| interferon gamma | #1914 |
| chromosome | #1916 |
| erythematosus sle | #1916 |
| totally | #1918 |
| 6 hours | #1920 |
| cartilage tissue | #1923 |
| anti | #1924 |
| 721 | #1924 |
| gαq | #1926 |
| pronounced | #1927 |
| ears | #1929 |
| isoantigens | #1931 |
| bcell receptors | #1933 |
| expression cytokines | #1934 |
| trypanosoma brucei | #1937 |
| animals lymphocytes | #1937 |
| sialyltransferases | #1939 |
| mice receptors | #1940 |
| antigen tcell receptors | #1944 |
| type plasminogen | #1945 |
| predisposition | #1949 |
| subclasses | #1950 |
| prevented | #1950 |
| constituting | #1955 |
| cardiac allografts | #1956 |
| snakes | #1957 |
| perforin | #1957 |
| agp | #1959 |
| mmc | #1962 |
| edition | #1967 |
| levels serum | #1967 |
| pinocytosis | #1967 |
| iga igg | #1967 |
| fcγ receptor | #1969 |
| possibilities | #1969 |
| strong | #1971 |
| intravenous injection | #1972 |
| react | #1975 |
| mip | #1977 |
| stimulations | #1978 |
| synovial tissues | #1979 |
| carp | #1979 |
| inbred cba | #1980 |
| ova | #1980 |
| cd154 | #1982 |
| pregnant rats | #1983 |
| cell clone | #1985 |
| disease pathology | #1985 |
| milder | #1988 |
| spans | #1997 |
| mast cell | #1999 |
| cd18 | #2000 |
| transgenic rats | #2001 |
| microglia activation | #2002 |
| presenting cell | #2006 |
| heteroplasmy | #2007 |
| reverted | #2008 |
| contact dermatitis | #2008 |
| rats effects | #2008 |
| prototypic | #2011 |
| abca1 | #2016 |
| response infection | #2016 |
| barré syndrome | #2018 |
| knockout | #2020 |
| tissue inflammation | #2021 |
| immunoglobulin | #2023 |
| genes | #2025 |
| cell | #2027 |
| mabs | #2028 |
| cytokine secretion | #2028 |
| demyelination | #2030 |
| chord | #2031 |
| tetramers | #2032 |
| c5ar | #2033 |
| beta gene | #2035 |
| conformational epitopes | #2035 |
| mesenteric lymph | #2035 |
| factor mif | #2041 |
| 4 tlr4 | #2041 |
| mab | #2042 |
| diethyldithiocarbamate | #2043 |
| immunomodulatory properties | #2044 |
| sex chromosome | #2045 |
| cell immunity | #2047 |
| hypergammaglobulinemia | #2050 |
| oestrogens | #2050 |
| species signal | #2053 |
| cell function | #2053 |
| castration | #2053 |
| coinciding | #2055 |
| emphysema | #2056 |
| glycosylation humans | #2057 |
| increased frequency | #2058 |
| innate inflammation | #2058 |
| dramatically | #2059 |
| vitro vivo | #2061 |
| activation complement | #2061 |
| accompanied | #2067 |
| genetic differences | #2068 |
| dominant | #2070 |
| contributors | #2071 |
| proteomics analysis | #2072 |
| hyaluronoglucosaminidase | #2072 |
| mdsc | #2076 |
| polyradiculoneuropathy | #2077 |
| mature cells | #2077 |
| respiratory tract | #2079 |
| lysine residues | #2080 |
| antiphospholipid syndrome | #2081 |
| cell depletion | #2082 |
| mice pregnancy | #2083 |
| methotrexate mtx | #2094 |
| complement | #2094 |
| conditional deletion | #2095 |
| lysine | #2096 |
| addressed | #2097 |
| αβ | #2100 |
| bioreactor | #2100 |
| suggested | #2102 |
| evokes | #2103 |
| led | #2103 |
| antigens hla | #2104 |
| patients rheumatoid arthritis | #2105 |
| human chondrocytes | #2110 |
| nose | #2117 |
| lentiviral vectors | #2120 |
| glycan | #2122 |
| pulmonary inflammation | #2122 |
| immune functions | #2126 |
| pad4 | #2127 |
| oxidants | #2129 |
| total igg | #2130 |
| secondary receptors | #2133 |
| inducing | #2136 |
| occurring | #2139 |
| histopathological | #2140 |
| target tissues | #2141 |
| selective estrogen | #2141 |
| dissection | #2142 |
| plasminogen | #2143 |
| transduction lymphocytes | #2145 |
| subphenotypes | #2146 |
| extracellular calcium | #2146 |
| h2d | #2147 |
| bound | #2147 |
| circulating monocytes | #2149 |
| 129 strain mice | #2151 |
| immunohistochemical analysis | #2151 |
| reality | #2153 |
| clinical aspects | #2157 |
| periphery | #2161 |
| major histocompatibility complex | #2162 |
| rheumatoid biomarkers | #2165 |
| late stages | #2165 |
| moabs | #2165 |
| prone | #2169 |
| entire | #2174 |
| syringes | #2176 |
| mimics | #2177 |
| animal model | #2179 |
| immune regulation | #2180 |
| human leukocytes | #2181 |
| dynorphins | #2184 |
| psoriatic arthritis | #2184 |
| dnp | #2185 |
| native | #2188 |
| injury ali | #2200 |
| dss | #2203 |
| lps stimulation | #2204 |
| structural requirements | #2211 |
| molecular pathways | #2213 |
| confirming | #2214 |
| 12th | #2215 |
| interleukin2 | #2216 |
| therapeutic effects | #2216 |
| animal mice mice | #2217 |
| activation cells | #2217 |
| naïve | #2219 |
| regulates | #2220 |
| galactose | #2220 |
| suggesting | #2221 |
| wt mice | #2224 |
| immunoreactivity | #2225 |
| mammalian | #2232 |
| shrna | #2232 |
| governs | #2233 |
| neutralized | #2233 |
| presentation | #2234 |
| accelerates | #2236 |
| reduced susceptibility | #2239 |
| ctla4 | #2239 |
| autoimmune conditions | #2239 |
| lacked | #2240 |
| graft rejection | #2244 |
| cholera toxin | #2248 |
| inflammatory phenotype | #2248 |
| cell priming | #2252 |
| exacerbated | #2253 |
| monoclonal antibodies | #2254 |
| cell receptors | #2256 |
| tcell proliferation | #2261 |
| sjögren | #2263 |
| regulation immune | #2265 |
| involved pathogenesis | #2267 |
| hla | #2269 |
| mph | #2274 |
| progeny | #2274 |
| immunospot | #2278 |
| antigenic | #2279 |
| murine | #2279 |
| neutrophil apoptosis | #2280 |
| mice treatment | #2280 |
| lymph nodes | #2281 |
| dependent | #2284 |
| inflammatory | #2288 |
| immunizations | #2289 |
| homologous | #2292 |
| plasmatic | #2293 |
| modified proteins | #2296 |
| histological evaluation | #2296 |
| determining | #2296 |
| cba mice | #2297 |
| regulatory mechanisms | #2299 |
| knockout mice | #2300 |
| apocynin | #2302 |
| segregating | #2308 |
| infiltrating macrophages | #2309 |
| presentation antigens | #2310 |
| wounding | #2312 |
| drastically | #2315 |
| genetic basis | #2315 |
| il10 | #2317 |
| healthy donors | #2318 |
| hydroxylation | #2320 |
| barré | #2320 |
| inflammatory mechanisms | #2321 |
| sera | #2325 |
| throughput nucleotide | #2325 |
| p00002 | #2326 |
| antigens histocompatibility | #2328 |
| wild | #2329 |
| cells induced | #2331 |
| demyelinating disease | #2336 |
| n24 | #2338 |
| lewis | #2345 |
| gk | #2347 |
| reciprocal | #2353 |
| receptor α | #2353 |
| ethylenes | #2358 |
| specific igg | #2358 |
| illness stress | #2361 |
| monosaccharide | #2363 |
| hyaline | #2364 |
| biological agents | #2365 |
| lectins type | #2366 |
| acrylamides | #2366 |
| sex hormone | #2366 |
| degradative | #2367 |
| phosphoproteins | #2369 |
| eliminated | #2374 |
| wf | #2374 |
| immunogens | #2375 |
| lymphotoxin | #2375 |
| peptides derived | #2375 |
| treatment rheumatoid arthritis | #2376 |
| genetic selection | #2376 |
| amps | #2382 |
| cxcl1 | #2382 |
| antinociceptive | #2383 |
| nonalcoholic steatohepatitis | #2384 |
| mouse model | #2386 |
| contaminating | #2386 |
| sidechain | #2391 |
| phenotypes | #2391 |
| receptor transforming | #2392 |
| knock | #2394 |
| syngeneic | #2394 |
| septic arthritis | #2396 |
| systemic lupus erythematosus | #2397 |
| hla genes | #2398 |
| p38 mapk | #2400 |
| inflammatory reaction | #2400 |
| serum autoantibodies | #2408 |
| increased incidence | #2409 |
| mice models | #2411 |
| equina | #2413 |
| intraperitoneal injections | #2418 |
| genetic receptors | #2420 |
| genetic studies | #2420 |
| structure analysis | #2423 |
| realtime pcr | #2424 |
| mice expression | #2426 |
| tlr2 tlr4 | #2429 |
| lentivirus | #2430 |
| suggestive evidence | #2430 |
| acute phase | #2430 |
| unmodified | #2431 |
| cytokines chemokines | #2432 |
| collagen fibrils | #2432 |
| lymphocytes cd4 | #2432 |
| cko | #2432 |
| cells antigens | #2434 |
| early phases | #2440 |
| agents arthritis | #2440 |
| inflammatory activity | #2442 |
| mice multiple | #2446 |
| genetic predisposition | #2449 |
| b6 | #2450 |
| receptors complement | #2450 |
| 551 | #2451 |
| lipoxin | #2458 |
| inflammatory demyelinating | #2459 |
| animal disease models | #2463 |
| exemplified | #2466 |
| idiotype | #2468 |
| antibody responses | #2469 |
| strains | #2471 |
| administration intranasal | #2473 |
| animals cd4 | #2473 |
| translational modifications | #2477 |
| additively | #2477 |
| axotomy | #2477 |
| class | #2480 |
| quantitative | #2480 |
| regulatory | #2487 |
| animal experiments | #2492 |
| specific | #2493 |
| organ specific | #2497 |
| transforming growth factor | #2498 |
| negative feedback | #2501 |
| alleviated | #2502 |
| albeit | #2502 |
| cystatin | #2504 |
| mhc class genes | #2505 |
| multiparous | #2511 |
| transgenic microscopy | #2512 |
| bystander | #2515 |
| il17a | #2516 |
| ppd | #2518 |
| chemokines cytokines | #2519 |
| dichotomous | #2519 |
| contribute | #2522 |
| naturally | #2523 |
| treatment rheumatoid | #2524 |
| hyperostosis | #2525 |
| amiloride | #2526 |
| nod mice | #2527 |
| microsatellite markers | #2534 |
| pathogenicity | #2534 |
| infiltration | #2541 |
| resemblance | #2542 |
| undertaken | #2545 |
| postmenopausal osteoporosis | #2546 |
| proteolipid | #2552 |
| dapsone | #2560 |
| similarities | #2561 |
| igm iga | #2562 |
| plp | #2563 |
| kynurenine | #2563 |
| deprotection | #2564 |
| nox | #2566 |
| succeeded | #2567 |
| fine | #2573 |
| transferring | #2573 |
| passive | #2574 |
| rp patients | #2575 |
| dying cells | #2575 |
| tumor models | #2576 |
| incomplete | #2577 |
| quantitative traits | #2577 |
| complementarity | #2580 |
| peptides | #2585 |
| chick | #2589 |
| calgranulin | #2590 |
| antibody levels | #2591 |
| peritoneal macrophages | #2591 |
| misinterpretation | #2593 |
| interferon type | #2595 |
| sex hormones | #2597 |
| fibrinolysin | #2598 |
| antiinflammatory properties | #2603 |
| onset | #2603 |
| unlinked | #2605 |
| zymosan | #2610 |
| induction | #2611 |
| postulated | #2614 |
| exert | #2615 |
| antimicrobial peptides | #2618 |
| surprising | #2621 |
| interferon beta | #2623 |
| proteolipid protein | #2632 |
| ifn α | #2634 |
| single chain | #2639 |
| sialoglycoproteins | #2643 |
| plasmin | #2647 |
| unable | #2649 |
| asparagine | #2651 |
| tlr9 | #2653 |
| antigens | #2656 |
| disease genotype | #2658 |
| hla antigens | #2659 |
| functional impact | #2663 |
| submandibular gland | #2663 |
| antinuclear | #2663 |
| eluted | #2666 |
| osteonectin | #2667 |
| n22 | #2670 |
| invading | #2670 |
| brucei | #2670 |
| microliters | #2671 |
| biological pathways | #2673 |
| bordetella | #2680 |
| new therapeutic strategies | #2683 |
| ease | #2683 |
| leukocyte antigen | #2688 |
| th1 | #2690 |
| acd | #2696 |
| day treatment | #2697 |
| allelic | #2697 |
| igg3 | #2698 |
| genetic variations | #2698 |
| animal encephalomyelitis | #2702 |
| neutrophils macrophages | #2703 |
| gamma mice | #2711 |
| peptides protein | #2714 |
| γδ | #2716 |
| treatment mice | #2717 |
| rat model | #2718 |
| human complement | #2725 |
| patients anti | #2727 |
| polymorphic | #2729 |
| lymphocyte subsets | #2730 |
| ifngamma | #2730 |
| biased | #2730 |
| post partum | #2731 |
| lamina propria | #2735 |
| fumigatus | #2735 |
| serum anti | #2738 |
| vav | #2743 |
| fragment | #2743 |
| mice exposed | #2750 |
| leucocyte | #2754 |
| resemble | #2762 |
| bromocriptine | #2768 |
| transgenic mouse | #2772 |
| depleting | #2773 |
| human leukocyte | #2774 |
| tyrosine phosphatase | #2774 |
| strong evidence | #2777 |
| cytolysis | #2777 |
| qtls | #2777 |
| iga igm | #2780 |
| enigmatic | #2780 |
| detectable | #2780 |
| genetically | #2782 |
| finemapping | #2785 |
| explanation | #2785 |
| alcoholic steatohepatitis | #2786 |
| treated rats | #2786 |
| intraperitoneal | #2787 |
| tolerogenic | #2789 |
| bone cartilage | #2790 |
| sjogren syndrome | #2791 |
| inbred mrl | #2798 |
| current review | #2798 |
| animal encephalomyelitis autoimmune | #2799 |
| hk | #2801 |
| callithrix | #2804 |
| spleen | #2812 |
| 261 | #2813 |
| neuropathology | #2817 |
| genistein | #2819 |
| alpha | #2821 |
| lack | #2822 |
| activated macrophages | #2825 |
| hyaluronidase | #2830 |
| conventionally | #2831 |
| narrowed | #2832 |
| prl | #2835 |
| olive oil | #2838 |
| demyelinating diseases | #2841 |
| resistant | #2842 |
| hallmark | #2843 |
| glucose uptake | #2846 |
| beta receptor | #2847 |
| beta tgf | #2848 |
| bind | #2848 |
| th1 response | #2852 |
| demyelinating | #2852 |
| polymorphonuclear leukocytes | #2856 |
| phases | #2858 |
| treg cell | #2859 |
| dependent cell | #2859 |
| interleukin receptors | #2864 |
| polymorphonuclear | #2864 |
| antibodies antinuclear | #2864 |
| splenocytes | #2865 |
| characterising | #2865 |
| interleukin33 | #2869 |
| rats inbred strains | #2869 |
| cyanogen bromide | #2874 |
| disease characterized | #2875 |
| guillain | #2875 |
| cells cd8 | #2881 |
| periodontitis | #2882 |
| parvalbumin | #2884 |
| clone cells | #2885 |
| reveals | #2885 |
| exacerbate | #2888 |
| igg iga | #2891 |
| migration inhibitory | #2892 |
| costimulatory molecules | #2895 |
| tgfbeta | #2895 |
| dce | #2896 |
| innate immune responses | #2896 |
| antigens class humans | #2898 |
| dq | #2905 |
| antigen hla | #2907 |
| atp synthase | #2909 |
| enhancement | #2911 |
| linked immunosorbent | #2911 |
| studying | #2918 |
| diseases disease | #2920 |
| shortly | #2920 |
| allogenic | #2921 |
| ergometry | #2921 |
| vaccine development | #2925 |
| steadily | #2925 |
| type lectin | #2926 |
| obvious | #2927 |
| ifn γ | #2931 |
| autoimmune disorder | #2935 |
| dextran | #2939 |
| female flow | #2943 |
| expression macrophages | #2944 |
| injections | #2944 |
| ifn gamma | #2945 |
| proteins peptides | #2946 |
| cd68 | #2947 |
| patients antibodies | #2949 |
| interleukin4 | #2950 |
| cells immune | #2955 |
| eventually | #2956 |
| toll receptor | #2961 |
| cell infiltration | #2962 |
| expressions | #2963 |
| calcium ions | #2964 |
| qtl | #2965 |
| histocytochemistry | #2967 |
| suppressed | #2967 |
| hnrnp | #2980 |
| genetics | #2982 |
| ifn response | #2985 |
| cepacia | #2988 |
| antirheumatic agents | #2993 |
| elusive | #2994 |
| hdac | #2995 |
| thymus gland | #2997 |
| swedish | #2998 |
| respective | #3000 |
| lineage commitment | #3003 |
| indoleamine | #3009 |
| time points | #3009 |
| cells female | #3010 |
| innate | #3014 |
| therapeutic strategies | #3014 |
| illustrating | #3017 |
| anthrax | #3019 |
| interferon ifn | #3020 |
| wild type mice | #3026 |
| defensins | #3027 |
| vdr | #3031 |
| accelerating | #3033 |
| lung inflammation | #3033 |
| macrophage migration | #3036 |
| t‐cell | #3039 |
| endo | #3039 |
| synthetic peptides | #3040 |
| appearance | #3045 |
| quinoxalines | #3047 |
| cd8 | #3048 |
| immunomodulator | #3050 |
| model mice | #3051 |
| longterm treatment | #3052 |
| twin studies | #3053 |
| complex traits | #3055 |
| ppt | #3058 |
| interleukin23 | #3061 |
| profound | #3067 |
| sjögren syndrome | #3069 |
| prevailing | #3073 |
| salivary | #3076 |
| mediated immune | #3077 |
| role cell | #3078 |
| beta | #3080 |
| destruction | #3082 |
| irrespective | #3083 |
| model human | #3083 |
| gene expression profiling | #3086 |
| impairing | #3087 |
| nodes | #3091 |
| glutamic | #3092 |
| inhibitory factors | #3092 |
| parvalbumins | #3093 |
| inbred balb mice | #3098 |
| receptor 4 | #3098 |
| genetic deletion | #3100 |
| detailed description | #3101 |
| postpartum period | #3107 |
| germinal | #3108 |
| antirheumatic | #3109 |
| staphylococcus | #3114 |
| type wt | #3120 |
| neuronal cell | #3123 |
| effects treatment | #3124 |
| suspect | #3127 |
| igm igg | #3130 |
| specificity | #3131 |
| glycans | #3136 |
| monoclonal antibody | #3137 |
| receptors tlrs | #3142 |
| psoriasis | #3142 |
| logarithm | #3146 |
| cd4 cd8 | #3147 |
| preformed | #3151 |
| immune systems | #3152 |
| possibility | #3153 |
| cell activity | #3154 |
| molecule | #3155 |
| propria | #3155 |
| cba | #3164 |
| posttranslational modification | #3167 |
| sjogren | #3171 |
| massively | #3172 |
| accumulated | #3180 |
| precedes | #3185 |
| cell specific | #3185 |
| blockage | #3187 |
| dynorphin | #3191 |
| tissue specific | #3191 |
| pertussis toxin | #3192 |
| adult mice | #3193 |
| cells rats | #3193 |
| keratinocytes | #3194 |
| unravel | #3199 |
| reactivity | #3202 |
| helper | #3204 |
| modified | #3205 |
| ovx | #3208 |
| serum levels | #3210 |
| erbeta | #3211 |
| antiinflammatory | #3211 |
| phagosomes | #3212 |
| nitroarginine | #3212 |
| abs | #3216 |
| publication arthritis | #3224 |
| cells animals | #3224 |
| gpi | #3226 |
| chromosome 1 | #3237 |
| class iii | #3239 |
| clarified | #3242 |
| permitting | #3246 |
| collagenous | #3247 |
| macrophage | #3247 |
| lod score | #3252 |
| bacterial antibodies | #3254 |
| backbone | #3257 |
| nonalcoholic steatohepatitis nash | #3260 |
| female gonadal | #3263 |
| treated animals | #3264 |
| acrylic | #3265 |
| chronic inflammatory | #3267 |
| meps | #3270 |
| immunosorbent assay | #3272 |
| implicate | #3274 |
| proteoglycans | #3278 |
| inflammation interferon | #3278 |
| sch | #3280 |
| nephritis | #3283 |
| arthralgia | #3283 |
| gonadal steroid | #3284 |
| normal rats | #3287 |
| abundantly | #3289 |
| models genetic | #3298 |
| igg1 | #3298 |
| immunoglobulin heavy | #3303 |
| erythematosus | #3305 |
| proteins mice | #3309 |
| adaptations | #3309 |
| elicits | #3314 |
| characterise | #3314 |
| blastocyst | #3315 |
| nociception | #3316 |
| absence | #3318 |
| diseases autoimmune | #3321 |
| beta receptors | #3325 |
| publication animals | #3325 |
| mice protein | #3327 |
| anticardiolipin | #3328 |
| confirmed | #3329 |
| gc cells | #3331 |
| serologically | #3332 |
| suppression | #3338 |
| regional lymph nodes | #3341 |
| macromolecular | #3343 |
| clinical phenotypes | #3345 |
| cd62l | #3353 |
| influenced | #3355 |
| trypanosoma | #3358 |
| akr | #3371 |
| vitamin d3 | #3373 |
| editor | #3377 |
| antinuclear antibodies | #3382 |
| sle | #3384 |
| genetic polymorphisms | #3385 |
| ovariectomy | #3386 |
| mechanistic studies | #3395 |
| macroporous | #3395 |
| levels inflammatory | #3395 |
| explains | #3396 |
| mount | #3397 |
| tubercle | #3402 |
| somatic mutations | #3406 |
| receptors transforming | #3410 |
| early phase | #3413 |
| haptens | #3413 |
| positions | #3418 |
| erythematosus systemic | #3419 |
| nk cells | #3419 |
| neutrophil activation | #3421 |
| reacts | #3421 |
| penetrant | #3425 |
| reply | #3432 |
| receptor type | #3434 |
| proving | #3434 |
| dendritic cells | #3436 |
| serum igg | #3437 |
| alleles | #3440 |
| permitted | #3441 |
| cauda | #3443 |
| 4 months | #3444 |
| injection | #3445 |
| superoxide production | #3446 |
| protein tyrosine | #3447 |
| obscure | #3448 |
| humans immunization | #3448 |
| increased sensitivity | #3449 |
| antimicrobial peptide | #3451 |
| diffusely | #3459 |
| characterised | #3469 |
| h5n1 | #3470 |
| patients sle | #3470 |
| flow cytometry | #3476 |
| modifying | #3477 |
| multimers | #3491 |
| inflammatory mediators | #3491 |
| proteoglycan | #3496 |
| successes | #3497 |
| il21 | #3500 |
| ly | #3501 |
| elucidate | #3503 |
| classical | #3505 |
| developed | #3505 |
| protein processing | #3506 |
| salivary gland | #3507 |
| publication animals animals | #3509 |
| neutrophilic | #3510 |
| pathobiology | #3511 |
| pathological features | #3517 |
| specific cd4 | #3519 |
| globulins | #3526 |
| 267 | #3528 |
| deoxyguanosine | #3528 |
| germline | #3529 |
| phenotypically | #3529 |
| predispose | #3532 |
| micrometer | #3534 |
| lacrimal | #3534 |
| transglutaminases | #3535 |
| radiolabelled | #3539 |
| cyclosporins | #3540 |
| regulatory cells tregs | #3540 |
| mbq | #3541 |
| dominantly | #3548 |
| histological examination | #3554 |
| investigate | #3559 |
| infections staphylococcus | #3561 |
| mast cells | #3563 |
| cultured disease models | #3568 |
| socs1 | #3570 |
| humans interferon | #3571 |
| histological | #3574 |
| homogenate | #3576 |
| gamma | #3580 |
| interesting | #3580 |
| negative patients | #3583 |
| artificially | #3584 |
| role development | #3585 |
| cytolytic | #3589 |
| hindlimb | #3590 |
| il33 | #3593 |
| compared wild | #3597 |
| triggered | #3597 |
| usage | #3601 |
| immunohistochemical staining | #3608 |
| upregulation | #3612 |
| previous findings | #3617 |
| intranasal | #3619 |
| tcr | #3622 |
| cleave | #3624 |
| potential roles | #3624 |
| genetic association | #3629 |
| rp | #3633 |
| attenuate | #3633 |
| mapping chromosomes | #3634 |
| valuable | #3637 |
| genetic | #3637 |
| adhere | #3638 |
| today | #3645 |
| cultured culture media | #3651 |
| allele | #3655 |
| gene deletion | #3657 |
| enhances | #3657 |
| cd4 positive | #3659 |
| exerts | #3663 |
| tolllike receptor | #3665 |
| clinical severity | #3665 |
| luminol | #3667 |
| 95 association | #3671 |
| cd44 | #3678 |
| il23 | #3690 |
| tgf beta | #3691 |
| female genes | #3694 |
| fibronectins | #3697 |
| toll receptors | #3700 |
| igg igm | #3702 |
| heavy chain | #3705 |
| synovitis | #3708 |
| publication animals humans | #3708 |
| cyclohexanecarboxylic | #3709 |
| aggregated | #3717 |
| inbred nod mice | #3730 |
| systemic male | #3735 |
| sequence deletion | #3740 |
| dh | #3742 |
| 378 | #3746 |
| cells produce | #3750 |
| therapeutic benefit | #3752 |
| macrophage cell | #3753 |
| mediate | #3754 |
| contributing | #3754 |
| complement c4 | #3758 |
| immunochemistry | #3759 |
| biomedicine | #3763 |
| type 4 | #3763 |
| lymphocytes tumor | #3766 |
| epitope mapping | #3767 |
| identification | #3771 |
| partum | #3772 |
| mtdna | #3773 |
| d3 | #3775 |
| jakob | #3786 |
| th17 | #3786 |
| reduced expression | #3787 |
| diphtheria | #3803 |
| immunohistochemical | #3805 |
| hind | #3808 |
| skewed | #3820 |
| superoxide | #3822 |
| integrins | #3822 |
| ribonucleoprotein | #3823 |
| new opportunities | #3831 |
| models immunological | #3834 |
| encompassing | #3838 |
| mmp9 expression | #3839 |
| puerperal | #3839 |
| noncoding rna | #3840 |
| unclear | #3847 |
| amelioration | #3854 |
| il17 | #3858 |
| postulate | #3858 |
| identical | #3859 |
| housed | #3861 |
| genetic dna | #3867 |
| cells treg | #3873 |
| genetic promoter regions | #3880 |
| prominent | #3887 |
| kinase2 | #3887 |
| glycoside | #3887 |
| reacting | #3888 |
| dinucleotide | #3894 |
| decreased levels | #3896 |
| synoviocytes | #3900 |
| microsatellite repeats | #3903 |
| superoxides | #3904 |
| dominate | #3907 |
| recognition | #3912 |
| endogenous | #3918 |
| established | #3919 |
| animal studies | #3926 |
| rats messenger | #3931 |
| hladr | #3934 |
| immunophenotyping | #3941 |
| manifestations | #3942 |
| nerves | #3944 |
| toes | #3946 |
| neutrophils | #3947 |
| affect | #3947 |
| polymorphism | #3949 |
| gingivalis | #3957 |
| nets | #3958 |
| mechanisms involved | #3961 |
| involvement | #3973 |
| associate | #3975 |
| disrupted | #3975 |
| 297 | #3982 |
| adult arthritis | #3988 |
| heavy chains | #3992 |
| stimulate | #3992 |
| ifn β | #3999 |
| question | #3999 |
| broader | #4001 |
| patients osteoarthritis | #4009 |
| elevated levels | #4012 |
| sinuses | #4016 |
| superoxide dismutase | #4018 |
| chondrocytes | #4018 |
| individual patients | #4028 |
| ags | #4029 |
| inflammatory processes | #4033 |
| influences | #4034 |
| higher expression | #4034 |
| efficiently | #4050 |
| glycoproteins | #4054 |
| hla alleles | #4059 |
| expression cell | #4063 |
| conferred | #4065 |
| c1q | #4069 |
| fragments | #4072 |
| produce | #4072 |
| hinge | #4074 |
| eliciting | #4075 |
| requirement | #4076 |
| stat4 | #4076 |
| glycoprotein | #4077 |
| plethora | #4077 |
| contrast | #4085 |
| llc | #4089 |
| upregulated | #4090 |
| systemic lupus | #4092 |
| expression type | #4098 |
| fine mapping | #4102 |
| atpases | #4103 |
| leukocyte | #4105 |
| glands | #4107 |
| conferring | #4108 |
| neutrophil | #4113 |
| creutzfeldt | #4115 |
| current concepts | #4116 |
| gelatin | #4120 |
| absent | #4121 |
| therapy genetic | #4122 |
| sclerosis animals | #4124 |
| regulatory cells | #4126 |
| drives | #4126 |
| protect | #4131 |
| mycobacterial | #4133 |
| promoter polymorphism | #4137 |
| stat1 | #4144 |
| functionally | #4147 |
| articular cartilage | #4161 |
| lupus erythematosus | #4162 |
| hla dq | #4165 |
| motor neurons | #4166 |
| polygenic | #4169 |
| placenta pregnancy | #4173 |
| tumour necrosis factor | #4177 |
| stimulatory | #4178 |
| early pregnancy | #4180 |
| immunology | #4183 |
| effector | #4184 |
| systemic disease | #4187 |
| superoxide anion | #4191 |
| infiltrating lymphocytes | #4192 |
| spe | #4193 |
| monocyte | #4201 |
| breeders | #4203 |
| enterotoxin | #4206 |
| ici | #4207 |
| porphyromonas gingivalis | #4207 |
| beads | #4213 |
| antigens cd8 | #4214 |
| animal drug | #4222 |
| depletion | #4223 |
| cytometric analysis | #4224 |
| parathyroid | #4225 |
| long noncoding | #4227 |
| mutant | #4232 |
| inbred balb | #4239 |
| treated mice | #4242 |
| macrophage infiltration | #4244 |
| kidneys | #4244 |
| granulocytic | #4249 |
| chondrosarcoma | #4250 |
| continuously | #4250 |
| witnessed | #4252 |
| conjunction | #4256 |
| immunological | #4257 |
| immunity innate | #4258 |
| bout | #4260 |
| igh | #4262 |
| lymphoid | #4264 |
| cell repertoire | #4268 |
| day1 | #4270 |
| denominator | #4270 |
| complex | #4272 |
| suggestive | #4276 |
| experimental mice | #4285 |
| dermatitis | #4285 |
| clues | #4286 |
| gene targeting | #4290 |
| cd4 | #4291 |
| balb | #4292 |
| disease genetic | #4294 |
| repertoire | #4302 |
| provocation | #4303 |
| molecular modeling | #4303 |
| sciatic | #4307 |
| shares | #4307 |
| tuberculin | #4308 |
| positive cells | #4309 |
| functional role | #4310 |
| receptors interleukin2 | #4317 |
| cell populations | #4317 |
| suppressive effects | #4320 |
| hydroxy2deoxyguanosine | #4331 |
| pparγ | #4350 |
| new insight | #4353 |
| trypanosomiasis | #4358 |
| glutamine | #4364 |
| fungal infection | #4364 |
| peritonitis | #4365 |
| wildtype | #4370 |
| immunoassays | #4373 |
| swelling | #4375 |
| caused | #4381 |
| penetrance | #4381 |
| cell clones | #4396 |
| disease chronic | #4402 |
| mucous | #4402 |
| prevents | #4414 |
| restored | #4417 |
| joint | #4420 |
| modulating | #4426 |
| closer | #4434 |
| receptor beta | #4434 |
| disturbed | #4434 |
| buprenorphine | #4435 |
| model systems | #4443 |
| early | #4453 |
| acute chronic | #4454 |
| aspartic | #4458 |
| parathyroid glands | #4470 |
| confers | #4473 |
| inflammatory pain | #4477 |
| disease duration | #4480 |
| thymocytes | #4481 |
| calmette | #4488 |
| strains rats | #4489 |
| synthase type | #4490 |
| treg | #4493 |
| neutralizing antibodies | #4503 |
| thickened | #4503 |
| human cell | #4505 |
| genetic loci | #4510 |
| extensively | #4516 |
| colitis | #4526 |
| derived cells | #4532 |
| therapeutic implications | #4534 |
| immunotoxins | #4535 |
| beta cells | #4539 |
| cells th2 | #4541 |
| challenged | #4542 |
| lymphocytes cd8 | #4545 |
| 101 | #4546 |
| cytotoxic lymphocytes | #4547 |
| articular chondrocytes | #4553 |
| interleukin5 | #4558 |
| messenger rats rats | #4564 |
| beta cell | #4566 |
| extracellular ca2 | #4576 |
| homing | #4576 |
| hydrolases | #4577 |
| fasl | #4578 |
| cell separation | #4580 |
| proliferative | #4581 |
| neurosecretory | #4585 |
| immunologic | #4592 |
| production inflammatory | #4593 |
| suggests | #4596 |
| inbred shr rats | #4607 |
| modulatory | #4608 |
| igg antibody | #4613 |
| interact | #4613 |
| ros levels | #4613 |
| confer | #4616 |
| depleted | #4639 |
| conditioned medium | #4642 |
| environmental factors | #4643 |
| positive selection | #4658 |
| fashion | #4658 |
| porphyromonas | #4666 |
| visualized | #4667 |
| endorphins | #4669 |
| implicated | #4670 |
| determinant | #4675 |
| causing | #4678 |
| langerhans | #4681 |
| chains | #4681 |
| monocytes macrophages | #4683 |
| animals antigens | #4693 |
| 259 | #4696 |
| female rats | #4699 |
| protecting | #4707 |
| lymph | #4707 |
| inherited | #4709 |
| defined | #4710 |
| destabilization | #4716 |
| facs | #4718 |
| human studies | #4720 |
| orthomyxoviridae infections | #4725 |
| humans inflammation | #4729 |
| cell population | #4734 |
| positive patients | #4736 |
| α1 | #4739 |
| clone | #4741 |
| mediating | #4744 |
| factor 88 | #4750 |
| panel | #4753 |
| gout | #4757 |
| new drugs | #4764 |
| histopathology | #4767 |
| orchiectomy | #4773 |
| cellular localization | #4775 |
| alveolar macrophages | #4776 |
| e4 | #4776 |
| purified | #4778 |
| differing | #4793 |
| eralpha | #4798 |
| male membrane | #4800 |
| rodents | #4801 |
| displaying | #4809 |
| osteoclastogenesis | #4809 |
| hydrolyzed | #4815 |
| tumor antigens | #4816 |
| effector cells | #4819 |
| cytokines | #4821 |
| cd4 cd8 cells | #4821 |
| paw | #4821 |
| cholera | #4822 |
| distinct | #4831 |
| coincides | #4833 |
| litters | #4843 |
| stress rats | #4846 |
| tissue injury | #4847 |
| rats receptors | #4850 |
| interferon γ | #4852 |
| matrix ecm | #4852 |
| stemness | #4860 |
| articular | #4861 |
| venules | #4863 |
| infiltrate | #4868 |
| th17 cells | #4872 |
| tlr2 | #4880 |
| hpa axis | #4882 |
| ifn | #4885 |
| exocrine | #4888 |
| multifactorial | #4889 |
| 116 | #4891 |
| lod | #4892 |
| specific binding | #4893 |
| ige | #4896 |
| humoral immunity | #4897 |
| induced lung | #4899 |
| preimplantation | #4905 |
| essential roles | #4915 |
| discuss | #4916 |
| immunosorbent | #4917 |
| correlating | #4923 |
| interleukins | #4927 |
| deacetylases | #4928 |
| closely | #4932 |
| timepoints | #4940 |
| humans multiple | #4945 |
| deficiency | #4946 |
| naturally occurring | #4962 |
| disease process | #4962 |
| monitored | #4964 |
| elicit | #4966 |
| forelimb | #4967 |
| contradictory | #4975 |
| point mutation | #4976 |
| cell antigen | #4990 |
| understand | #4995 |
| male rats | #4998 |
| kupffer cells | #5001 |
| thymic | #5003 |
| eosinophilia | #5004 |
| innate immune | #5004 |
| modulates | #5011 |
| wt | #5012 |
| isotype | #5012 |
| upa | #5014 |
| opened | #5018 |
| sh3 | #5019 |
| granuloma | #5021 |
| gland | #5024 |
| expand | #5026 |
| enhancing | #5026 |
| vimentin | #5026 |
| poliomyelitis | #5041 |
| explaining | #5042 |
| il5 | #5044 |
| diamines | #5048 |
| heterozygous | #5049 |
| coculture techniques | #5051 |
| cd8 cells | #5055 |
| caveolin | #5065 |
| th1 cells | #5067 |
| linkage | #5067 |
| phospholipid | #5071 |
| arthritis juvenile | #5072 |
| sitedirected mutagenesis | #5076 |
| molecular basis | #5084 |
| cells blood | #5085 |
| bcg | #5086 |
| autologous | #5087 |
| alum | #5087 |
| olive | #5088 |
| new treatment | #5089 |
| multiple sclerosis | #5098 |
| master regulator | #5100 |
| osteopontin | #5109 |
| aged anti | #5110 |
| occurs | #5112 |
| elispot | #5112 |
| sulfasalazine | #5115 |
| isoantibodies | #5120 |
| dq antigens | #5134 |
| contributes | #5139 |
| lesser | #5145 |
| traditionally | #5148 |
| cytosolic | #5152 |
| epidermis | #5158 |
| connection | #5165 |
| cytokines female | #5170 |
| titrated | #5171 |
| preceded | #5175 |
| antigen receptor | #5178 |
| lymphocytes cytotoxic | #5179 |
| binding | #5185 |
| sex characteristics | #5186 |
| transfer | #5187 |
| polymorphism single | #5188 |
| phenotypic | #5191 |
| complement proteins | #5192 |
| molecular level | #5196 |
| ovariectomized | #5210 |
| popliteal | #5224 |
| ers | #5235 |
| serves | #5238 |
| beta2 | #5238 |
| chimeric | #5241 |
| immunosuppressive | #5246 |
| epidermal | #5250 |
| cognate | #5258 |
| mucus | #5258 |
| cd86 | #5261 |
| tested | #5262 |
| deleterious effects | #5266 |
| progenitors | #5270 |
| costimulation | #5275 |
| osteoclast | #5277 |
| detects | #5277 |
| erosion | #5278 |
| prolactin | #5280 |
| therapeutic intervention | #5280 |
| maternally | #5289 |
| gels | #5292 |
| leu | #5294 |
| plasmapheresis | #5298 |
| clinical findings | #5299 |
| key component | #5301 |
| drug humans | #5301 |
| neutralization | #5301 |
| amino | #5310 |
| staphylococcus aureus | #5312 |
| suggestion | #5312 |
| anhydrases | #5315 |
| c57bl 6j | #5320 |
| manner | #5320 |
| spontaneous | #5321 |
| lipopolysaccharides macrophages | #5345 |
| genetic mapping | #5348 |
| ketoglutarate | #5350 |
| opposing | #5352 |
| proinflammatory | #5365 |
| clathrin | #5369 |
| multiplexed | #5371 |
| glomerulonephritis | #5377 |
| modifies | #5379 |
| cultured human | #5386 |
| expansion | #5387 |
| il1α | #5391 |
| tolllike receptors | #5397 |
| oxidation reduction | #5398 |
| new strategies | #5401 |
| positive lymphocytes | #5402 |
| mice molecular | #5402 |
| tnf α | #5411 |
| epigenetic mechanisms | #5417 |
| antiinflammatory agents | #5417 |
| adversely | #5418 |
| fulvestrant | #5420 |
| activation | #5420 |
| dendritic | #5428 |
| antigens surface | #5429 |
| compartments | #5429 |
| signaling molecules | #5432 |
| mif | #5457 |
| cell culture | #5458 |
| wide spectrum | #5473 |
| sideeffects | #5478 |
| multitude | #5482 |
| located | #5499 |
| immunoglobulins | #5500 |
| reproduced | #5507 |
| histological analysis | #5507 |
| lactating | #5515 |
| cytotoxic | #5519 |
| cytokines humans | #5525 |
| balb mice | #5542 |
| therapeutic | #5547 |
| thymus | #5551 |
| immunosuppressive agents | #5559 |
| sexual dimorphism | #5560 |
| pv | #5560 |
| nociceptive | #5565 |
| redox | #5572 |
| cell expansion | #5578 |
| acute lung | #5583 |
| t1d | #5585 |
| percentage | #5588 |
| allergic reactions | #5592 |
| typed | #5596 |
| lipopolysaccharide lps | #5598 |
| potently | #5600 |
| acute lung injury | #5603 |
| oxidase activity | #5613 |
| control animals | #5614 |
| structural homology | #5616 |
| sequence amino | #5621 |
| synthases | #5633 |
| biotinylation | #5642 |
| bead | #5645 |
| pemphigus | #5649 |
| urgent | #5650 |
| type ifn | #5655 |
| proliferative responses | #5658 |
| explants | #5660 |
| abolished | #5660 |
| regarded | #5663 |
| 198 | #5671 |
| directing | #5676 |
| lung mice | #5677 |
| heterotrimeric | #5684 |
| numbers | #5685 |
| antioxidant defense | #5685 |
| aetiology | #5687 |
| triggers | #5689 |
| keratins | #5695 |
| progression disease | #5697 |
| cytokine expression | #5697 |
| skeletal muscle | #5698 |
| experimental animals | #5700 |
| immune mediated | #5710 |
| avenues | #5715 |
| effective treatments | #5735 |
| altogether | #5737 |
| variable | #5759 |
| integrases | #5760 |
| hfd | #5762 |
| ecm | #5776 |
| mechanisms | #5794 |
| mast | #5802 |
| linking | #5808 |
| b16 | #5808 |
| frozen | #5808 |
| inflammatory disorders | #5809 |
| diabetes t1d | #5814 |
| allergic | #5820 |
| splenic | #5829 |
| bal | #5830 |
| hampered | #5832 |
| toxoid | #5835 |
| earliest | #5837 |
| key regulators | #5844 |
| gabapentin | #5847 |
| type receptors | #5850 |
| large proportion | #5851 |
| proteinases | #5862 |
| cfa | #5868 |
| stronger | #5871 |
| disease genotype humans | #5872 |
| hyaluronan receptors | #5875 |
| deleted | #5875 |
| vitro experiments | #5880 |
| microtomography | #5882 |
| single cells | #5896 |
| evidence role | #5898 |
| modulation | #5900 |
| ace2 | #5917 |
| standardization | #5918 |
| abp | #5919 |
| synthetic | #5920 |
| low doses | #5925 |
| bronchoalveolar lavage fluid | #5925 |
| ics | #5932 |
| subclass | #5941 |
| identifying | #5941 |
| genomic regions | #5947 |
| depend | #5947 |
| explain | #5951 |
| interfere | #5953 |
| biobank | #5960 |
| cytokine production | #5962 |
| expression humans | #5965 |
| nerve regeneration | #5966 |
| factor 1 | #5968 |
| avidin | #5970 |
| foxp3 | #5975 |
| costimulatory | #5977 |
| clarify | #5980 |
| symptom onset | #5983 |
| denaturation | #5986 |
| inability | #5988 |
| knee joint | #5990 |
| eosinophils | #5991 |
| cell subset | #6000 |
| immunity | #6010 |
| glyburide | #6010 |
| 88 | #6014 |
| tetanus | #6019 |
| stress induced | #6022 |
| consisting | #6023 |
| fluorescent dyes | #6044 |
| cnvs | #6045 |
| stimulated | #6056 |
| nih | #6065 |
| igm | #6073 |
| tumor infiltrating | #6074 |
| cleared | #6074 |
| laminin | #6075 |
| genetic therapy | #6077 |
| relapsing remitting | #6083 |
| sle patients | #6089 |
| responsible | #6091 |
| undertook | #6097 |
| messengers | #6100 |
| cages | #6103 |
| stat6 | #6105 |
| ligated | #6107 |
| uncoupling | #6115 |
| bone diseases | #6115 |
| telomeric | #6122 |
| infection mice | #6127 |
| unique | #6140 |
| replacing | #6149 |
| plasma cells | #6150 |
| lowers | #6156 |
| inguinal | #6166 |
| responses | #6171 |
| susceptibility gene | #6171 |
| prophylactic | #6183 |
| genomewide association studies | #6193 |
| instances | #6210 |
| cell functions | #6210 |
| models human | #6217 |
| interferon | #6220 |
| translation | #6222 |
| humans lupus | #6235 |
| characterized | #6236 |
| progesterone | #6253 |
| introduction | #6260 |
| cell type | #6265 |
| exclusively | #6269 |
| protective | #6270 |
| microarray | #6272 |
| serum concentration | #6278 |
| sexes | #6280 |
| immune cell | #6285 |
| myelomonocytic | #6286 |
| histone | #6287 |
| biological evaluation | #6290 |
| difficult | #6298 |
| dermis | #6313 |
| sheath | #6316 |
| monolithic | #6318 |
| minor | #6320 |
| allowed | #6320 |
| tracheal | #6322 |
| estrus | #6336 |
| immunomodulatory | #6337 |
| lymphocyte count | #6339 |
| localize | #6347 |
| tumor immune | #6348 |
| remitting | #6355 |
| cell biology | #6355 |
| borrelia burgdorferi | #6355 |
| microsatellite | #6356 |
| virgin | #6356 |
| signs | #6360 |
| tears | #6363 |
| tryptic | #6370 |
| pertussis | #6372 |
| unresolved | #6378 |
| ros generation | #6379 |
| cells cell | #6381 |
| metalloproteinase | #6392 |
| human subjects | #6394 |
| nicotinamide | #6408 |
| registers | #6410 |
| prodromal | #6450 |
| gonadal | #6451 |
| neuropathological | #6454 |
| models molecular | #6455 |
| peritoneum | #6460 |
| express | #6470 |
| biologic | #6473 |
| transgenes | #6474 |
| c4 | #6475 |
| immunity mucosal | #6476 |
| inoculation | #6477 |
| genetic variants | #6477 |
| severe | #6501 |
| gene function | #6502 |
| demonstrates | #6508 |
| organ specificity | #6511 |
| cell numbers | #6513 |
| stages | #6515 |
| chronic | #6523 |
| nitrite | #6523 |
| synergy | #6523 |
| share | #6539 |
| played | #6540 |
| proteins animals | #6559 |
| apc | #6559 |
| antibody titers | #6572 |
| cytotoxicity immunologic | #6575 |
| pace | #6583 |
| proteases | #6588 |
| rheumatic | #6588 |
| toll | #6603 |
| expression genes | #6603 |
| stain | #6604 |
| major source | #6614 |
| translocating | #6615 |
| parturition | #6635 |
| hpa | #6636 |
| whitney | #6639 |
| solid phase | #6644 |
| affinity | #6645 |
| regulation | #6650 |
| parenchyma | #6650 |
| presently | #6651 |
| sclerosis | #6655 |
| memory cell | #6657 |
| cystine | #6658 |
| cells cd4 | #6665 |
| subfamily | #6672 |
| animals antioxidants | #6683 |
| melatonin | #6683 |
| current understanding | #6687 |
| burgdorferi | #6696 |
| macrophages alveolar | #6701 |
| long noncoding rnas | #6715 |
| histone deacetylases | #6742 |
| normal levels | #6747 |
| pups | #6747 |
| estrogens | #6749 |
| demonstration | #6755 |
| relevant | #6761 |
| comparative genomics | #6768 |
| elastase | #6774 |
| cd8 positive | #6776 |
| helpful | #6782 |
| interleukin18 | #6782 |
| cytometric | #6804 |
| demonstrate | #6812 |
| study role | #6813 |
| glucose transport | #6814 |
| crystal structure | #6819 |
| intra articular | #6825 |
| induced acute | #6825 |
| cd19 | #6829 |
| cterminal | #6829 |
| eosinophil | #6829 |
| conflicting | #6830 |
| lname | #6833 |
| antilymphocyte | #6836 |
| molecules | #6840 |
| aspergillosis | #6852 |
| case control | #6852 |
| lymphoid tissues | #6854 |
| periodontal disease | #6855 |
| participates | #6855 |
| vascular endothelium | #6862 |
| sciatic nerve | #6863 |
| alter | #6865 |
| bioreactors | #6867 |
| activating | #6871 |
| facial nerve | #6873 |
| cell communication | #6882 |
| tool | #6883 |
| cytokine release | #6887 |
| lethality | #6889 |
| inflammatory responses | #6893 |
| lung injury | #6900 |
| ankle joint | #6907 |
| harboring | #6908 |
| gastritis | #6915 |
| tumour necrosis | #6921 |
| recessive | #6922 |
| acetaldehyde | #6925 |
| induced pulmonary | #6931 |
| alternative | #6934 |
| microarray analysis | #6937 |
| cyclic | #6951 |
| inflammatory response | #6953 |
| sulfones | #6960 |
| player | #6974 |
| likewise | #6976 |
| exacerbations | #6984 |
| cdr | #6993 |
| equally | #7001 |
| rac1 | #7013 |
| biological function | #7014 |
| mapping | #7016 |
| degrade | #7020 |
| translational | #7020 |
| mimic | #7025 |
| assay elisa | #7033 |
| fewer | #7033 |
| suppressing | #7047 |
| th1 th2 | #7048 |
| histology | #7056 |
| nucleotide | #7060 |
| genome wide | #7063 |
| target cells | #7063 |
| heterogeneous | #7071 |
| aureus | #7072 |
| subjected | #7072 |
| immune cells | #7075 |
| serine proteases | #7082 |
| proportion | #7083 |
| reduced | #7086 |
| glomeruli | #7088 |
| finally | #7092 |
| atherosclerotic lesions | #7094 |
| orthomyxoviridae | #7108 |
| lyme disease | #7115 |
| thp1 cells | #7121 |
| apoptotic cells | #7124 |
| dividing | #7134 |
| mounted | #7137 |
| autophagy | #7144 |
| extracellular | #7153 |
| immunity cellular | #7161 |
| genetic markers | #7162 |
| messenger rats | #7166 |
| cascades | #7175 |
| synteny | #7188 |
| moiety | #7194 |
| promoted | #7198 |
| higher incidence | #7202 |
| lymphoid tissue | #7205 |
| bovine serum albumin | #7219 |
| dependency | #7223 |
| amino acid | #7225 |
| relevance | #7233 |
| mtx | #7237 |
| recognised | #7238 |
| polysaccharides | #7242 |
| sirt1 | #7251 |
| participate | #7253 |
| prevalent | #7262 |
| immuno | #7265 |
| role pathogenesis | #7272 |
| breeding | #7286 |
| inheritance | #7292 |
| rolling | #7300 |
| prime | #7313 |
| dissecting | #7326 |
| avidity | #7332 |
| expressed genes | #7334 |
| adhesins | #7335 |
| inflammasome | #7342 |
| potential targets | #7343 |
| secreted | #7347 |
| disease specific | #7350 |
| uncontrolled | #7353 |
| metalloendopeptidases | #7355 |
| microglobulin | #7363 |
| adulthood | #7369 |
| transduction animals | #7370 |
| oxide nitric | #7377 |
| array | #7387 |
| analyses | #7391 |
| nervous | #7406 |
| transglutaminase | #7410 |
| chemokines | #7411 |
| interleukin6 | #7411 |
| proven | #7418 |
| supernatants | #7428 |
| genotyping | #7446 |
| immunocytochemistry | #7453 |
| fusion protein | #7456 |
| cells peripheral | #7461 |
| β2 | #7467 |
| airways | #7489 |
| adjuvant | #7493 |
| inhibitory factor | #7500 |
| cytotoxic cells | #7518 |
| disease incidence | #7535 |
| anchor | #7536 |
| eliminate | #7540 |
| early disease | #7541 |
| il1 beta | #7545 |
| lesser extent | #7547 |
| interleukin1beta | #7549 |
| necrotic | #7550 |
| activity relationship | #7553 |
| responder | #7562 |
| elevations | #7589 |
| interacting | #7594 |
| micrograms | #7596 |
| hydrocarbon | #7610 |
| appeared | #7610 |
| arginine | #7621 |
| evident | #7628 |
| cytometry | #7630 |
| unexplained | #7632 |
| allogeneic | #7640 |
| peripheral nervous | #7645 |
| sustain | #7654 |
| receptors immunologic | #7659 |
| component | #7661 |
| graft survival | #7661 |
| murine model | #7665 |
| considerable | #7704 |
| histone deacetylase | #7707 |
| placental | #7712 |
| differentially expressed | #7721 |
| chromosomes | #7722 |
| activators | #7728 |
| motifs | #7730 |
| critical roles | #7731 |
| bacterial toxins | #7735 |
| diagnostics | #7735 |
| initiation | #7745 |
| 325 | #7749 |
| rodent | #7751 |
| chain | #7753 |
| granulocyte | #7754 |
| leukocytes mononuclear | #7766 |
| candidate genes | #7769 |
| mer | #7772 |
| activates | #7772 |
| 37°c | #7773 |
| manuscript | #7780 |
| resolving | #7797 |
| carbonic | #7798 |
| cells tregs | #7800 |
| cell surface receptors | #7807 |
| diet fat | #7810 |
| tgf beta1 | #7831 |
| lipopolysaccharides | #7836 |
| patients levels | #7843 |
| strain | #7844 |
| cells pbmcs | #7853 |
| sirtuin | #7854 |
| retinoid | #7862 |
| interleukin1 | #7866 |
| ifnγ | #7872 |
| gene therapy | #7878 |
| amenable | #7895 |
| analyze | #7897 |
| illness | #7901 |
| lymphopenia | #7909 |
| 2nd | #7917 |
| th2 | #7918 |
| fact | #7925 |
| mann | #7929 |
| myocarditis | #7932 |
| discoveries | #7955 |
| cellular immune | #7957 |
| immunodiffusion | #7959 |
| transform infrared | #7960 |
| positive | #7982 |
| nitrites | #7983 |
| candidate gene | #7987 |
| scoring | #7989 |
| tregs | #7991 |
| direct effects | #7991 |
| unknown | #7993 |
| immune function | #7994 |
| oxidative | #7996 |
| fertilized | #8002 |
| identifies | #8007 |
| haplotypes humans | #8011 |
| polymorphisms | #8012 |
| psa | #8015 |
| essential | #8017 |
| hydroxy | #8030 |
| capacity | #8031 |
| raised | #8040 |
| lncrna | #8047 |
| macroscopic | #8049 |
| myeloid differentiation | #8054 |
| respiratory distress | #8063 |
| address | #8064 |
| drive | #8066 |
| evaluation preclinical | #8067 |
| ascertained | #8077 |
| factor signal | #8077 |
| spanning | #8085 |
| hypophyseal | #8087 |
| appearing | #8088 |
| tetramer | #8088 |
| clinical evaluation | #8089 |
| suboptimal | #8101 |
| physiological | #8105 |
| homozygosity | #8108 |
| prolongation | #8108 |
| considerably | #8109 |
| intronic | #8113 |
| prerequisite | #8120 |
| reasons | #8130 |
| bovine | #8133 |
| nash | #8133 |
| latest | #8134 |
| definition | #8141 |
| macrophages peritoneal | #8141 |
| dying | #8148 |
| trachea | #8156 |
| peripheral nerve | #8160 |
| relapses | #8166 |
| conditioned | #8167 |
| elevated | #8167 |
| harbor | #8170 |
| characterize | #8170 |
| bacterial infection | #8176 |
| expression | #8180 |
| member | #8181 |
| induced inflammation | #8186 |
| rescue | #8192 |
| sacrificed | #8197 |
| cassette | #8198 |
| analysing | #8209 |
| underlying | #8214 |
| preferential | #8216 |
| sulphate | #8225 |
| genetic associations | #8225 |
| defective | #8238 |
| ors | #8241 |
| marginal zone | #8244 |
| foster | #8245 |
| wide | #8261 |
| cultured cytokines | #8268 |
| ppar | #8274 |
| fibrinogen | #8275 |
| bone resorption | #8290 |
| clinical manifestations | #8294 |
| disease genome | #8295 |
| differ | #8295 |
| subcutaneous injection | #8300 |
| streptococcal | #8302 |
| oxygen | #8304 |
| combined treatment | #8309 |
| monoester | #8310 |
| remodeling | #8311 |
| aspergillus fumigatus | #8316 |
| peptide1 | #8316 |
| 11 | #8316 |
| genetically modified | #8320 |
| tlr | #8339 |
| cov2 infection | #8349 |
| vh | #8363 |
| boronic | #8363 |
| frequency | #8364 |
| parietal | #8367 |
| firstly | #8379 |
| fibrils | #8388 |
| migrate | #8391 |
| expressed | #8400 |
| residue | #8401 |
| poly | #8401 |
| p001 | #8404 |
| cd11b | #8408 |
| unaffected | #8411 |
| hydrophilicity | #8420 |
| advancement | #8424 |
| notion | #8424 |
| macrophage activation | #8429 |
| highlights | #8433 |
| defense | #8436 |
| viable | #8460 |
| 14 | #8468 |
| lamina | #8472 |
| manifestation | #8482 |
| protein conformation | #8485 |
| damaging | #8500 |
| promotes | #8502 |
| booster | #8512 |
| inflammatory process | #8516 |
| involves | #8520 |
| cells express | #8525 |
| mildly | #8527 |
| phenotype | #8539 |
| drug development | #8539 |
| burkholderia | #8540 |
| forkhead transcription | #8544 |
| human neutrophils | #8545 |
| estradiol | #8546 |
| copy | #8554 |
| tubule | #8558 |
| adaptive | #8568 |
| inflammatory cytokines | #8576 |
| responsive | #8580 |
| cellular functions | #8582 |
| marginal | #8600 |
| productive | #8609 |
| region | #8618 |
| stress reactive | #8622 |
| chickens | #8638 |
| xanthine | #8641 |
| positivity | #8659 |
| uncovered | #8689 |
| inducers | #8705 |
| outline | #8708 |
| experimental mice mice | #8716 |
| vigorous | #8717 |
| constitutive expression | #8717 |
| ccaat | #8720 |
| staphylococci | #8725 |
| regulatory cell | #8734 |
| cytokine | #8750 |
| recovered | #8751 |
| resorption | #8757 |
| rejection | #8759 |
| larynx | #8761 |
| subset | #8775 |
| chemokine receptor | #8777 |
| impaired | #8781 |
| highlight | #8782 |
| promoter | #8789 |
| cells human | #8790 |
| homozygous | #8792 |
| 4 weeks | #8792 |
| generate | #8799 |
| fungal infections | #8807 |
| occasionally | #8808 |
| human serum | #8808 |
| parotid | #8809 |
| chemically | #8809 |
| generates | #8811 |
| female male | #8812 |
| cytokine levels | #8825 |
| correlated | #8830 |
| kupffer | #8836 |
| cell phenotype | #8866 |
| pathway | #8867 |
| precisely | #8877 |
| bovis | #8882 |
| pathways | #8883 |
| unidentified | #8885 |
| frequencies | #8890 |
| deletion | #8893 |
| key regulator | #8903 |
| endopeptidases | #8922 |
| flow cytometric | #8932 |
| hypothalamo | #8941 |
| strengthen | #8941 |
| and or | #8942 |
| staining | #8944 |
| chemiluminescence | #8945 |
| modulate | #8948 |
| pge2 | #8966 |
| pitfalls | #8967 |
| subpopulation | #8967 |
| attack | #8975 |
| neonatal | #8981 |
| gene | #8983 |
| endosomal | #8987 |
| 129 | #8990 |
| vasculature | #9008 |
| rna long | #9017 |
| chemoattractant | #9019 |
| adrenocorticotropic | #9019 |
| discriminate | #9043 |
| thp1 | #9068 |
| leading | #9074 |
| positioned | #9075 |
| specific role | #9081 |
| glut4 | #9084 |
| hl60 | #9115 |
| cd4 cell | #9129 |
| differentially | #9131 |
| human | #9131 |
| cell surface | #9135 |
| pad | #9136 |
| ongoing | #9160 |
| reconstitution | #9166 |
| negative | #9175 |
| causative | #9182 |
| preincubation | #9186 |
| secrete | #9196 |
| tnf | #9198 |
| lethal | #9205 |
| serologic | #9213 |
| respiratory syndrome | #9222 |
| started | #9233 |
| innate immunity | #9233 |
| sequence | #9238 |
| cells isolated | #9241 |
| glomerulus | #9242 |
| immortalized | #9244 |
| severely | #9250 |
| orphan | #9255 |
| offer | #9255 |
| millions | #9268 |
| ubiquitous | #9272 |
| matrix | #9273 |
| killer | #9278 |
| crystal structures | #9313 |
| clear | #9315 |
| smoking status | #9329 |
| sdspage | #9335 |
| copolymers | #9346 |
| carbohydrate | #9368 |
| neutralizing | #9381 |
| immunoblot | #9395 |
| sweden | #9420 |
| functionality | #9425 |
| cysteine | #9458 |
| ifnα | #9459 |
| lacks | #9460 |
| treatment strategies | #9463 |
| immunomodulation | #9473 |
| luminescent | #9474 |
| molecular | #9484 |
| endotoxins | #9487 |
| tlr4 | #9501 |
| immobilized | #9505 |
| immunofluorescence | #9519 |
| cyclosporin | #9519 |
| hormonal | #9519 |
| sensitized | #9523 |
| detrimental | #9524 |
| heritable | #9530 |
| preexisting | #9543 |
| neuroinflammation | #9558 |
| factor beta1 | #9560 |
| interferon regulatory | #9572 |
| regulated | #9576 |
| culture techniques | #9577 |
| analogous | #9593 |
| entering | #9608 |
| affinities | #9614 |
| steroid hormones | #9615 |
| pretreated | #9624 |
| vaccinated | #9638 |
| gestation | #9639 |
| mammalian cells | #9643 |
| attached | #9647 |
| genetic models | #9655 |
| basement membrane | #9657 |
| key | #9658 |
| vehicle | #9670 |
| cell adhesion | #9678 |
| dramatic | #9694 |
| slight | #9694 |
| accessible | #9708 |
| snp | #9709 |
| azathioprine | #9721 |
| ear | #9723 |
| environment interaction | #9730 |
| humanized | #9753 |
| livers | #9753 |
| maintenance | #9756 |
| metabolic syndrome mets | #9758 |
| functional analysis | #9772 |
| blocked | #9776 |
| cleavage | #9781 |
| adhesion cell | #9784 |
| microscopic | #9784 |
| nasal | #9786 |
| plasminogen activator | #9788 |
| structure activity | #9789 |
| infectious | #9804 |
| lowered | #9804 |
| sterile | #9810 |
| driven | #9836 |
| fibronectin | #9846 |
| delineation | #9856 |
| rheumatology | #9870 |
| phage | #9872 |
| memory cells | #9874 |
| nonhuman primates | #9876 |
| pathogens | #9902 |
| serological | #9907 |
| coculture | #9927 |
| interleukin8 | #9936 |
| healthy control | #9938 |
| reactions | #9953 |
| monkeys | #9973 |
| anticipated | #9993 |
| nucleic acids | #10007 |
| flare | #10014 |
| inflammatory cytokine | #10023 |
| genotype | #10053 |
| serum | #10061 |
| leukocytes | #10067 |
| administered | #10070 |
| differentiation factor | #10076 |
| inflammation male | #10091 |
| generating | #10093 |
| surface receptors | #10102 |
| fibrin | #10105 |
| virulence factors | #10110 |
| cells patients | #10110 |
| activated | #10122 |
| ccl4 | #10125 |
| il1beta | #10131 |
| edge | #10132 |
| new strategy | #10136 |
| host cells | #10139 |
| mitogens | #10140 |
| cell signaling | #10143 |
| kappa | #10143 |
| th2 cells | #10147 |
| retroviridae | #10157 |
| postmenopausal | #10172 |
| traps | #10177 |
| hydrogen peroxide | #10184 |
| placenta | #10185 |
| named | #10188 |
| tlrs | #10207 |
| delta | #10218 |
| summarize | #10236 |
| day | #10244 |
| molecular biology | #10259 |
| rats spraguedawley receptors | #10277 |
| arg | #10279 |
| reproducible | #10283 |
| animals anti | #10304 |
| germ | #10305 |
| gene environment | #10307 |
| tendency | #10317 |
| scid | #10324 |
| lectins | #10329 |
| dismutase | #10332 |
| avian influenza | #10343 |
| reductive | #10347 |
| complete | #10365 |
| mediators | #10378 |
| nterminal | #10392 |
| partially | #10400 |
| lasting | #10406 |
| promote | #10424 |
| determine | #10429 |
| cterminus | #10432 |
| refined | #10437 |
| kill | #10441 |
| cattle | #10446 |
| assays | #10447 |
| indirectly | #10460 |
| mediates | #10474 |
| thioredoxin | #10475 |
| occur | #10477 |
| motif | #10479 |
| redundant | #10502 |
| receptor binding | #10504 |
| developing | #10513 |
| behavior animal | #10515 |
| promoter regions | #10545 |
| phosphate | #10548 |
| produced | #10552 |
| exception | #10554 |
| dysregulated | #10557 |
| critical | #10564 |
| influence | #10568 |
| understood | #10572 |
| converting enzyme | #10584 |
| progressive | #10597 |
| rise | #10608 |
| female | #10609 |
| shortened | #10612 |
| small molecule | #10616 |
| nf kappa | #10617 |
| extracellular matrix | #10620 |
| paralysis | #10632 |
| primers | #10636 |
| collectively | #10637 |
| underlie | #10642 |
| testosterone | #10659 |
| macrophage colony | #10664 |
| selective inhibitor | #10667 |
| aged osteoarthritis | #10675 |
| summary | #10684 |
| repeats | #10685 |
| pbs | #10702 |
| respond | #10705 |
| cerebrospinal fluid | #10708 |
| 17 | #10713 |
| disruption | #10729 |
| issue | #10762 |
| conformation | #10767 |
| il18 | #10770 |
| generation | #10781 |
| cleaved | #10800 |
| 103 | #10811 |
| conditional | #10821 |
| capture | #10822 |
| operated | #10824 |
| seropositive | #10826 |
| cellular mechanisms | #10838 |
| saline | #10857 |
| belonging | #10857 |
| restraint | #10864 |
| phosphatase | #10866 |
| immunoblotting | #10872 |
| factor1 | #10880 |
| base | #10885 |
| connective tissue | #10896 |
| multifunctional | #10904 |
| phagocytosis | #10904 |
| avoid | #10909 |
| ineffective | #10909 |
| luciferase | #10915 |
| bronchoalveolar | #10916 |
| promise | #10920 |
| pivotal | #10926 |
| secondary | #10926 |
| mulatta | #10929 |
| mannose | #10934 |
| persisted | #10939 |
| concluded | #10955 |
| methotrexate | #10967 |
| myeloid cells | #10978 |
| airway inflammation | #10982 |
| degrading | #10983 |
| immunoassay | #10984 |
| subcutaneously | #10984 |
| characterization | #10986 |
| governing | #10998 |
| ethanol | #11000 |
| septic | #11000 |
| tnfα | #11003 |
| mpo | #11010 |
| cell subsets | #11012 |
| originally | #11016 |
| 263 | #11027 |
| immunohistochemistry | #11028 |
| occurrence | #11030 |
| scid mice | #11030 |
| messenger | #11037 |
| hyper | #11040 |
| optical imaging | #11045 |
| skin | #11056 |
| establish | #11066 |
| calcitriol | #11067 |
| tumor progression | #11088 |
| paternal | #11094 |
| add | #11096 |
| freezing | #11102 |
| systemic | #11112 |
| infection animals | #11117 |
| focusing | #11144 |
| genetic polymorphism | #11161 |
| innate immune response | #11167 |
| male | #11167 |
| osteoarthritis | #11176 |
| receptors | #11177 |
| subsequent | #11177 |
| influx | #11177 |
| affinity chromatography | #11186 |
| genes involved | #11187 |
| ankylosing spondylitis | #11197 |
| article | #11201 |
| directly | #11208 |
| bsa | #11210 |
| limited | #11223 |
| sorting | #11229 |
| elicited | #11230 |
| interleukin10 | #11232 |
| disulfides | #11233 |
| contributed | #11248 |
| peptidase | #11251 |
| human blood | #11281 |
| ability | #11284 |
| extensive | #11297 |
| humans influenza | #11314 |
| genotyped | #11318 |
| compared controls | #11322 |
| depends | #11323 |
| oxidant | #11344 |
| caution | #11347 |
| addressing | #11351 |
| tissue damage | #11352 |
| correlate | #11354 |
| extra | #11356 |
| histopathologic | #11376 |
| neuroglia | #11384 |
| modifications | #11385 |
| experimental evidence | #11409 |
| increased expression | #11410 |
| pharmacology | #11413 |
| oxidative phosphorylation | #11428 |
| eosinophilic | #11432 |
| interleukin12 | #11437 |
| quantified | #11438 |
| receptor | #11445 |
| hla class | #11447 |
| cell death | #11460 |
| enhance | #11461 |
| reduces | #11466 |
| governed | #11476 |
| initiating | #11479 |
| contrasting | #11480 |
| melanoma cells | #11488 |
| compared healthy | #11489 |
| cd8 cell | #11498 |
| ankle | #11508 |
| serine | #11525 |
| cytosol | #11542 |
| recipient | #11546 |
| ca2 | #11559 |
| therapeutic interventions | #11561 |
| mets | #11566 |
| jurkat | #11569 |
| backgrounds | #11570 |
| inflammatory effects | #11595 |
| culture medium | #11599 |
| differential expression | #11606 |
| alteration | #11627 |
| frequently | #11627 |
| chicken | #11649 |
| swiss | #11652 |
| enhanced | #11661 |
| exerted | #11663 |
| immunologic memory | #11672 |
| transforming growth | #11678 |
| relief | #11691 |
| synergism | #11703 |
| psychotic | #11730 |
| controls | #11730 |
| toxin | #11735 |
| aiming | #11737 |
| innovative | #11751 |
| amyotrophic | #11769 |
| cell lineage | #11773 |
| constitutes | #11774 |
| inoculated | #11781 |
| commentary | #11785 |
| multiple | #11805 |
| selective | #11814 |
| display | #11817 |
| moderately | #11819 |
| altered | #11829 |
| insufficient | #11830 |
| sequence homology | #11840 |
| 9 | #11857 |
| graft | #11866 |
| analogues | #11871 |
| forkhead | #11888 |
| stained | #11890 |
| enzyme | #11942 |
| augmentation | #11943 |
| classic | #11944 |
| supplied | #11946 |
| gastrointestinal tract | #11958 |
| reveal | #11966 |
| animals bone | #11966 |
| maternal fetal | #11968 |
| adherent | #11980 |
| stress response | #11991 |
| contribution | #11998 |
| tgf | #12005 |
| biomarker | #12016 |
| antiserum | #12017 |
| cricetulus | #12021 |
| deacetylase | #12050 |
| encoding | #12051 |
| plasma cell | #12059 |
| aethiops | #12067 |
| propose | #12072 |
| fat diet | #12104 |
| immunologic factors | #12106 |
| downstream | #12107 |
| protection | #12107 |
| il2 | #12111 |
| tyrosine | #12113 |
| lung | #12116 |
| effectively | #12118 |
| replaced | #12144 |
| induced cell | #12147 |
| bromide | #12152 |
| humans | #12155 |
| switched | #12181 |
| quiescent | #12181 |
| genetic vectors | #12203 |
| oligodeoxyribonucleotides | #12204 |
| myd88 | #12222 |
| histologic | #12222 |
| lectin | #12223 |
| therapeutics | #12230 |
| mesenteric | #12231 |
| toxic | #12231 |
| represents | #12233 |
| receptors estrogen | #12236 |
| corticosterone | #12242 |
| noncoding | #12244 |
| diabetic mice | #12257 |
| fibroblasts humans | #12268 |
| recombinant | #12270 |
| splice | #12271 |
| involving | #12273 |
| fluorescent antibody | #12276 |
| mineral | #12297 |
| tnf alpha | #12300 |
| streptococcus | #12310 |
| harmful | #12319 |
| depending | #12361 |
| acid | #12363 |
| leukocyte count | #12369 |
| syndromes | #12371 |
| tradeoff | #12389 |
| interplay | #12412 |
| origin | #12416 |
| clonal | #12420 |
| microfilament | #12423 |
| reversed | #12439 |
| publication adaptor proteins | #12462 |
| weaker | #12464 |
| protein expression | #12503 |
| pain | #12532 |
| hydrochloride | #12535 |
| drug design | #12567 |
| functional | #12573 |
| suppressor | #12596 |
| rats treated | #12596 |
| binding site | #12597 |
| monomeric | #12605 |
| medullary | #12637 |
| cells natural | #12637 |
| explained | #12643 |
| macaca | #12645 |
| notably | #12664 |
| chronic diseases | #12665 |
| fetuses | #12665 |
| adenine | #12679 |
| cdnas | #12679 |
| 6 weeks | #12681 |
| p38 mitogen | #12681 |
| investigation | #12697 |
| instance | #12709 |
| persistent | #12729 |
| alveolar | #12729 |
| receptor alpha | #12743 |
| modulators | #12770 |
| interactions | #12785 |
| aimed | #12791 |
| nature | #12795 |
| influencing | #12800 |
| diminished | #12804 |
| initiated | #12813 |
| tibia | #12813 |
| sole | #12814 |
| metalloproteinases | #12819 |
| thought | #12823 |
| twin | #12854 |
| isolated | #12871 |
| solely | #12882 |
| disadvantages | #12886 |
| sulfhydryl | #12921 |
| sustained | #12922 |
| assay | #12926 |
| breakdown | #12984 |
| cell division | #13004 |
| embryonic development | #13020 |
| damage | #13056 |
| removing | #13067 |
| tryptophan | #13079 |
| tightly | #13087 |
| crystallography | #13101 |
| hyaluronic | #13102 |
| enabling | #13133 |
| time pcr | #13141 |
| publications | #13143 |
| receptors cell | #13145 |
| stereoisomerism | #13158 |
| distress syndrome | #13175 |
| ancestral | #13179 |
| retained | #13203 |
| valine | #13205 |
| division | #13213 |
| suffering | #13215 |
| single nucleotide polymorphisms | #13234 |
| opportunity | #13243 |
| opportunities | #13258 |
| 1 protein | #13270 |
| chemotaxis | #13279 |
| modulator | #13283 |
| lavage fluid | #13293 |
| transgene | #13297 |
| ascending | #13302 |
| regulators | #13320 |
| elucidated | #13323 |
| purity | #13330 |
| bronchoalveolar lavage | #13334 |
| nk | #13353 |
| fisher | #13357 |
| inhibitory effects | #13362 |
| lymphoproliferative | #13372 |
| amyotrophic lateral | #13377 |
| facilitating | #13380 |
| overexpressed | #13383 |
| scattered | #13389 |
| borrelia | #13393 |
| intact | #13410 |
| independently | #13433 |
| thiol | #13434 |
| fibroblast | #13447 |
| oocytes | #13463 |
| embryos | #13465 |
| marrow derived | #13484 |
| spraguedawley receptors | #13488 |
| overcome | #13489 |
| endopeptidase | #13500 |
| aspect | #13523 |
| lateral sclerosis | #13577 |
| tail | #13589 |
| selectively | #13591 |
| lipopolysaccharide | #13598 |
| elisa | #13612 |
| heritability | #13616 |
| vertebrates | #13627 |
| renal disease | #13634 |
| cure | #13674 |
| peripheral | #13689 |
| reproductive | #13755 |
| clones | #13757 |
| requires | #13783 |
| profiling gene | #13808 |
| lavage | #13811 |
| exon | #13822 |
| arising | #13831 |
| secretory | #13835 |
| techniques | #13873 |
| 6 | #13879 |
| killer cells | #13891 |
| exposed | #13917 |
| cloned | #13927 |
| iga | #13936 |
| hepatocytes | #13938 |
| tolerant | #13992 |
| lncrnas | #14002 |
| anti inflammatory | #14010 |
| killed | #14033 |
| selectin | #14034 |
| sensitization | #14035 |
| environmental | #14057 |
| insertion | #14063 |
| recombinant proteins | #14070 |
| neighboring | #14098 |
| reflects | #14102 |
| great | #14120 |
| preclinical | #14123 |
| highlighting | #14145 |
| preventing | #14148 |
| healthy individuals | #14159 |
| administration | #14164 |
| vaccination | #14176 |
| potent | #14183 |
| retroviral | #14208 |
| multigene | #14246 |
| advances | #14275 |
| amino acids | #14298 |
| ester | #14310 |
| oxidative stress | #14315 |
| cord | #14319 |
| incidence | #14322 |
| impairs | #14323 |
| domain | #14325 |
| psychosis | #14326 |
| p38 | #14329 |
| bovine serum | #14329 |
| isolation | #14334 |
| differentiation | #14342 |
| multiprotein | #14366 |
| mineral density | #14406 |
| #14414 | |
| differentiation cells | #14414 |
| resolve | #14420 |
| colony stimulating | #14421 |
| consistently | #14448 |
| paracrine | #14452 |
| kinases animals | #14452 |
| adenoviridae | #14472 |
| chlorocebus | #14481 |
| marrow transplantation | #14485 |
| targeted | #14490 |
| pathology | #14492 |
| il1 | #14500 |
| integrative | #14510 |
| cells vitro | #14537 |
| monocytes | #14540 |
| bone density | #14589 |
| infectious diseases | #14593 |
| biomedical | #14605 |
| nitrate | #14616 |
| nf kappab | #14627 |
| recombinant human | #14632 |
| divergent | #14638 |
| pathological | #14640 |
| enzyme activation | #14658 |
| lupus nephritis | #14661 |
| smoking | #14673 |
| transforming | #14675 |
| gfp | #14681 |
| inborn | #14696 |
| hand | #14698 |
| green fluorescent | #14703 |
| scarce | #14718 |
| risk developing | #14724 |
| substances | #14724 |
| nitrates | #14728 |
| oxide synthase | #14731 |
| p005 | #14732 |
| particulate | #14751 |
| oxidoreductases | #14753 |
| protein binding | #14757 |
| blood vessels | #14759 |
| human cells | #14768 |
| interferon alpha | #14780 |
| il1β | #14800 |
| degenerative | #14815 |
| proteinase | #14817 |
| originating | #14824 |
| vitro | #14829 |
| overlapping | #14835 |
| biocompatible | #14851 |
| prostaglandins | #14881 |
| controlled | #14895 |
| interaction | #14916 |
| chronically | #14923 |
| genomic dna | #14929 |
| potential therapeutic | #14939 |
| colleagues | #14950 |
| plays | #15011 |
| cross | #15041 |
| implications | #15063 |
| escape | #15078 |
| granule | #15079 |
| receptor gene | #15089 |
| phosphoric | #15090 |
| converting | #15126 |
| acute respiratory | #15173 |
| spinal cord | #15185 |
| seroepidemiologic | #15205 |
| bmd | #15213 |
| proliferation cells | #15219 |
| covalently | #15234 |
| preferentially | #15252 |
| adhesion | #15299 |
| fetus | #15300 |
| processed | #15329 |
| allografts | #15337 |
| synthase | #15339 |
| bone mineral density | #15340 |
| accelerate | #15346 |
| neurodegenerative | #15377 |
| pretreatment | #15379 |
| blood mononuclear | #15414 |
| interleukin6 il6 | #15440 |
| comparative | #15474 |
| selected | #15486 |
| antigens bacterial | #15511 |
| cells dcs | #15513 |
| locally | #15521 |
| transcriptase polymerase | #15530 |
| influenza human | #15537 |
| basis | #15540 |
| hormone | #15542 |
| central nervous | #15566 |
| estrogen receptor | #15572 |
| transduction | #15579 |
| vaccines | #15623 |
| responsiveness | #15647 |
| rna interference | #15649 |
| binds | #15651 |
| accelerator | #15673 |
| limitation | #15675 |
| pyruvate | #15682 |
| sequenced | #15696 |
| conformational | #15701 |
| cd28 | #15708 |
| connective | #15748 |
| gastric | #15775 |
| single | #15789 |
| fluorescent | #15793 |
| bone loss | #15832 |
| induced expression | #15835 |
| protein structure | #15849 |
| spinal | #15861 |
| vasculitis | #15884 |
| treating | #15887 |
| kappab | #15894 |
| gcsf | #15908 |
| competitive | #15910 |
| positron emission | #15913 |
| downregulation | #15914 |
| systemic inflammation | #15944 |
| neurodegeneration | #15945 |
| methylated | #15945 |
| involve | #15980 |
| ap1 | #15985 |
| plasmon resonance | #15986 |
| reflected | #15993 |
| chromatographic | #16019 |
| cnv | #16065 |
| oligonucleotide array | #16092 |
| 106 | #16097 |
| responding | #16105 |
| pluripotent | #16135 |
| bone mineral | #16141 |
| undetectable | #16148 |
| skeletal | #16151 |
| neurons | #16154 |
| tissue distribution | #16155 |
| disequilibrium | #16156 |
| beta1 | #16172 |
| exhibited | #16189 |
| response treatment | #16236 |
| grafted | #16238 |
| array sequence | #16239 |
| glandular | #16252 |
| functional studies | #16273 |
| responders | #16278 |
| new class | #16282 |
| subunit | #16293 |
| required | #16309 |
| animals base | #16310 |
| subclinical | #16311 |
| linkage disequilibrium | #16342 |
| receptor signaling | #16351 |
| difference | #16367 |
| remarkably | #16382 |
| molecular structure | #16391 |
| form | #16409 |
| signalling | #16414 |
| molecular mechanism | #16419 |
| publication antibodies | #16433 |
| cd40 | #16468 |
| shr | #16471 |
| capable | #16496 |
| grouped | #16512 |
| subcutaneous | #16522 |
| fibroblasts | #16525 |
| revealing | #16544 |
| targeting | #16552 |
| respiratory | #16585 |
| node | #16585 |
| organs | #16586 |
| tumor cells | #16600 |
| antibodies bacterial | #16603 |
| subunits | #16626 |
| profiling | #16651 |
| necrosis | #16655 |
| establishing | #16709 |
| negatively | #16709 |
| uric | #16743 |
| irradiated | #16757 |
| nick | #16765 |
| intramolecular | #16795 |
| deeper | #16801 |
| instrumental | #16812 |
| detected | #16851 |
| immunoreactive | #16859 |
| clinically | #16859 |
| serve | #16878 |
| inhibitory | #16881 |
| documented | #16904 |
| greatly | #16907 |
| colony | #16928 |
| turn | #16941 |
| immunosuppression | #16942 |
| mmps | #16957 |
| inhibition | #16959 |
| receptor 1 | #16964 |
| additionally | #16970 |
| humans hydrogen | #16982 |
| structurally | #16985 |
| prior | #16994 |
| additional | #17005 |
| binding protein | #17006 |
| recombinant fusion | #17013 |
| sulfate | #17069 |
| b7 | #17077 |
| count | #17083 |
| il12 | #17096 |
| sex factors | #17111 |
| consist | #17113 |
| minimal | #17116 |
| alpha subunit | #17119 |
| lysosomal | #17126 |
| unexpected | #17137 |
| tissue | #17148 |
| pluripotent stem | #17151 |
| receptors tumor | #17172 |
| csf | #17185 |
| activator | #17202 |
| lymph node | #17208 |
| underlying mechanisms | #17217 |
| stimulation | #17249 |
| starting | #17298 |
| peritoneal | #17299 |
| cell proliferation | #17318 |
| fluid | #17330 |
| propensity | #17345 |
| generations | #17377 |
| humans immunity | #17410 |
| constitute | #17425 |
| demonstrated | #17444 |
| membrane | #17466 |
| muscle skeletal | #17479 |
| types | #17505 |
| allowing | #17505 |
| fibrous | #17515 |
| transcriptase | #17515 |
| type iii | #17546 |
| localization | #17547 |
| constitutive | #17559 |
| cytometry humans | #17570 |
| discovery | #17583 |
| treatments | #17596 |
| peripheral blood | #17615 |
| variation | #17616 |
| packed | #17678 |
| differed | #17683 |
| expanded | #17687 |
| proved | #17691 |
| plasmon | #17698 |
| longitudinally | #17713 |
| pbmcs | #17728 |
| stimulating factor | #17743 |
| somatic | #17805 |
| inflammatory bowel disease | #17815 |
| dcs | #17827 |
| relating | #17861 |
| alpha tnf | #17880 |
| neuroendocrine | #17920 |
| oligonucleotide | #17954 |
| homology | #17962 |
| surface plasmon | #17971 |
| pregnancy | #17985 |
| chromosomal | #17994 |
| post | #17998 |
| inhibit | #18002 |
| labelled | #18004 |
| damaged | #18064 |
| osmolar | #18107 |
| 2 4 | #18130 |
| creating | #18142 |
| cytoplasm | #18155 |
| released | #18157 |
| trigger | #18161 |
| corticosteroids | #18164 |
| species | #18168 |
| endocrine | #18192 |
| vertebrate | #18206 |
| labeled | #18208 |
| subcellular | #18231 |
| rna messenger | #18235 |
| protein serine | #18279 |
| limiting | #18281 |
| reverse transcriptase | #18325 |
| evidenced | #18329 |
| truncated | #18336 |
| avian | #18345 |
| net | #18345 |
| males | #18375 |
| critically | #18389 |
| assumed | #18433 |
| modulated | #18444 |
| rats wistar | #18448 |
| pathogen | #18464 |
| immunogenicity | #18486 |
| acids | #18490 |
| reaching | #18494 |
| nonparametric | #18512 |
| constitutively | #18518 |
| processing | #18609 |
| hyaluronan | #18609 |
| sulfonamides | #18643 |
| investigating | #18651 |
| 15 | #18656 |
| 22 | #18658 |
| verify | #18669 |
| signal transduction | #18682 |
| agents steroidal | #18685 |
| remaining | #18721 |
| aim | #18788 |
| cerebrospinal | #18788 |
| created | #18803 |
| balanced | #18823 |
| cultured | #18823 |
| carry | #18829 |
| pathophysiological | #18830 |
| production | #18927 |
| nerve | #18943 |
| nested | #18957 |
| nfκb | #18987 |
| failed | #18988 |
| sequence analysis | #19002 |
| specific antigen | #19050 |
| observations | #19062 |
| provided | #19067 |
| bone marrow | #19084 |
| lungs | #19111 |
| stimulating | #19136 |
| protein | #19164 |
| bearing | #19167 |
| publication administration | #19185 |
| gained | #19200 |
| mitochondrial | #19260 |
| symptoms | #19288 |
| lost | #19298 |
| majority | #19304 |
| intra | #19311 |
| interacts | #19344 |
| hormones | #19441 |
| fatal | #19464 |
| interferons | #19489 |
| analyzing | #19515 |
| exogenous | #19526 |
| adrenal | #19553 |
| cytoskeletal | #19553 |
| rapidly | #19574 |
| inducible | #19616 |
| etiology | #19652 |
| environment | #19668 |
| implanted | #19680 |
| lps | #19681 |
| mice scid | #19683 |
| vesicular | #19701 |
| lineage | #19719 |
| markers | #19789 |
| histologically | #19817 |
| offers | #19826 |
| cutaneous | #19834 |
| precise | #19836 |
| pharmacological | #19854 |
| fetal | #19862 |
| shifted | #19875 |
| newly | #19892 |
| supporting | #19915 |
| vitro techniques | #19945 |
| yielded | #19948 |
| 8 | #19978 |
| 28 | #19979 |
| cns | #19979 |
| response relationship | #20014 |
| transient | #20038 |
| modify | #20055 |
| designated | #20056 |
| reverse | #20057 |
| casecontrol study | #20088 |
| mutagenesis | #20118 |
| illustrated | #20126 |
| downregulated | #20133 |
| ultimately | #20202 |
| κb | #20256 |
| 1 diabetes | #20263 |
| hypothalamic | #20285 |
| primary | #20303 |
| entered | #20310 |
| nitric | #20316 |
| gene expression | #20364 |
| markedly | #20453 |
| genotype humans | #20460 |
| mature | #20491 |
| microglia | #20561 |
| circulating | #20574 |
| overexpressing | #20593 |
| human pair | #20604 |
| polyacrylamide | #20612 |
| marrow | #20651 |
| defining | #20660 |
| pregnant | #20665 |
| equal | #20678 |
| resting | #20729 |
| injured | #20739 |
| mild | #20819 |
| local | #20825 |
| discovered | #20835 |
| cricetinae | #20839 |
| reduction | #20847 |
| illustrate | #20874 |
| lactic | #20908 |
| hypothesized | #20913 |
| tended | #20919 |
| successful | #20952 |
| 10 | #20952 |
| cell derived | #20955 |
| aberrant | #20961 |
| animals biomarkers | #21033 |
| 2 | #21085 |
| attractive | #21228 |
| acute | #21279 |
| produces | #21297 |
| transfected | #21316 |
| marked | #21340 |
| decreased | #21383 |
| maternal | #21389 |
| emerged | #21445 |
| survived | #21524 |
| confirms | #21558 |
| membrane proteins | #21585 |
| forming | #21593 |
| preserved | #21732 |
| contained | #21802 |
| previous | #21805 |
| 16 | #21813 |
| doses | #21835 |
| immunodeficiency | #21852 |
| electrophoresis | #21867 |
| mellitus type | #21871 |
| natural killer | #21877 |
| cell count | #21898 |
| prolonged | #21903 |
| heavy | #21965 |
| increasing | #21979 |
| polymeric | #22042 |
| gradually | #22067 |
| glial | #22202 |
| selecting | #22242 |
| extremely | #22248 |
| 4 | #22274 |
| opportunistic | #22307 |
| accepted | #22356 |
| emission tomography | #22395 |
| enable | #22402 |
| humans models | #22445 |
| initially | #22458 |
| microscopy confocal | #22466 |
| physiologic | #22470 |
| appears | #22488 |
| releasing | #22497 |
| suitable | #22522 |
| humans immunosuppressive | #22529 |
| confirm | #22553 |
| chemokine | #22558 |
| metabolic | #22585 |
| actins | #22597 |
| loss | #22611 |
| nf | #22756 |
| reactive protein | #22834 |
| utilizing | #22899 |
| transformed | #22917 |
| progression female | #22918 |
| detailed | #23005 |
| natural | #23089 |
| cell types | #23132 |
| sex | #23234 |
| null | #23277 |
| untranslated | #23305 |
| signaling | #23324 |
| syndrome | #23335 |
| bone | #23397 |
| necrosis factor | #23407 |
| rich | #23430 |
| cells tumor | #23467 |
| nucleic | #23501 |
| continued | #23663 |
| cellular | #23667 |
| expression gene | #23728 |
| attenuated | #23757 |
| mitogen | #23814 |
| serine threonine | #23835 |
| examine | #23864 |
| fusion proteins | #23968 |
| organ | #23990 |
| remained | #23998 |
| prevent | #24026 |
| confined | #24245 |
| oxidized | #24325 |
| called | #24330 |
| discussed | #24334 |
| genomic | #24394 |
| covering | #24485 |
| embryonic | #24490 |
| interleukin | #24583 |
| varying | #24640 |
| weeks | #24698 |
| mechanistic | #24796 |
| putative | #24897 |
| detect | #24963 |
| sarcoidosis | #24963 |
| remains | #25082 |
| controversial | #25175 |
| implies | #25192 |
| stromal | #25269 |
| type 1 diabetes | #25410 |
| enriched | #25470 |
| relation | #25543 |
| attributed | #25618 |
| 7 | #25632 |
| proteins | #25644 |
| tumor necrosis | #25683 |
| dysregulation | #25711 |
| cytoplasmic | #25732 |
| inflammatory agents | #25735 |
| energetic | #25813 |
| healthy | #25887 |
| representing | #25917 |
| challenging | #25976 |
| threonine | #25988 |
| mechanisms underlying | #26094 |
| signal | #26163 |
| tnfalpha | #26432 |
| frequent | #26487 |
| individuals | #26568 |
| antibodies viral | #26579 |
| growth factor | #26602 |
| validated | #26686 |
| lower | #26708 |
| treat | #26713 |
| 3 | #26751 |
| tolerated | #26780 |
| pathophysiology | #26782 |
| explored | #26850 |
| tumor necrosis factor | #26925 |
| comparable | #26955 |
| normal | #27016 |
| define | #27055 |
| exist | #27121 |
| presented | #27123 |
| consists | #27152 |
| intracellular | #27233 |
| invariant | #27331 |
| animals cells | #27339 |
| adaptor proteins | #27447 |
| chromosomes human | #27524 |
| associations | #27560 |
| kda | #27648 |
| tract | #27680 |
| possess | #27765 |
| exclude | #27824 |
| cell tumor | #27826 |
| attributable | #28018 |
| proteins humans | #28150 |
| heterozygote | #28266 |
| treated | #28436 |
| observe | #28472 |
| remain | #28560 |
| regulation humans | #28667 |
| threonine kinases | #28809 |
| hypothesis | #28819 |
| require | #28838 |
| examined | #29041 |
| infection | #29082 |
| 5 | #29247 |
| animals apoptosis | #29491 |
| intracellular signaling | #29517 |
| easily | #29557 |
| effective | #29656 |
| 005 | #29706 |
| fully | #29936 |
| exhibit | #29947 |
| gtp binding | #29997 |
| intravenous | #30185 |
| cell movement | #30520 |
| oxide | #30546 |
| reached | #30655 |
| active | #30908 |
| versus | #30963 |
| 1 | #31228 |
| cell differentiation | #31374 |
| vary | #31548 |
| blotting western | #31843 |
| free | #32409 |
| expression regulation | #32516 |
| needed | #32543 |
| objectives | #32805 |
| generally | #33368 |
| inhibited | #33394 |
| clinical | #33439 |
| sought | #34008 |
| reduce | #34128 |
| biological | #34247 |
| reflect | #34701 |
| separately | #34818 |
| agents | #34868 |
| assess | #34935 |
| polymerase | #35201 |
| nuclear | #35715 |
| polymerase chain | #36180 |
| formed | #36819 |
| chain reaction | #36949 |
| 001 | #36954 |
| measured | #42007 |
Open the FULL List in Excel | |
Prominent publications by Rikard Holmdahl
KOL-Index: 15284
The purpose of the study was to map the dominant T cell epitope of the CB11 sequence of CII in RTlu haplotype rats and to determine if, when used as a synthetic peptide, it would induce tolerance to protect against CIA. A dominant epitope corresponding to residues 184-198 included in the sequence of the CB11 fragment of bovine CII was identified in proliferation assay using peptides in an epitope scanning system using synthetic peptides of 15 amino acids, overlapping by 12 amino acids. ...
| Known for Mucosal Tolerance | Synthetic Peptide | Cell Epitope | Cia Cii | Collagen‐induced Arthritis |
KOL-Index: 14658
An antibody response to defined epitopes located on the triple helical portion of type II collagen (CII) is associated with the development of collagen-induced arthritis (CIA) and rheumatoid arthritis (RA). Monoclonal antibodies to epitopes associated with arthritis, but not antibodies specific for epitopes not associated with arthritis, induce arthritis in mice, the so-called collagen antibody induced arthritis (CAIA) model. We have selected monoclonal IgG antibodies specific for four ...
| Known for Collagen Antibody | Induced Arthritis | Monoclonal Antibodies | Mice Inbred | Specific Epitopes |
KOL-Index: 13984
The Aq major histocompatibility complex (MHC) class II molecule is associated with susceptibility to murine collagen-induced arthritis (CIA), whereas the closely related H-2Ap molecule is not. To understand the molecular basis for this difference, we have analyzed the ability of H-2Aq and H-2Ap molecules (referred to as Aq and Ap) to bind and present collagen type II (CII)-derived glycosylated and non-glycosylated peptides. T cell clones specific for the immunodominant CII 256-270 ...
| Known for Collagen‐induced Arthritis | Transgenic Models | Aq Molecule | Structural Basis | C3h Mice |
KOL-Index: 13727
BACKGROUND: Autoantibodies to cyclic citrullinated peptides (anti-CCP) are present in most patients with rheumatoid arthritis (RA), and associate with HLA-DRB1 shared epitope (SE) alleles.
OBJECTIVE: To investigate reactivities of anti-CCP to various citrullinated proteins/peptides, which represent potential autoantigens in RA, and to examine the relationship between such antibodies, and their association with genetic variants within HLA-DRB1 SE alleles.
METHODS: Serum samples from 291 ...
| Known for Citrullinated Antigens | Rheumatoid Arthritis | Drb1 Alleles | Ccp Patients | Antibody Reactivities |
Localization of a critical restriction site on the I-A beta chain that determines susceptibility to collagen-induced arthritis in mice
[ PUBLICATION ]
Type II collagen-induced arthritis (CIA) in mice is an autoimmune experimental model for rheumatoid arthritis. Susceptibility to CIA is associated with certain major histocompatibility complex class II haplotypes. The two very closely related haplotypes H-2q and H-2p differ in susceptibility to CIA. Only mice of H-2q (DBA/1, B10G strains) but not mice of H-2p-expressing strains (like strain B10P) develop CIA and an autoimmune response to type II collagen (CII) after immunization with ...
| Known for Mice Cia | Beta Chain | Rheumatoid Arthritis | H2q Haplotype | Type Collagen Cii |
KOL-Index: 13513
INTRODUCTION: It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent ...
| Known for Citrullinated Peptides | Onset Symptoms | Development Rheumatoid Arthritis | Combination Acpa | Hlase Smoking |
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients
[ PUBLICATION ]
OBJECTIVE: High titers of specific anti-citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well-defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their ...
| Known for Citrullinated Antigens | Synovial Fluid | Rheumatoid Arthritis Patients | Type Collagen | Antibodies Acpas |
Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats
[ PUBLICATION ]
INTRODUCTION: Toll-like receptors (TLRs) are involved in both innate and adaptive immune responses and are likely to play a complex role in the pathogenesis of human rheumatoid arthritis (RA) and experimental arthritis. The objective of this study was to identify the key TLR in pristane-induced arthritis (PIA), a rat model for RA, and to clarify its roles in the initiation and maintenance of arthritis.
METHODS: Arthritis in DA rats was induced by pristane and the severity was evaluated ...
| Known for Induced Arthritis | Tlr3 Expression | Rats Pristane | Receptor 3 | Inbred Strains Severity |
KOL-Index: 12776
Multiple sclerosis (MS) is a complex chronic neurologic disease with a suspected autoimmune pathogenesis1,2. Although there is evidence that the development of MS is determined by both environmental influences and genes, these factors are largely undefined3,4, except for major histocompatibility (MHC) genes. Linkage analyses and association studies have shown that susceptibility to MS is associated with genes in the human histocompatibility leukocyte antigens (HLA) class II region, but ...
| Known for Multiple Sclerosis | Transgenic Mice | Hla Dr2 | Humanized Model | Spontaneous Disease |
KOL-Index: 12721
Polymorphism of the major histocompatibility complex (MHC) influences susceptibility to experimental autoimmune encephalomyelitis (EAE) induced by myelin basic protein (MBP) in rats. Current concepts relate such influences to the capacity of class II molecules to present relevant peptides to autoreactive T cells. We have here analyzed the MHC influence on the immune response and the development of EAE after immunization with the immunodominant peptide MBP-63-88. Analysis of MHC-congenic ...
| Known for Myelin Basic Protein | Experimental Autoimmune | Major Histocompatibility | Rats Eae | Immune Response |
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
[ PUBLICATION ]
OBJECTIVE: The presence of antibodies against cyclic citrullinated peptides has been demonstrated to precede the onset of symptoms of rheumatoid arthritis (RA) by several years. The aim of this study was to analyze antibodies against 10 citrullinated autoantigen-derived peptides for reactivity before the onset of RA symptoms.
METHODS: A case-control study was conducted within the Medical Biobank of Northern Sweden. The study was performed in 409 individuals, 386 of whom donated 717 blood ...
| Known for Citrullinated Peptides | Rheumatoid Arthritis | Onset Symptoms | Antibodies Cep1 | Type Collagen |
KOL-Index: 12510
Antibodies against type II collagen (anti-CII) are arthritogenic and have a crucial role in the initiation of collagen-induced arthritis. Here, we have determined the dependence of T and B cells in collagen-antibody-induced arthritis (CAIA) during different phases of arthritis. Mice deficient for B and/or T cells were susceptible to the CAIA, showing that the antibodies induce arthritis even in the absence of an adaptive immune system. To determine whether CII-reactive T cells could have ...
| Known for Collagen Type | Arthritis Mice | Antigen Tcell | Antibodies Cii | Adaptive Immune |
KOL-Index: 12427
The nonobese diabetic (NOD) mouse spontaneously develops autoimmune-mediated diseases such as diabetes and Sjögren's syndrome. To investigate whether NOD genes also promote autoimmune-mediated arthritis we established a NOD strain with an MHC class II fragment containing the A(q) class II gene predisposing for collagen induced arthritis (NOD.Q). However, this mouse was resistant to arthritis in contrast to other A(q) expressing strains such as B10.Q and DBA/1. To determine the major ...
| Known for Genetic Control | Complement Factor | Induced Arthritis | Locus Chromosome | Mice Inbred |
Key People For Rheumatoid Arthritis
Top KOLs in the world
Select a search phrase rheumatoid arthritis , rheumatoid arthritis patients , rheumatoid arthritis treatment , rheumatoid arthritis risk , rheumatoid arthritis study
Rikard Holmdahl:Expert Impact
Concepts for whichRikard Holmdahlhas direct influence:Rheumatoid arthritis, Induced arthritis, Experimental arthritis, Collagen type, Type collagen, Animal models, Reactive oxygen species, Autoimmune diseases.
Rikard Holmdahl:KOL impact
Concepts related to the work of other authors for whichfor which Rikard Holmdahl has influence:Rheumatoid arthritis, Multiple sclerosis, Autoimmune diseases, Oxidative stress, Animal models, Reactive oxygen species, Nadph oxidase.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |